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Abstract 
 
A selection of twelve non-dietary plants were subjected to Soxhlet extraction with n-hexane 
and methanol and the crude extracts were screened for Nrf2 induction potential using a 
AREc32 cell-based luciferase gene reporter assay. Screening for free-radical scavenging 
activity using the DPPH assay was also performed. The highest increase in Nrf2 induction 
was achieved by the methanol extract of Centaurea dichroa Boiss.& Heldr. (CD-Me, 250 
µg/ml), with a 22.7-fold to control induction, followed by the n-hexane extract of Solanum 
anguivi Lam. (SA-He, 100 µg/ml), with 20.2-fold to control induction.The Nrf2/ARE signaling 
pathway was also up-regulated by two other methanol extracts, of Centaurea pamphylica 
Boiss. & Heldr. (CP-Me, 100 µg/ml) and Gardenia ternifolia Schumach. & Thonn. (GT-Me, 
750 µg/ml), with 11.22-fold and 8.94-fold to control luciferase induction, respectively. The 
bioassay guided investigation led to further fractionation of the bioactive methanol extracts 
so that the less polar methanolic fractions F3 and F4 of CP-Me and GT-Me increased Nrf2 
activity more than their respective crude extracts; up to 12.6 - 13.4-fold for CP-Me fractions, 
and up to 11.6 – 12.6-fold for GT-Me fractions. Moreover, compounds isolated from the 
bioactive fractions indicated flavonoid type structures, identifying sakuranetin for the first time 
in Gardenia ternifolia Schumach.& Thonn. Stachyose, mannitol and betulinic acid were also 
identified as precipitates from solvent extraction. Because of limited amount of material, 
various types of flavonoids such as flavones, flavanones and flavonols were purchased with 
the purpose of screening them for Nrf2 activity in AREc32 cells. The flavonoids alone 
increased the luciferase activity to no more than 3.1-fold (hesperetin, 40 µM), with most 
reaching slightly above 2-fold induction, indicating a possible synergy in the way of action of 
the natural products since mixtures of compounds showed higher bioactivity in the same 
assay. Fractions F3 of CP-Me and GT-Me showed the highest free radical-scavenging 
potential in the DPPH assay, with IC50 values of 0.072 mg/ml and 0.132 mg/ml respectively 
(IC50 exerted by positive control quercetin was 0.005 mg/ml). Finally, all flavonoids tested 
offered protection against oxidative stress induced by ethacrynic acid (ETA) in MCF-7 cells 
(LD50=68.5 µM), with the flavone velutin (2.5 µM) and flavanone sakuranetin (20 µM) 
increasing the LD50 of ETA more than 200 times, while all flavonoid pretreatment conditions 
generally increased the LD50 of ETA more than 9 times. 
 
  
7 
 
Declaration 
 
 
I declare that no portion of the work referred to in the thesis has been submitted in support 
of an application for another degree or qualification of this or any other university or other 
institute of learning. 
 
 
 
Alexandra-Georgiana Zavoianu 
 
 
 
 
 
 
 
 
 
 
 
 
  
8 
 
List of Abbreviations 
ACF aberrant crypt foci 
AOM azoxymethane 
ARE/EpRE antioxidant-responsive element/electrophile-responsive element  
tBHQ tert-butylhydroquinone 
CAN acetonitrile 
COX1 cyclooxygenase-1 
COX-2 cyclooxygenase-2 
DCM dichloromethane 
DPPH 2,2-diphenyl-1-picrylhydrazyl 
ETA ethacrynic acid 
EtOAc ethyl acetate 
EtOH ethanol 
GCL glutamate-cysteine ligase 
GPx glutathione peroxidase 
GSH glutathione 
GST glutathione S-transferase 
HMOX-1/HO-1 heme oxygenase 1 
Keap 1 Kelch-like ECH-associated protein 1 
MAPK mitogen-activated protein kinase 
MeOH methanol 
MMP-9 matrix metalloproteinase-1 
MS Mass Spectrometry 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
NAD(P)H nicotine adenine dinucleotide phosphate 
  
9 
 
NMR Nuclear Magnetic Resonance 
NQO1 NAD(P)H dehydrogenase (quinone 1) 
Nrf2 nuclear factor erythroid 2-related factor 2 
PG prostaglandins 
PKC protein kinase C 
RhoA Ras homolog family member A 
RT room temperature 
SFN sulforaphane 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
10 
 
List of Tables 
Table 1 Fruits and vegetables intake associated with a decreased risk of various types of 
cancer. Adapted from Turati et al. 2015 ............................................................................ 28 
Table 2 Chemical structures of some dietary flavonoids with cancer chemoprevention 
properties .......................................................................................................................... 43 
Table 3 Subclasses of terpenoids and their chemopreventive properties (Source: Huang et 
al. 2012) ............................................................................................................................ 52 
Table 4 Amounts of plant materials used for Soxhlet extraction ........................................ 72 
Table 5 SPE solvent gradient steps................................................................................... 74 
Table 6 Preparative HPLC gradient method ...................................................................... 76 
Table 7 Polyphenolic phytochemicals used in bioassays and their chemical structure. 
Structures generated in ChemDraw .................................................................................. 77 
Table 8 Code names of plant extracts and fractions .......................................................... 79 
Table 9  Concentrations (µM) of bioactive compounds used, with tBHQ as positive control
 .......................................................................................................................................... 83 
Table 10 Summary of crude extracts resulted after Soxhlet extraction. Note that as different 
sample materials have different densities, the masses contained in the same thimble vary.
 .......................................................................................................................................... 87 
Table 11 TLC retention factors (Rf) of compounds observed at 254 nm and 366 nm for n-
hexane and methanol extracts. A 1:4 ethyl acetate:n-n-hexane solvent system was used for 
non-polar extracts and a 2:3 ethyl acetate:n-hexane for methanol extracts. For non-polar 
extracts extra spots were observed after spraying with anisaldehyde reagent. .................. 89 
Table 12 TLC retention factors (Rf) of compounds observed at 254 nm and 366 nm for n-
hexane and methanol extracts. A 1:4 ethyl acetate:n-hexane solvent system was used for 
non-polar extracts and a 2:3 ethyl acetate:n-n-hexane for methanol extracts. For non-polar 
extracts extra spots were observed after spraying with anisaldehyde reagent. .................. 89 
Table 13 The DPPH IC50 values (mg/ml) of methanol extracts of Arctium lappa, Ziziphus 
mucronata, Gardenia ternifolia, Equisetum arvense, Centaurea pamphylica, Solanum anguivi 
and Hyssopus officinalis, and positive control quercetin .................................................... 93 
  
11 
 
Table 14 Overview of LD50 of ethacrynic acid after pre-treatment with various flavonoids and 
without pretreatment ....................................................................................................... 169 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
12 
 
List of Figures 
Figure 1 Oxidative stress: causes and consequences (Adapted from Sharma, 2014) ....... 30 
Figure 2 Chemical formation of reactive oxygen and nitrogen species (Source: Ríos-Arrabal 
et al. 2013) ........................................................................................................................ 31 
Figure 3 Main reaction steps for antioxidant defense, where SOD = superoxide dismutase, 
CAT = catalase, GPx = glutathione peroxidase and GR = glutathione reductase .............. 32 
Figure 4 Classification of cancer chemoprevention agents (Adapted from Surh, 2003) ..... 34 
Figure 5 The Nrf2/Keap1 regulatory pathway. Under homeostatic conditions, Nrf2 is localised 
in the cytoplasm, bound to a Keap1 homodimer, which forms a complex with Cullin3-Rbx1 
E3 ubiquitin ligase. This facilitates the ubiquitination and proteolysis of Nrf2 via the 26S 
proteasome. Under electrophilic/oxidative stress, the Keap1-Cul3-E3 ubiquitin complex is 
disrupted and Nrf2 can translocate to the nucleus where it forms a heterodimer with small 
Maf proteins and binds to the ARE, promoting the transcription of cytoprotective genes. 
(Source: Sznarkowska et al. 2017) .................................................................................... 39 
Figure 6 Example of primary metabolites (Sources: https://pubchem.ncbi.nlm.nih.gov/; Xu, 
2002) ................................................................................................................................. 41 
Figure 7 Examples of secondary metabolites (source: PubChem)..................................... 42 
Figure 8 Structural backbone of flavonoids (C6-C3-C6) showing a chromane ring (A and C) 
attaching a second aromatic ring (B) in position 2, 3 or 4. Source: Balentine et al. 2015 ... 48 
Figure 11  Mechanisms of chemoprevention exhibited by phytochemicals (Source: Iqbal et 
al. 2018) ............................................................................................................................ 57 
Figure 10 Photo of Centaurea sp. Source: Jouko Lehmuskallio at http://www.luontoportti.com
 .......................................................................................................................................... 59 
Figure 13 Photo of Arctium lappa. Source: 
http://www.herbgarden.co.za/mountainherb/seedinfo.php?id=201 .................................... 60 
Figure 14 Photo of Equisetum arvense. Source: Bobby Hattaway at 
https://www.discoverlife.org/mp/20p?see=I_TQBH11687&res=640................................... 61 
Figure 13 Chemical structure of N,N-dimethyltryptamine from the Rubiaceae 
(Source:https://pubchem.ncbi.nlm.nih.gov/compound/6089#section=2D-Structure) .......... 62 
  
13 
 
Figure 16 Photo of Gardenia ternifolia Schumach.& Thonn. Source: D.C.H. Plowes at 
www.zambiaflora.com ....................................................................................................... 63 
Figure 17 Photo of Gypsophila fastigiata. Source: Jouko Lehmuskallio at 
http://www.luontoportti.com ............................................................................................... 64 
Figure 16 Photo of Hyssopus officinalis. Source: Jouko Lehmuskallio at 
http://www.luontoportti.com ............................................................................................... 65 
Figure 17 Photo of Kitaibelia balansae. Source: Prof. Avinoam Danin at 
https://flora.org.il/en/plants/KITBAL/ .................................................................................. 66 
Figure 18 Photo of Solanum anguivi. Source: Robert v. Blittersdorff at 
http://www.africanplants.senckenberg.de .......................................................................... 67 
Figure 19 Photo of mature Ziziphus mucronata. Source: Michael Briza at 
http://www.krugerpark.co.za/africa_buffalothorn.html ........................................................ 68 
Figure 20 Flow diagram of the bioassay-guided investigation ............................................ 70 
Figure 21 Soxhlet apparatus at the end of a reflux cycle (500 ml) ..................................... 72 
Figure 22 Evaporation of methanol from an extract fraction using a rotary evaporator ...... 73 
Figure 23 %Inhibition of DPPH by methanol extracts of CP, GT, SA, ZM and quercetin at 10-
fold dilutions between 0.0001 and 1 mg/ml. Graph shows the average values of triplicate 
experiments. ..................................................................................................................... 90 
Figure 24 %Inhibition of DPPH by methanol extracts of Equisetum arvense, Arctium Lappa, 
Hyssopus officinalis, Centaurea dichroa and the positive control quercetin at concentrations 
between 0.0001 and 1 mg/ml. Graph shows the average values of triplicate experiments. 91 
Figure 25 %Inhibition of DPPH by quercetin at 1-fold dilutions between 0.001 and 0.01 mg/ml. 
Graph shows the average values of duplicate experiments. .............................................. 92 
Figure 26 %Inhibition of DPPH by CP-ME, GTME, SAME, EAME and HOME at 
concentrations of 1-fold dilutions between 0.1 and 1 mg/ml. Graph shows the average values 
of duplicate experiments. .................................................................................................. 92 
Figure 27 Graph showing the %inhibition of DPPH by ZM-Me and AL-Me at 1-fold dilutions 
between 0.01 and 0.1 mg/ml. Graph shows the average values of duplicate experiments 93 
  
14 
 
Figure 28 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 
cells for 24 h with tBHQ (10-100 µM). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=12) ................... 95 
Figure 29 Effect of tBHQ on the induction of luciferase activity. AREc32 cells were incubated 
for 24 h with non-cytotoxic concentrations of tBHQ (10-50 µM). DMSO represents the vehicle 
control and its concentration is expressed as v/v%. Values show the average of n=3. ...... 95 
Figure 32 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 
cells for 24 h with AL-Me (0.01-1 mg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) . 96 
Figure 33 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 
cells for 24 h with CA-Me (0.01-1 mg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) . 97 
Figure 32 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 
cells for 24 h with CD-Me (0.01-1 mg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) . 98 
Figure 35 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 
cells for 24 h with CK-Me (0.01-1 mg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) . 98 
Figure 36 Cell viability percentage of control (0 mg/ml) observed after treatment of AREc32 
cells for 24 h with CP-Me  (0.025-1 mg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) . 99 
Figure 37 Cell viability percentage of control (0 mg/ml) observed after treatment of AREc32 
cells for 24 h with EA-Me (0.01-1 mg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) . 99 
Figure 38 Cell viability percentage to control (0 mg/ml) observed after treatment of AREc32 
cells for 24 h with GP-Me (0.025-1 mg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 100 
Figure 39 Cell viability percentage to control (0 mg/ml) observed after treatment of AREc32 
cells for 24 h with GT-Me (0.025-1 mg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 101 
  
15 
 
Figure 40  Cell viability percentage to control (0 mg/ml) observed after treatment of AREc32 
cells for 24 h with HO-Me (0.01-1 mg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 101 
Figure 41 Cell viability percentage to control (0 mg/ml) observed after treatment of AREc32 
cells for 24 h with KB-Me (0.005-1 mg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 102 
Figure 42 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 
cells for 24 h with SA-Me (0.005-1 mg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 102 
Figure 43 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 
cells for 24 h with ZA-Me (0.025-1 mg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 103 
Figure 42 Simulation of MTT assay on ZMME extract (0.025-1 mg/ml) without seeded cells. 
The methanol extract reacts with the MTT in the culture medium in a concentration-
dependent manner. ......................................................................................................... 104 
Figure 45 Cell viability percentage to control (0 mg/ml) observed after treatment of AREc32 
cells for 24 h with ZM-Me (0.025-1 mg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates).
 ........................................................................................................................................ 104 
Figure 46 Effect of methanol extracts on the induction of luciferase activity and tBHQ as 
postive control. AREc32 cells were incubated for 24 h with non-cytotoxic concentrations of 
methanol extracts of AL, CA, CD, CK, CP, EA, GP, GT, HO, KB, SA and ZM. DMSO 
represents the vehicle control and its concentration is expressed as v/v%. Values show mean 
+/- SEM (n=3, 3 replicates), control=1. ............................................................................ 106 
Figure 47 Cell viability as percentage to control (0 µg/ml) observed after treatment of AREc32 
cells for 24 h with AL-He (5-1000 µg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 107 
Figure 48 Cell viability as percentage to control (0 µg/ml) observed after treatment of AREc32 
cells for 24 h with CA-He (10-1000 µg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 108 
  
16 
 
Figure 49 Cell viability as percentage to control (0 µg/ml) observed after treatment of AREc32 
cells for 24 h with CK-He (10-1000 µg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 108 
Figure 50 Cell viability percentage to control (0 µg/ml) observed after treatment of AREc32 
cells for 24 h with CP-He (10 - 1000 µg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 109 
Figure 49 Cell viability percentage to control (0 µg/ml) observed after treatment of AREc32 
cells for 24 h with EA-He (5-1000 µg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 109 
Figure 52 Cell viability percentage to control (0 µg/ml) observed after treatment of AREc32 
cells for 24 h with GP-He (10-1000 µg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates).
 ........................................................................................................................................ 110 
Figure 53 Cell viability percentage to control (0 µg/ml) observed after treatment of AREc32 
cells for 24 h with GT-He (5-1000 µg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates).
 ........................................................................................................................................ 111 
Figure 54 Cell viability percentage to control (0 µg/ml) observed after treatment of AREc32 
cells for 24 h with HO-He (5-1000 µg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 111 
Figure 55 Cell viability percentage to control (0 µg/ml) observed after treatment of AREc32 
cells for 24 h with HO-He (5-1000 µg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 112 
Figure 56 Cell viability percentage of control (0 µg/ml) observed after treatment of AREc32 
cells for 24 h with SA-He (5-1000 µg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates).
 ........................................................................................................................................ 113 
Figure 57 Cell viability percentage of control (0 µg/ml) observed after treatment of AREc32 
cells for 24 h with ZM-He (5-1000 µg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates).
 ........................................................................................................................................ 113 
  
17 
 
Figure 58 Cell viability as percentage to control (0 µg/ml) observed after treatment of AREc32 
cells for 24 h with CD-He (1-500 µg/ml). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 114 
Figure 59 Effect of n-hexane extracts on the induction of luciferase activity and tBHQ as 
positive control. AREc32 cells were incubated for 24 h with non-cytotoxic concentrations of 
AL-He, CA-He, CD-He, CK-He, CP-He, EA-He, GP-He, GT-He, HO-He, KB-He, SA-He and 
ZM-He. DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Values show mean +/- SEM (n=3, 3 replicates), control=1. ............................................. 115 
Figure 60 Cell viability as percentage of control (0 mg/ml) observed after treatment of AREc32 
cells for 24 h with betulinic acid (0.625-40 μM). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 4 replicates) 116 
Figure 59 Cell viability as percentage to control (0 µg/ml) observed after treatment of AREc32 
cells for 24 h with CD-Me fractions (1-500 µg/ml). Results show the mean +/- SEM (n=3, 3 
replicates). ...................................................................................................................... 118 
Figure 62 Cell viability as percentage to control (0 µg/ml) observed after treatment of AREc32 
cells for 24 h with CP-Me fractions (20-1000 µg/ml). Results show the mean +/- SEM (n=3, 3 
replicates). ...................................................................................................................... 119 
Figure 63 Cell viability as percentage to control (0 µg/ml) observed after treatment of AREc32 
cells for 24 h with fractions of GT-Me (20-1000 µg/ml). Results show the mean +/- SEM (n=3, 
3 replicates). ................................................................................................................... 120 
Figure 64 Cell viability as percentage to control (0 µg/ml) observed after treatment of AREc32 
cells for 24 h with ZM-Me fractions (20-1000 µg/ml). Results show the mean +/- SEM (n=3, 3 
replicates). ...................................................................................................................... 121 
Figure 63 Effect of fractions of Centaurea dichroa methanol extract on the induction of 
luciferase activity and of tBHQ as positive control. AREc32 cells were incubated for 24 h with 
non-cytotoxic concentrations of CD-Me. Values show mean +/- SEM (n=3, 3 replicates), 
control=1. ........................................................................................................................ 122 
Figure 66 Effect of fractions of Centaurea pamphilica methanol extract on the induction of 
luciferase activity and of tBHQ as positive control. AREc32 cells were incubated for 24 h with 
non-cytotoxic concentrations of CP-Me. Values show mean +/- SEM (n=3, 3 replicates), 
control=1. ........................................................................................................................ 122 
  
18 
 
Figure 65 Effect of fractions of Gardenia ternifolia methanol extract on the induction of 
luciferase activity and tBHQ as positive control. AREc32 cells were incubated for 24 h with 
non-cytotoxic concentrations of GT-Me. Values show mean +/- SEM (n=3, 3 replicates), 
control=1. ........................................................................................................................ 123 
Figure 66 Effect of fractions of Ziziphus mucronata methanol extract on the induction of 
luciferase activity and tBHQ as positive control. AREc32 cells were incubated for 24 h with 
non-cytotoxic concentrations of ZM-Me. Values show mean +/- SEM (n=3, 3 replicates), 
control=1. ........................................................................................................................ 123 
Figure 69 %Inhibition of DPPH by fractions F3 of methanol extracts of Centaurea dichroa, 
Centaurea pamphylica, Gardenia ternifolia and the positive control quercetin at 
concentrations between 0.0001 and 1 mg/ml. Graph shows the average values of triplicate 
experiments. ................................................................................................................... 124 
Figure 70 Graph showing the %inhibition of DPPH by CD-Me and GT-Me at 1-fold dilutions 
between 0.1 and 0.01 mg/ml. Graph shows the average values of duplicate experiments125 
Figure 71 Graph showing the %inhibition of DPPH by CP-Me at 1-fold dilutions between 0.1 
and 0.01 mg/ml. Graph shows the average values of duplicate experiments ................... 126 
Figure 70 Graph showing the %inhibition of DPPH by quercetin at 1-fold dilutions between 
0.001 and 0.01 mg/ml. Graph shows the average values of duplicate experiments. ........ 126 
Figure 73  Chemical structure of stachyose C24H42O21, 666 g/mol. .................................. 127 
Figure 74 GPS1 experimental NMR assignments (in black) compared to those for stachiose 
in literature (blue and magenta in the image) .................................................................. 129 
Figure 75 Chemical structure of mannitol ........................................................................ 130 
Figure 74 1H and 13C assignments for mannitol (upper left) based on NMR spectra presented 
in Appendix A.2; 1H and 13C assignments for mannitol (lower right) based on NMR spectra 
from literature .................................................................................................................. 131 
Figure 77 1H and 13C assignments for mannitol from online catalogues. ......................... 131 
Figure 78 Chemical structure of betulinic acid ................................................................. 132 
Figure 77 1H and 13C assignments for betulinic acid based on NMR data recorded for ZMPH1 
(in black) and on NMR data from literature (blue and magenta; Berger and Sicker, 2009)133 
  
19 
 
Figure 80 Preparative HPLC chromatogram of F3 CD-Me (30% to 90% MeOH in H2O 
gradient solvent system, 200 µL injection) ....................................................................... 134 
Figure 81 UV spectrum of Peak 1 of F3 CD-Me .............................................................. 135 
Figure 80 UV spectrum of Peak 2 of F3 CD-Me .............................................................. 135 
Figure 83 UV spectrum of Peak 3 of F3 CD-Me .............................................................. 136 
Figure 82 Analytical chromatogram of isolated compound F3CD-Me-P2, with the UV 
spectrum recorded on Agilent 1260 in methanol:water gradient solvent system. ............. 136 
Figure 83 MS spectrum of F3CD-Me-P2 ......................................................................... 137 
Figure 84 Analytical HPLC chromatogram of isolated compound F3CDMe-P3 in 
methanol/water solvent system with gradient; 10 mg/ml. ................................................. 137 
Figure 87 MS spectrum of F3CD-Me-P3 ......................................................................... 138 
Figure 86 Preparative HPLC chromatogram for F3 CP-Me ............................................. 139 
Figure 89 Analytical HPLC chromatogram of F3CPME-P5, 1 mg/ml ............................... 139 
Figure 90 Analytical chromatogram of apigenin, 10 mg/ml .............................................. 140 
Figure 91 Analytical HPLC chromatogram of F3CP-Me-P7(IV) and recorded UV spectrum
 ........................................................................................................................................ 140 
Figure 92 Preparative HPLC chromatogram for F3 GT-Me ............................................. 141 
Figure 91 Analytical HPLC chromatogram for F3 GT-Me-P4/PA, 1 mg/ml ....................... 141 
Figure 94 Chemical structure of sakuranetin C16H14O5, 286 g/mol ................................... 142 
Figure 95 Experimental NMR assignments for F3GT-Me-P4/PA as sakuranetin ............. 143 
Figure 96 NMR assignments presented in literature for sakuranetin (in blue or magenta 
depending on source; references in text) ........................................................................ 143 
Figure 97 Analytical HPLC chromatogram for F3 GT-Me-PB/P6, 1 mg/ml ....................... 144 
Figure 98 UV spectrum of Peak 2 as F3 GT-Me-PB/P6 ................................................... 144 
Figure 99 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 
cells for 24 h with apigenin (1-50 µM). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 145 
  
20 
 
Figure 100 Cell viability as percentage to control (0 mg/ml) observed after treatment of 
AREc32 cells for 24 h with genkwanin (1-50 µM). DMSO represents the vehicle control and 
its concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates)
 ........................................................................................................................................ 146 
Figure 99 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 
cells for 24 h with hesperetin (1-50 µM). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 146 
Figure 102 Cell viability as percentage to control (0 mg/ml) observed after treatment of 
AREc32 cells for 24 h with hispidulin (1-50 µM). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 147 
Figure 101 Cell viability as percentage to control (0 mg/ml) observed after treatment of 
AREc32 cells for 24 h with kaempferol (1-50 µM). DMSO represents the vehicle control and 
its concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates)
 ........................................................................................................................................ 147 
Figure 104 Cell viability as percentage to control (0 mg/ml) observed after treatment of 
AREc32 cells for 24 h with luteolin (1-50 µM). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 148 
Figure 103 Cell viability as percentage to control (0 mg/ml) observed after treatment of 
AREc32 cells for 24 h with naringenin (1-50 µM). DMSO represents the vehicle control and 
its concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates)
 ........................................................................................................................................ 148 
Figure 104 Cell viability as percentage to control (0 mg/ml) observed after treatment of 
AREc32 cells for 24 h with quercetin (1-50 µM). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 149 
Figure 105 Cell viability as percentage to control (0 mg/ml) observed after treatment of 
AREc32 cells for 24 h with sakuranetin (1-50 µM). DMSO represents the vehicle control and 
its concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates)
 ........................................................................................................................................ 149 
Figure 108 Cell viability as percentage to control (0 mg/ml) observed after treatment of 
AREc32 cells for 24 h with velutin (1-50 µM). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 150 
  
21 
 
Figure 107 Effect of various flavonoids on the induction of luciferase activity and tBHQ as 
positive control. AREc32 cells were incubated for 24 h with non-cytotoxic concentrations of 
apigenin, genkwanin, hesperetin, hispidulin, kaempferol, luteolin, naringenin, quercetin, 
sakuranetin and velutin. DMSO represents the vehicle control and its concentration is 
expressed as v/v%. Values show mean +/- SEM (n=3, 3 replicates), control=1. .............. 151 
Figure 108 Cell viability as percentage to control (0 mg/ml) observed after treatment of MCF-
7 cells for 24 h with quercetin (2.5 µM). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 154 
Figure 111 Cell viability as percentage to control (0 mg/ml) observed after treatment of MCF-
7 cells for 24 h with apigenin (5 µM). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 154 
Figure 112 Cell viability as percentage to control (0 mg/ml) observed after treatment of MCF-
7 cells for 24 h with genkwanin (2.50 µM). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 155 
Figure 113 Cell viability as percentage to control (0 mg/ml) observed after treatment of MCF-
7 cells for 24 h with hesperetin (1 µM). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 155 
Figure 114 Cell viability as percentage to control (0 mg/ml) observed after treatment of MCF-
7 cells for 24 h with hispidulin (2.5 µM). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 156 
Figure 115 Cell viability as percentage to control (0 mg/ml) observed after treatment of MCF-
7 cells for 24 h with kaempferol (2.5 µM). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 156 
Figure 116 Cell viability as percentage to control (0 mg/ml) observed after treatment of MCF-
7 cells for 24 h with luteolin (2.5 µM). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 157 
Figure 117 Cell viability as percentage to control (0 mg/ml) observed after treatment of MCF-
7 cells for 24 h with naringenin (2.5 µM). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 157 
  
22 
 
Figure 118 Cell viability as percentage to control (0 mg/ml) observed after treatment of MCF-
7 cells for 24 h with sakuranetin (20 µM). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 158 
Figure 117 Cell viability as percentage to control (0 mg/ml) observed after treatment of MCF-
7 cells for 24 h with velutin (1-50 µM). DMSO represents the vehicle control and its 
concentration is expressed as v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 158 
Figure 118 Effect of 24 h treatment of MCF-7 cells with (a) sakuranetin and (b) naringenin on 
NQO1 protein expression. ............................................................................................... 160 
Figure 119 Cell viability as percentage to control (no treatment) observed after treatment of 
MCF-7 cells for 24 h with ethacrynic acid (3.125-1000 µM). Results of the MTT assay show 
the mean of 3 experiments (n=3, 2 replicates). ................................................................ 161 
Figure 122 Cell viability as percentage to control (no treatment) observed after pre-treatment 
of MCF-7 cells for 24 h with tBHQ (10 µM) and ethacrynic acid (3.125-1000 µM). Results of 
the MTT assay show the mean of 2 experiments (total n=6). P<.0001, significant difference 
between the cytotoxicity of ETA in pretreated cells and the cytotoxicity of ETA alone. .... 162 
Figure 123 Cell viability as percentage to control (no treatment) observed after pre-treatment 
of MCF-7 cells for 24 h with apigenin (5 µM) and ethacrynic acid (3.125-1000 µM). Results 
of the MTT assay show the mean of 2 experiments (total n=6). P<.0001, significant difference 
between the cytotoxicity of ETA in pretreated cells and the cytotoxicity of ETA alone. .... 163 
Figure 124 Cell viability as percentage to control (no treatment) observed after pre-treatment 
of MCF-7 cells for 24 h with genkwanin (2.5 µM) and ethacrynic acid (3.125-1000 µM). 
Results of the MTT assay show the mean of 2 experiments (total n=6). P<.0001, significant 
difference between the cytotoxicity of ETA in pretreated cells and the cytotoxicity of ETA 
alone. .............................................................................................................................. 163 
Figure 125 Cell viability as percentage to control (no treatment) observed after pre-treatment 
of MCF-7 cells for 24 h with hesperetin (1 µM). and ethacrynic acid (3.125-1000 µM). Results 
of the MTT assay show the mean of 2 experiments (total n=6). P<.0001, significant difference 
between the cytotoxicity of ETA in pretreated cells and the cytotoxicity of ETA alone. .... 164 
Figure 124 Cell viability as percentage to control (no treatment) observed after pre-treatment 
of MCF-7 cells for 24 h with hispidulin (2.5 µM) and ethacrynic acid (3.125-1000 µM). Results 
  
23 
 
of the MTT assay show the mean of 2 experiments (total n=6). P<.0001, significant difference 
between the cytotoxicity of ETA in pretreated cells and the cytotoxicity of ETA alone. .... 165 
Figure 125 Cell viability as percentage to control (no treatment) observed after pre-treatment 
of MCF-7 cells for 24 h with kaempferol (2.5 µM) and ethacrynic acid (3.125-1000 µM). 
Results of the MTT assay show the mean of 2 experiments (total n=6). P<.0001, significant 
difference between the cytotoxicity of ETA in pretreated cells and the cytotoxicity of ETA 
alone. .............................................................................................................................. 166 
Figure 128 Cell viability as percentage to control (no treatment) observed after pre-treatment 
of MCF-7 cells for 24 h with luteolin (2.5 µM) and ethacrynic acid (3.125-1000 µM). Results 
of the MTT assay show the mean of 2 experiments (total n=6). P<.0001, significant difference 
between the cytotoxicity of ETA in pretreated cells and the cytotoxicity of ETA alone. .... 166 
Figure 127 Cell viability as percentage to control (no treatment) observed after pre-treatment 
of MCF-7 cells for 24 h with naringenin (2.5 µM) and ethacrynic acid (3.125-1000 µM). Results 
of the MTT assay show the mean of 2 experiments (total n=6). P<.0001, significant difference 
between the cytotoxicity of ETA in pretreated cells and the cytotoxicity of ETA alone. .... 167 
Figure 128 Cell viability as percentage to control (no treatment) observed after pre-treatment 
of MCF-7 cells for 24 h with sakuranetin (20 µM) and ethacrynic acid (3.125-1000 µM). 
Results of the MTT assay show the mean of 2 experiments (total n=6). P<.0001, significant 
difference between the cytotoxicity of ETA in pretreated cells and the cytotoxicity of ETA 
alone. .............................................................................................................................. 168 
Figure 129 Cell viability as percentage to control (no treatment) observed after pre-treatment 
of MCF-7 cells for 24 h with velutin (2.5 µM) and ethacrynic acid (3.125-1000 µM). Results of 
the MTT assay show the mean of 2 experiments (total n=6). P<.0001, significant difference 
between the cytotoxicity of ETA in pretreated cells and the cytotoxicity of ETA alone. .... 168 
Figure 132 +H NMR spectrum of GPS1 ........................................................................... 196 
Figure 133 DEPTQ experiment spectrum of GPS1 ......................................................... 197 
Figure 134 COSY experiment spectrum of stachyose ..................................................... 197 
Figure 135 HSQC experiment spectrum of stachyose ..................................................... 198 
Figure 136 HMBC experiment spectrum of stachyose ..................................................... 198 
Figure 137  +H NMR spectrum of mannitol isolated after filtration of GT methanol extract 199 
  
24 
 
Figure 138 +H NMR spectrum of mannitol isolated after evaporation of GT methanol extract
 ........................................................................................................................................ 199 
Figure 139 +H NMR spectrum of betulinic acid ................................................................ 200 
Figure 140 Expansion of +H NMR spectrum of betulinic acid ........................................... 200 
Figure 141 DEPTQ experiment spectrum of betulinic acid .............................................. 201 
Figure 142 HSQC experiment spectrum of betulinic acid ................................................ 201 
Figure 143 HMBC experiment spectrum of betulinic acid ................................................ 202 
Figure 144 Proton NMR spectrum of F3GT-Me-P4/PA .................................................... 203 
Figure 145 Proton NMR spectrum of F3GT-Me-P4/PA .................................................... 204 
Figure 146 +H NMR spectrum of F3 GT-Me-P4 ............................................................... 205 
Figure 147 COSY experiment spectrum for F3GT-Me-P4/PA .......................................... 205 
Figure 148 13C NMR spectrum of F3 GT-Me-P4/PA ........................................................ 206 
Figure 149 HSQC experiment spectrum of F3 GT-Me-P4/PA .......................................... 207 
Figure 150 MS spectrum for F3 GT-Me-P4/PA (data entry error for sample name displayed 
at the top of spectrum) .................................................................................................... 208 
Figure 151 MS spectrum for F3 GT-Me-P4/PA (data entry error for sample name displayed 
at the top of spectrum) .................................................................................................... 209 
  
25 
 
CHAPTER 1 General Introduction 
 
1.1 Cancer Outlines 
1.1.1 Statistics  
Cancer represents a major public health problem worldwide. According to The Global Cancer 
Observatory (GLOBOCAN), there will be an estimated 18.1 million new cancer cases  and 
9.6 million cancer deaths  globally in 2018 (Bray et al. 2018). These data indicate an increase 
compared to the 2015 world estimates: a rise of about 0.6 million cancer cases and 0.9 million 
cancer deaths (Fitzmaurice et al. 2017). It is estimated that about 1 in 5 men and 1 in 6 
women will develop cancer during their lifetime, with 1 in 8 men and 1 in 10 women dying of 
this cause (Bray et al. 2018). Globally, about 1 in 6 deaths is due to cancer (World Health 
Organization, 2018). Worldwide, the estimated 5-year cancer prevalence is 43.8 million, while 
cancer is the second leading cause of death, showing a need for an effective reduction of the 
global cancer burden, especially through prevention and early diagnosis (Bray et al. 2018; 
World Health Organization, 2018). 
Globally, the latest GLOBOCAN estimates show that the highest number of new cancer 
cases was noted for lung and breast cancer equally (approximately 2.1 million), while the 
highest number of cancer deaths was recorded for lung cancer (approximately 1.8 million), 
followed by stomach and liver cancer (Bray et al. 2018). Incidence rates per 100,000 persons 
vary substantially across the world; in men, incidence rates vary from 571.2 in Australia/New 
Zealand to 95.6 in Western Africa, and in women from 362 in Australia/ New Zealand to 96.2 
in South-Central Asia. Similarly, death rates varied from 171 per 100,000 in Eastern Europe 
to 67.4 per 100,000 in Central America in men and from 120.7 per 100,000 in Melanesia to 
64.2 per 100,000 in Central America and Eastern Asia in women (Bray et al. 2018). 
The differences in cancer incidence and mortality can be attributed to differences in the 
prevalence of risk factors and the availability of preventive, diagnostic and treatment services 
in different countries. The major risk factors identified globally are tobacco use, unhealthy 
diet, insufficient physical activity, being overweight and obese, exposure to ionizing and 
ultraviolet (UV) radiation, certain hormones, alcohol use, infection by some viruses and 
bacteria (Human papillomavirus (HPV), Hepatitis B virus, Hepatitis C virus, Epstein-Barr virus, 
Helicobacter pylori), and certain chemicals (urban air pollution) (Sauer et al. 2017; World 
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Health Organization, 2018). Also, the differences and rise in cancer incidence and mortality 
can partly be attributed to population growth, varying socio-economic factors, and aging of 
the population. The latter indicates a need for a lifetime approach to cancer prevention 
(Shoemaker et al. 2015). 
1.1.2  Cancer biology and lifestyle  
Cancer is characterized by abnormal cell growth. Carcinogenesis is a complex multi-stage 
process in which normal cells alter their behaviour and metabolism. As a result, they start 
unregulated and uncontrolled proliferation in any part of the body (site of origin), with the 
potential of subsequent invasion of surrounding tissues and spreading to other locations in 
the body, i.e., metastasis (Hesketh, 2013;Timofte, 2017).  
The cause of cancer is attributed to a mix of altering genetic and non-genetic factors 
(Toyokuni, 2016). The non-genetic factors, also called external, can be of physical (UV and 
ionising radiation), chemical (asbestos, carcinogenic substances from tobacco smoke) or 
biological in nature (infections with certain viruses and bacteria e.g. HPV, Helicobacter pylori) 
(World Health Organization, 2018). Some of the factors linked to cancer occurrence are 
modifiable (binge drinking, tobacco smoking, diet which includes frequent consumption of red 
and processed meat, obesity, recreational sunlight exposure and indoor tanning, 
environmental and work exposure to carcinogenic substances, etc.) while others are not 
(genetics, age) (White et al. 2017; World Health Organization, 2018). Prevention strategies 
and efforts are aimed at modifiable risk factors (White et al. 2017).  
The above mentioned factors can initiate or contribute to carcinogenesis by causing 
mutations in healthy cells. Mutations which affect genes involved in the process of apoptosis 
(programmed cell death) can lead to uncontrolled proliferation. The programmed cell death 
reponse is still being investigated, as it involves a complex interplay of signaling pathways 
and is dependent on cell type, as well as the extent and type of DNA damage. To promote 
the malignant cellular phenotype, apoptotic pathways are usually impaired in cells 
undergoing neoplastic transformation, so that cells with irreparable DNA damage e.g. double 
strand DNA breaks or incomplete DNA repairs can continue proliferating. This process is 
important for both the initiation and progression phases of tumorigenesis, where uncontrolled 
proliferation supports the continued expansion of premalignant cells with high potential of 
continued proliferation and invasiveness. (Sun, Hail and Lotan, 2004; Hesketh, 2013; Surova 
and Zhivotovsky, 2013).Tissue homeostasis is maintained through a delicate balance 
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between cell proliferation and senescence/apoptosis. In non-cancer cells, apoptosis is 
activated, when DNA is damaged and helps remove damaged cells.  However, cells which 
suffer mutations in segments of DNA responsible for growth control, such as mutations in the 
regions coding transforming growth factor beta (TGF-β) and tumour suppressor gene p53, 
which controls both senescence and apoptosis, eventually avoid regulation and become 
cancer cells. Mutations of positive cell-cycle regulators (proto-oncogenes) lead to formation 
of oncogenes, which can cause growth of cancer cells, and mutations of negative cell-cycle 
regulators (tumour suppressor genes) can lead to unregulated cell division. All of these 
changes occur in carcinogenesis as consequences of a complex interaction between the 
genetic and non-genetic cancer risk factors and cells (Hesketh, 2013). 
The length of the carcinogenesis can take anywhere between a few years and a few decades 
(Toyokuni, 2016), during which time mutations are being accumulated until cells’ regulators 
of growth and division become uncontrolled. This loss of regulation manifests itself in altered 
response to positive and negative external growth signals leading to indefinite growth and 
proliferation. Still, the accumulation of mutations can happen over a lifetime and WHO 
estimates that currently between 30% and 50% of cancer cases can be prevented by altering 
diet and lifestyle habits (World Health Organization, 2018).  
Several case-control and cohort studies showed that an intake of at least five fruits and 
vegetables a day can decrease the risk of developing cancer by almost 50% (Surh, 2003). 
Notably, the European Prospective Investigation into Cancer and Nutrition (EPIC prospective 
cohort study) showed that intake of fruit, vegetables and fibre (plant-based complex 
carbohydrates) reduced the risk for colorectal cancer. The intake of fibre, usually found in 
cereal, as well as fruits, also correlated with a reduced the risk of liver and breast cancer, 
while the risk of both the upper gastrointestinal tract cancer and lung cancer (only in smokers) 
was inversely associated with fruit intake (Bradbury et al. 2014).  
Table 1 below shows a list of fruits and vegetables that have been implicated in cancer risk 
reduction and quantities associated with this decrease (Turati et al. 2015). As a result, several 
initiatives have been promoted in Europe and the United States with the purpose of 
encouraging people to include more fruits and vegetables in their diet as an incentive for 
cancer prevention. Examples are the ‘Five-A-Day for Better Health’ and ‘Savor the spectrum’ 
in the US and ‘5 A DAY’ in the United Kingdom (Surh, 2003). 
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Table 1 Fruits and vegetables intake associated with a decreased risk of various types of cancer. Adapted from 
Turati et al. 2015 
Fruit/ 
vegetable 
Cancer localisation Quantity 
Cabbages 
Cauliflowers 
Broccoli 
Brussels 
sprouts 
Turnip greens 
Oral cavity 
Pharynx 
Oesophagus 
Colorectum 
Breast 
Kidney 
 
 
≥1 portion/week 
Onion 
Garlic 
Oral cavity 
Pharynx 
Oesophagus 
Colorectum 
Larynx 
Endometrium 
Ovary 
Kidney (garlic only) 
 
 
 
≥7 portions/week 
High use 
Citrus fruit Oral cavity 
Pharynx 
Oesophagus 
 
≥4 portions/week 
Apple Oral cavity 
Pharynx 
Colorectum 
Larynx 
Breast 
 
 
 
 
At least one/day 
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Ovary 
Oesophagus (risk reduction did 
not reach statistical 
significance) 
Prostate (risk reduction did not 
reach statistical significance) 
Tomatoes Colorectum 
Oral cavity 
Pharynx 
Oesophagus 
Stomach (highest reduction) 
 
 
Highest vs. lowest intake (no 
quantity specified, higher intake 
favourable) 
 
1.1.3  Oxidative stress 
Oxidative stress relates to an imbalance between reactive oxygen/nitrogen species 
(ROS/RNS) and the counter acting activity of antioxidant defence mechanisms (enzymatic or 
non-enzymatic) (Su et al. 2013; Kaur et al. 2014). On a daily basis, we are persistently 
exposed to external factors such as air pollutants, heavy metals, industrial emissions of 
organic compounds or nuclear emissions. These factors, together with our diets and 
compounded by smoking, alcohol intake and sun exposure, cause oxidative stress.  
Oxidative stress is responsible for the development of a series of pathologies, among which 
cancer represents one of the most dangerous risks, as the oxidative stress ultimately 
threatens the integrity of the genome (Kaur et al. 2014). Other pathologies include 
neurodegenerative diseases such as Alzheimer’s and Parkinson disease, cardiovascular 
diseases and diabetes (Lee et al. 2013, Lichtenberg and Pinchuk, 2015).  
Reactive oxygen species (ROS) are a class of highly reactive molecules, which result from 
the metabolism of oxygen (Subhasree, 2008). This leads to the conclusion that all aerobic 
organisms produce ROS as a by-product of biochemical utilisation of oxygen and are prone 
to oxidative stress (Liu et al. 2007), as an excess of ROS can cause a redox imbalance and 
lead to important pathological states by means of lipid, protein and DNA damage (Cho and 
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Kleeberger, 2007). These effects are shown in Figure 1; membrane lipids undergo lipid 
peroxidation with production of toxic products, changes to proteins affect their function 
(enzymes, structural proteins) and lead to further production of free radicals through 
synthesis of protein hydroperoxides, while DNA undergoes mutations and fragmentation 
(Sharma, 2014).  These alterations are also responsible for ageing (Liu et al. 2007). Other 
reactive species that require oxygen for their production are reactive nitrogen species (RNS) 
– nitric oxide and nitrogen dioxide, and reactive chlorine species (Fang et al. 2002). 
 
Figure 1 Oxidative stress: causes and consequences (Adapted from Sharma, 2014) 
Important examples of ROS are superoxide (O2-), hydroxyl (OH-), peroxyl (RO-2), alkoxyl (RO-) 
and hydroxyperoxyl (HO-2) radicals (Figure 2). The extent of damage produced by ROS is 
amplified because they cause a series of reactions of lipid oxidation (Fang et al. 2002).  
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Figure 2 Chemical formation of reactive oxygen and nitrogen species (Source: Ríos-Arrabal et al. 2013) 
ROS are produced by mitochondria, phagocytes, peroxisomes and cytochrome P450s 
(Gordon, 2012). Enzymes, which participate in their production, are NADPH oxidase, 
xanthine oxidase, lipoxygenase, cyclooxygenase and uncoupled endothelial nitric oxide 
synthase, while the non-enzymatic reactions that lead to ROS production involve the 
mitochondrial respiratory chain (Gorrini et al. 2013). The latter source of ROS is mainly 
responsible for the formation of superoxide anions and hydrogen peroxide, as a result of 
regular oxidative metabolism. This is possible in a non-enzymatic manner because it is 
caused by an electron leakage that happens during the synthesis of ATP facilitated by the 
oxidative phosphorylation process. Oxidative phosphorylation is a process that depends on 
proton gradients (electron transfer reactions) in order to convert molecular oxygen to water 
and takes places in the electron-transport chain. When partial reduction of molecular oxygen 
happens, it leads to the formation of unstable intermediates (ROS); more specifically, during 
recycling of coenzyme Q (ubiquinone), an unstable intermediate is formed (free radical 
semiquinone anion) that can readily transfer electrons to molecular oxygen, resulting in a 
one-electron reduction of molecular oxygen to the superoxide ion, instead of the four-electron 
reduction catalysed by complex IV (cytochrome c oxidase) (Finkel and Holbrook, 2000). Thus, 
the electron leakage that happens during oxidative phosphorylation is responsible for the 
non-enzymatic production of ROS such as superoxide anions (one-electron reduction) and 
hydrogen peroxide (two-electron reduction) (Berg, 2002; Gogvadze et al. 2008). 
The endogenous defence against ROS is represented by glutathione, ubiquinol, uric acid and 
bilirubin, and enzymes, such as superoxide dismutase (converts O2- into O2 + H2O2), 
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gluthatione peroxidase (reduces H2O2 to H2O), catalase (dismutes H2O2 into O2 + H2O) 
(Fridovich, 1999; Gordon, 2012).  Figure 3 illustrates the enzyme-catalysed reactions that 
take place. On the other hand, the exogenous system of defense includes dietary 
antioxidants such as vitamin C, vitamin E, selenium and β-carotene (Turati et al. 2015).  
 
Figure 3 Main reaction steps for antioxidant defense, where SOD = superoxide dismutase, CAT = catalase, GPx 
= glutathione peroxidase and GR = glutathione reductase 
 
The homeostasis of free radicals is important for many processes in our bodies, such as 
muscle contraction, immune responses, food to energy conversion (Lichtenberg and Pinchuk, 
2015). However, increased ROS and oxidative stress can occur as a result of cigarette 
smoking, unhealthy diet and chronic inflammation due to chronic infection – all of which are 
known risk factors for cancer, as well as obesity and diabetes. ROS stimulate metabolic 
pathways, which are associated with tumour cell growth and survival, and they block the 
function of tumour suppressing molecules (Gorrini et al. 2013). 
1.1.4  Cancer Chemoprevention 
Cancer chemoprevention represents the use of synthetic or natural agents, including drugs 
and vitamins, with the aim of reducing the risk of cancer, delaying carcinogenesis or 
preventing recurrence of cancer (Steward and Brown, 2013; Meyskens et al. 2015).  The goal 
is to prevent occurrence of cancer, and in the case of metastasis, to prevent breach through 
the basement membrane (Wu et al. 2011). The term ‘’cancer chemoprevention’’ was first 
introduced by Michael Sporn, who defined it as ‘’the use of specific agents to reverse, 
suppress or prevent the carcinogenic process to invasive cancer’’ (Mukhtar, 2012). Lee 
Wattenberg used the term ‘’chemoprophylaxis’’ to refer to cancer prevention with the use of 
chemical agents (Mukhtar, 2012).  
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The definition and understanding of cancer chemoprevention have evolved over time since 
the term first appeared in medical literature more than 40 years ago, and it is currently 
considered a method of active preventive intervention, which is aimed at stopping, slowing 
down or reversing carcinogenesis (Meyskens et al. 2015). Because of the multiple factors 
and development stages of this disease, from the epigenetic to the cellular level, 
chemoprevention could prove more efficient than cancer treatment and it is also more cost-
effective (Amin et al. 2009). However, there has been much debate over the success of 
chemoprevention and its efficiency. 
Agents involved in cancer chemoprevention include natural agents, dietary compounds and 
drugs, many of which originally had different indications (Meyskens et al. 2015). The latter is 
the case with aspirin: its capacity to irreversibly inhibit enzymes that elicit pro-inflammatory 
responses, support cell proliferation, angiogenesis and apoptotic resistance, has made 
aspirin a promising cancer chemopreventive agent. The enzymes acetylated by aspirin are 
prostaglandin-endoperoxide synthase 1 (PTGS1 or COX1) and prostaglandin-endoperoxide 
synthase 2 (PTGS2 or COX2) (Drew, Cao and Chan, 2016). Moreover, because elevated 
levels of prostaglandins are found in colon cancer, this led to its use in chemoprevention of 
this malignant disease (Mukhtar, 2012). The Breast Cancer Prevention Trial was one of the 
first, which examined a chemopreventive agent – tamoxifen, and it showed a significant 
reduction in breast cancer occurrence in women with an increased risk of the disease. 
However, tamoxifen’s serious side effects have limited its use for this indication (Wu et al. 
2011).  
There are three stages of chemoprevention: primary – aimed at high-risk individuals, 
secondary – aimed at individuals with pre-malignant lesions, and tertiary – aimed at patients 
treated for a primary cancer to prevent secondary forms and reoccurrence (Rashid, 2017). 
Moreover, chemopreventive agents are classified (Figure 4) into inhibitors (prevent formation 
of carcinogens from precursors), blocking agents (prevent mutations caused by carcinogens, 
enhance detoxification pathways and trap ROS) and suppressing agents (intervene in cell 
proliferation, differentiation, senescence and apoptosis) (Priyadarsini and Nagini, 2012). 
Blocking agents are most effective if they are used prior to exposure to carcinogens. However, 
if the cell suffers damage from carcinogens, then suppressing agents take effect in the 
promotion and progression stages of carcinogenesis, with the aim of suppressing the 
development of cancer. Some chemopreventive agents can show both blocking and 
suppressing means of action (e.g. curcumin and indole-3-carbinol) (Rashid, 2017). 
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Figure 4 Classification of cancer chemoprevention agents (Adapted from Surh, 2003) 
 
Compounds that inhibit metabolic transformation of carcinogens and block their damaging 
effects on DNA are referred to as “blocking agents”, because they “block” mutagenic 
interactions of carcinogens with DNA. They do so by helping prevent the irreparable DNA 
damage that occurs during initiation in the following ways: by inactivating or metabolizing 
carcinogens directly, acting as free-radical scavengers, or inducing antioxidative enzyme 
activity and activating mechanisms of DNA repair. Furthermore, blocking agents can also 
exert epigenetic modifications (Priyadarsini and Nagini, 2012; Rashid, 2017). 
In contrast to blocking agents, “suppressing agents” are compounds that affect the later 
stages of carcinogenesis and they can interfere with cancer cell proliferation by down-
regulating signal transduction pathways such as the NF-B (see 1.1.5.1), mTOR (mammalian 
target of rapamycin) and STAT3 (part of STAT family of transcription factors: signal 
transducer and activator of transcription). mTOR has been shown to regulate cell 
differentiation in both murine and human cells through a signaling cascade that includes 
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STAT3. Disregulation of mTOR contributes to poor cell differentiation, which is commonly 
associated with uncontrolled cell proliferation and tumorigenesis (Ma et al. 2010). STAT3 
activity is relevant to cancer inflammation and immunity and as such, this transcription factor 
is observed in cancer cells and immune cells. Its activation is markedly increased in tumour 
cells and also in conditions of high inflammation, strongly indicating that STAT3 could play 
an important role in carcinogenesis. Furthermore, inhibition of the mTOR pathway in various 
cancer cell lines using rapamycin showed a decrease in the STAT3 activity, while 
hyperactivation of mTOR resulted in increased STAT3 activity (He et al. 2014). 
Suppressing agents also work by inhibiting cytochrome P450 enzymes that modulate signal 
transduction to hormone responsive elements. They induce terminal cell differentiation and 
restore immune response (Rashid, 2017).  
Additionally, suppressing agents are likely to reduce or delay metastasis by inducing 
apoptosis, promoting intercellular communication and inhibiting angiogenesis, basement 
membrane degradation, epithelial-mesenchymal transition (EMT), cell invasion and 
dissemination. All these processes lead to the onset of metastasis, a stage that is linked to 
poor clinical outcomes. Cells usually undergo transformations during embryonic development, 
regeneration of tissues or wound healing and this is a process where epithelial cells transition 
to a mesenchimal phenotype. This process is also observed in tumour progression; cancer 
cells exist in various transitional states with mixed epithelial and mesenchymal gene 
expression and this contributes to their ability to circlate in clusters (Roche, 2018). Increased 
N-cadherin expression in pancreatic cancer cells was linked to the acquisition of the 
mesenchymal phenotype (Nakajima et al. 2004) and phytochemicals such as silibinin, 
curcumin and resveratrol showed to modulate EMT pathways to increase expression of E-
cadherin instead, which is associated with the epithelial phenotype (Landis-Piwowar and Iyer, 
2014). By acquiring the mesenchymal phenotype, cancer cells acquire motility properties and 
their invasiveness potential increases, largely dependent on remodelling of the extracellular 
matrix. Inhibiting expression of matrix metalloproteinases (MMPs), for example, enables 
cancer cells to disseminate to other locations less hindered, thus advancing metastasis 
(Landis-Piwowar and Iyer, 2014). 
Still, the role of cancer chemoprevention agents as suppressors is not limited only to delaying 
the promotion and progression stages of carcinogenesis, as they also inhibit metabolism of 
polyamines providing protection from heterocyclic amines, which are known carcinogens 
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found particularly in well cooked meats (Zheng and Lee, 2009). Once a cell undergoes 
initiation, suppressive agents help by enhancing the apoptosis rate of such cells and reducing 
their proliferation (Priyadarsini and Nagini, 2012; Rashid, 2017). 
1.1.5  Targets and Mechanisms of Chemopreventive Agents 
Chemopreventive agents can have various targets, depending on the level of 
chemoprevention. Many molecules involved in cell cycle regulation, inflammation, 
metabolism of carcinogens, inter-cell communication and cell adhesion can be deregulated 
in carcinogenesis. All of these represent potential targets for cancer prevention. 
1.1.5.1 Modulation of signal transduction pathways 
Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-B) is involved in cancer 
progression through its role in regulation of cell cycle progression, apoptosis, proliferation 
and cell differentiation. This family of transcription factors is redox sensitive. Pro-inflammatory 
cytokines interact with the IB family of proteins, which are bound to members of NF-B 
family (Landis-Piwowar and Iyer, 2014). This results in activation of NF-B target genes. The 
NF-B is activated in most tumours (DiDonato et al. 2012). Chemopreventive agents that 
inhibit the NF-B signaling pathway are involved in tertiary chemoprevention due to NF-B’s 
involvement in inflammation, which plays a significant role in carcinogenesis (e.g. colitis-
associated colon cancer, hepatitis-associated liver cancer) (Di Donato et al. 2012; Landis-
Piwowar and Iyer, 2014). Reduced NF-B activity correlates with an increase in apoptosis 
rate. Also, it is important to note that inhibition of NF-B can also make cancers more 
susceptible to treatment (Kuno et al. 2012). 
Pro-inflammatory mediators can bind to cytokine receptor tyrosine kinases, activate Janus 
Kinase-3 (Jak3) and finally activate the mitogen activated protein kinase and extracellular 
receptor kinase (MAPK/Erk) pathway. The MAPK/Erk pathway regulates cell growth, 
proliferation, survival and invasion via the phosphatidylinositol-3 kinase (PI3K) pathway. The 
RAS-Erk and PI3K pathways are activated in inflammation-mediated carcinogenesis and 
their suppression represents a possible target for cancer chemoprevention.  Research shows 
that the effects of the activation of these pathways can be reduced significantly with the use 
of celecoxib, an NSAID (non-steroidal anti-inflammatory drug) (Setia et al. 2014). 
Toll-like receptors (TLRs) are specific transmembrane pattern recognition receptors (PRP) 
expressed on various cells, including immune cells. Cells of immune system respond to 
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various pathogens following their interaction with TLRs, which leads to production of pro-
inflammatory mediators. Recent research indicated a possible role of TLRs in cancer 
development, both as antitumour and pro-tumour promoters. TLR4 is found on membrane of 
immune cells and it shows antitumour effects in skin cancer, pro-tumour effects in prostate 
and head and neck cancer, and both in breast and lung cancer. Activation of TLR4 leads to 
production of IL-6 and IL-8 in breast cancer, as well as increased expression of VEGF and 
TGF-β1 in prostate cancer. It also increases production of NF-B. The TLR4 MyD88 pathway 
promotes carcinogenesis and curcumin, resveratrol, caffeic acid phenethyl ester and 6-
gingerol, among other phytochemicals, can inhibit the TLR4 signalling pathway (Chen et al. 
2018).  
1.1.5.2 Detoxification through cytochrome P450 enzymes 
Cytochrome P450 enzymes represent a superfamily of proteins involved in many significant 
biochemical processes, which involve biotransformation of various endogenous (hormones) 
and exogenous molecules, including carcinogenic substances (Landis-Piwowar and Iyer, 
2014; Rashid, 2017).  
It is known that human CYP1A1, 1A2, 2A6, 2A13, 2E1 and 3A4 enzymes have a major role 
in transformation of carcinogens to their active metabolites, which then cause DNA damage. 
Examples of carcinogenic compounds that can be metabolically activated by the P450 
enzymes are polycyclic aromatic hydrocarbons (PAH), arylamines and heterocyclic amines, 
but also estrogens and mycotoxins such as aflatoxins (Shimada, 2017). Increased 
expression of these proteins is noticed in tumours (Landis-Piwowar and Iyer, 2014). Inhibition 
of CYP-450 is the mechanism of action for certain blocking chemopreventive agents such as 
curcumin. These agents prevent formation of highly electrophilic products by inhibiting the 
CYP450. Diallyl-sulfide, present in allium vegetables, has the same mechanism of action 
(Rashid, 2017). Aromatase inhibitors block activity of CYP19, resulting in blocked 
transformation of androgens to estrogens (Landis-Piwowar and Iyer, 2014).  
Phase 2 enzymes conjugate the hydrophobic metabolic products of carcinogens to make 
them water-soluble, neutralising their reactivity and promoting their excretion from the body 
(Yu and Kensler, 2005). Induction of the Phase II detoxification enzymes such as glutathione 
S-transferase, UDP glucuronosyltransferase and quinone reductase can help inhibit 
development of cancer. Resveratrol increases detoxification of carcinogens by inducing the 
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activity of these enzymes, apart from also inhibiting activities of some CYP-450 enzymes 
(Chow et al. 2010).  
1.1.5.3 Detoxification through modulation of Keap1-Nrf2-ARE signaling 
pathway 
Nuclear factor-erythroid 2 related factor 2 (Nrf2) is a transcription factor, which interferes with 
the function of cytoprotective enzymes. These enzymes reduce the damage caused by 
carcinogens, electrophiles and free radicals and are involved in antioxidative and detoxifying 
processes.  The transcription factor Nrf2 binds to the antioxidant responsive elements (ARE) 
of cytoprotective genes (Zhao, Gao and Qu, 2010), which represent parts of genes whose 
main products are detoxifying enzymes such as NAD(P)H:quinone oxidoreductase 1 (NQO1) 
and glutathione S-transferases (GST), antioxidant proteins such as glutamate-cysteine ligase 
(GCL), glutathione reductase-1 (GR-1), glutathione peroxidase (GPx), thioredoxin 
redutactase-1 (TrxR1) and haem-oxigenase-1 (HMOX-1/HO-1) and drug transport proteins 
(Higgins et al. 2009). 
As Figure 5 below explains, Keap1-Nrf2-ARE pathway inducers, such as ROS producing 
oxidative stress, act by releasing Nrf2 from the acting binding Kelch-like ECH associating  
protein 1 (Keap1), leading to the accumulation of Nrf2 in the cytoplasm and its translocation 
to the nucleus, where it forms a heterodimer with small Maf proteins. This heterodimer binds 
specifically to the AREs of genes promoting the induction of cytoprotective enzymes (Zhao 
et al. 2010). Target genes of Nrf2 are involved in a plethora of processes: glutathione 
synthesis and conjugation, metabolism and transport of xenobiotics through efflux pumps, 
activity of antioxidant enzymes, metabolic genes and transcription factors (Lu et al. 2016). 
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Figure 5 The Nrf2/Keap1 regulatory pathway. Under homeostatic conditions, Nrf2 is localised in the cytoplasm, 
bound to a Keap1 homodimer, which forms a complex with Cullin3-Rbx1 E3 ubiquitin ligase. This facilitates the 
ubiquitination and proteolysis of Nrf2 via the 26S proteasome. Under electrophilic/oxidative stress, the Keap1-
Cul3-E3 ubiquitin complex is disrupted and Nrf2 can translocate to the nucleus where it forms a heterodimer 
with small Maf proteins and binds to the ARE, promoting the transcription of cytoprotective genes. (Source: 
Sznarkowska et al. 2017) 
The ARE element has been accepted as the consensus enhancer element for phase 2 
metabolic enzymes (Rashid, 2017), whilst the transcription factor Nrf2 up-regulates 
transcription of cytoprotective genes in response to chemopreventive inducers (e.g. 
isothiocyanates, allyl-sulfides, coumarins, flavonoids and triterpenoids) or oxidative stress 
(e.g. heavy metals, mercaptans, oxidisible polycyclic aromatic hydrocarbons, peroxides) 
(Dinkova-Kostova et al. 2004 and Yu and Kensler, 2005). What these xenobiotics have in 
common is their thiol-reactive structure that helps them bind to or oxidyse cysteine residues 
in Keap1, leading to the stabilisation/activation of Nrf2 (Higgins et al. 2009). 
Yet, a continuous activation of the Nrf2 pathway is considered to favour carcinogenesis and 
proliferation of cancer cells, as many tumours, especially lung, pancreatic and cervical, show 
high expression of Nrf2. This situation also correlates with anticancer drugs resistance and it 
is still a  complex process not well understood. Still, a down regulation of the Keap1-Nrf2 
pathway can happen because of genetic and epigenetic alterations, cooperation with diverse 
oncogenic pathways or from over-exposure of epithelial cells to oxidative stress, resulting in 
chronic inflammation (Schafer et al. 2014). 
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For example, overexpression of Nrf2 in human breast cancer cells has been linked to 
increased proliferation and migration of these cells and one of the causes for subsequent 
metastasis might be that Nrf2 promotes expression of RhoA, which correlates strongly with 
poor prognosis of breast cancer patients (Zhang et al. 2016; Zhang et al. 2019). RhoA (Ras 
homolog family member A) is a key regulatory enzyme for promotion of motility of cells and 
supports progression of breast cancer (Zhang et al. 2016).    
Therefore, Nrf2 is thought to have a dual role in the development of cancer, so that Nrf2 
inducers play an important role in cancer prevention in healthy subjects (as long as it does 
not disrupt the homeostatic control), whereas Nrf2 inhibitors could contribute to preventing 
cancer progression (Schafer et al. 2014).   
Moreover, newest research suggests a promising role of Nrf1 in prevention of cancer (triple-
negative breast cancer and multiple myeloma) and other diseases (e.g. neurodegenerative, 
hepatotoxic, mitochondrial injury), as it has a critical role in embryonic development, organ 
differentiation and neuronal protection (Yuan et al. 2018). 
1.1.5.4 Reduced expression of enzymes involved in cancer cell invasion 
Metastasis is the main cause of cancer-related death. Extracellular matrix can be remodelled 
by matrix metalloproteinase (MMP) enzymes. In tumours, these enzymes can lead to 
spreading of cancer cells and have a role in neo-vascularization. Therefore, reducing the 
expression of MMP-9 is one of the chemopreventive mechanisms (e.g. curcumin) (Landis-
Piwowar and Iyer, 2014).  
1.1.5.5 Down-Regulation of Cox-2 Pathway 
Prostaglandins (PGs) are molecules which are found in excess in colorectal cancer as well 
as in its precursors, benign polyps. Cyclooxygenases (COX) are enzymes involved in the 
metabolism of arachidonic acid. The COX-2 is the isoenzyme mostly induced by cytokines, 
growth factors and tumour promoters, which leads to increased expression of PGs. This 
causes induction of various growth factors, which promote angiogenesis, and it promotes 
division and spreading of cancer cells. At the same time levels of arachidonic acid are 
reduced which can reduce the rate of apoptosis. Studies have shown that the use of aspirin, 
non-steroidal anti-inflammatory drugs and COX-2 inhibitors leads to colorectal cancer 
prevention and risk reduction in patients with adenomas (Ranger, 2014). 
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1.2.1 Phytochemicals As Bioactive Compounds 
1.2.1  Sources, classes and functions of phytochemicals  
Plant natural products, commonly known as phytochemicals, are broadly classified into 
primary and seconday metabolites.  
 
Figure 6 Example of primary metabolites (Sources: https://pubchem.ncbi.nlm.nih.gov/; Xu, 2002) 
Primary metabolites (sugars, fats, amino-acids, starch etc.) are essential to plant life and they 
occur in all plants, as they are associated with vital processes such as photosynthesis, 
respiration and growth (Sato and Matsui, 2012). Examples of primary metabolites are in 
Figure 6 above. 
Secondary metabolites, although maybe not essential for the plants, do have a role in plant 
defence, allelopathy, pollination and UV protection (Fulda and Efferth, 2015). Therefore, they 
enable a plant’s survival as well as evolution. 
  
42 
 
Plant secondary metabolites have been proven useful for humans not only for their use as 
fibres, dyes, waxes, oils, flavouring and aromatic agents etc., but also for their 
pharmacological activity (Huang et al. 2012; Fulda and Efferth, 2015). Examples of secondary 
metabolites are in Figure 7. 
 
Figure 7 Examples of secondary metabolites (source: PubChem) 
 
Dietary phytochemicals are found in plants used as food – vegetables, fruits, grains and tea. 
Anticancer properties have been shown both for phytochemicals from dietary plants (see 
Table 2) such as garlic – selenium, soy – genistein, crucifers - phenethyl isothiocyanate, 
green tea - epigallocatechin-3-gallate) and non-dietary plants (Pacific yew tree – paclitaxel, 
Camptotheca – camptothecin, Evodia fruits - evodiamine, Madagascar periwinkle – 
vincristine and vinblastine (Oh et al. 2016). 
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Table 2 Chemical structures of some dietary flavonoids with cancer chemoprevention properties 
Dietary 
phytochemical 
Chemical structure 
Caffeic acid 
phenethyl ester 
 
Capsaicin 
 
Curcumin 
 
Diallylsulfide 
 
Epigallocatechin
-3-galate 
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Genistein 
 
Gingerol 
 
Indole-3-carbinol 
 
Lycopene 
 
Resveratrol 
 
Sulforaphane 
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Research into phytochemicals is focused not only on their effects on health, but also on the 
necessary doses and actual amounts that people ingest as food, bioavailability and ways to 
synthesize these compounds. The potency and bioavailability of natural products can also 
be increased by producing synthetic analogues i.e. EF24, the synthetic analogue of curcumin, 
showed a 10-fold potency increase (Amin et al. 2009). 
 
1.2.2  Polyphenols 
Polyphenols are the biggest group of phytochemicals (Tsao, 2010). They are produced by 
plants for their protection. The structure of polyphenols can vary a lot and the complexity of 
the structure is also highly variable. The simplest polyphenols can occur as simple phenolic 
molecules such as catechol while the complex polyphenols are highly polymerized molecules 
with large molecular size such as raspberry ellagitannin.  In nature, these compounds are 
present in conjugated form i.e. glycosides with one or more sugar residues substituting 
hydroxyl groups. The sugar residue can be monosaccharide, disaccharide, or polysaccharide 
(Bravo, 1998). These compounds suppress formation and neutralise already formed free 
radicals by absorbing and delocalising an electron from ROS. Also, they can stop damage 
caused by highly reactive hydroxyl radicals by reducing the rate of Fenton reaction. The 
positive health effects that polyphenols exhibit is considered complex. It is assumed that 
these chemicals also act as cell-signalling modulators, inhibitors of xanthine oxidase and 
inducers of superoxide dismutase, glutathione peroxidase and catalase (Tsao, 2010). They 
have features of phenolic structure and can be classified based on their function, source or 
chemical properties. Chemical subgrouping of polyphenols includes phenolic acids, 
flavonoids, polyphenolic amides and other polyphenols (Tsao, 2010).  
Phenolic acids can be found in free form in vegetables and fruits, while in seeds and grains 
they are mostly in the bound form. Hydrobenzoic acids can be found in vanilla, tea, 
raspberries, rhubarb etc., while hydroxycinnamic acids can be found in cinnamon, coffee, 
plums, kiwi, and wheat bran. 
Capsaicin found in chilli peppers is one of the most investigated phenolic amides. Another 
member of this group, avenanthramide, is found in oats. Resveratrol, curcumin and ellagic 
acid belong to the miscellaneous group of polyphenols and can be found in grapes and wine, 
turmeric and berries, respectively. This group also includes lignans found in sesame seeds 
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and grains (Thomas et al. 2015). Citrus fruits also contain polyphenolic compounds and the 
concentration of the polyphenolic compounds in citrus fruits depends upon the variety of the 
fruit as well as the growing conditions (Muscatello et al. 2018). Neohesperidosides are found 
in grapefruits, bergamot and bitter oranges. The bitter taste of these fruits is partially due to 
the bitter taste of Neohesperidosides. Rutinosides are tasteless polyphenols that are found 
in mildly tasting citrus fruits such as oranges, lemons, and tangerines.  
The activity of flavonoids as antioxidant chemicals varies based on their chemical structure 
and glycosylation patterns. Their biggest subcategory and also the one most often found in 
plants comprises flavones (e.g. apigenin, acacetin), flavonols (e.g. kaempferol, quercetin), 
flavanones (e.g. naringenin, pinocembrin) and flavanonols (e.g. taxifolin) (Thomas et al. 
2015). Less commonly found in plants are neoflavonoids, while the greatest source of 
isoflavones are leguminous plants. Black rice and red, blue and purple coloured parts of 
plants contain anthocyanidins. Proanthocyanidins are condensed tannins, while flavanols 
with strong antioxidant activity (catechin and epicatechin) are the main phytochemicals found 
in tea and chocolate and are known as tannins (Tsao, 2010; Thomas et al. 2015). 
Flavonoids 
Flavonoids constitute approximately 4,000 natural polyphenolic compounds, predominantly 
found in plants. Some of the properties like carcinogen inactivation, anti-oxidation, anti- 
Alzheimer's disease, anti-proliferation, cell cycle arrest, induction of apoptosis and 
differentiation, inhibition of angiogenesis, and multidrug resistance reversal make flavonoids 
a significant subject of research (Krishnadhas, Santhi & Annapurani, 2016). The compounds 
of flavonoids can be categorised as flavones, flavonols, flavanones, isoflavones and 
anthocyanidins (Hamed et al. 2019). Flavonoids constitute diverse chemical structures that 
contain 15 carbon atoms and exhibit the framework of C6-C3-C6, formed using two A-B 
aromatic rings, which are linked with a three carbon unit (Awouafack, Tane & Eloff, 2013). 
Extraction of flavonoids  
The extraction of flavonoids is generally used using the processes of refluxing, heating and 
boiling. However, before the extraction process is applied to the plants, the samples need to 
be prepared. Samples from different parts of the plants are dried and ground for the purpose 
of extraction of flavonoids (Rabeta & Lin, 2015). The yields on extraction of flavonoids are 
influenced by multiple factors including temperature, time duration, and ratio of water to 
solvents in case of aqueous mixtures (Tan et al. 2014). Some of the methods used for the 
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extraction of flavonoids from natural products include maceration, infusion, decoction, 
percolation, hot continuous extraction (Soxhlet), ultrasound-assisted extraction and 
microwave-assisted extraction. While undertaking these extraction processes, a number of 
solvents are used like water, methanol, ethanol, acetone, n-butanol, chloroform and ethyl 
acetate. Several studies have also shown that the processes of maceration and infusion are 
mostly used to extract flavonoids from the plants (Munhoz et al. 2014). For instance, the 
study by Jäger et al. (2010) found that the maceration and infusion were utilised to prepare 
herbal tea from Viscum album L., which yielded about 30-40% of flavonoids- substances. 
Another process used for extraction is decoction, which is known as a simple, convenient 
and cheap method of extracting flavonoids. The study by Chaisawangwong & Gritsanapan 
(2009) proved that the use of decoction method provided with the maximum flavonoids 
extractions at 17.54 mgRE/g, as compared to any other methods in dried-young flowers. 
Similarly, Vaidya et al. (2014) had undertaken the extraction of flavonoids contents from the 
seeds of Ziziphus mauritiana using different methods like maceration, decoction, Soxhlet 
extraction and sonication. The study reported that the maximum contents of flavonoids are 
extracted using sonication extraction method. 
Furthermore, the microwave-assisted technique is another extraction process which is 
considered superior than these conventional extraction processes. The key difference is that 
in the microwave-assisted technique, the heat and mass gradients during the process move 
from inside to outside (Veggi et al. 2013). In this extraction process, the solvent penetrates 
into the solid matrix, then the constituents breaks down or solubilize, and the solvent 
transports outside the matrix and then to solution, and finally, the extract and solid separates 
and discharges (Aguilera, 2003). The research by Zheng et al. (2016) extracted flavonoids 
from corn silk (Zea mays L.) using microwave-assisted solid-liquid method, and found a good 
yield of 1.13% and recommended the use of the plant for the development of natural 
antioxidant reagents in food products. 
However, Zhang et al. (2011) claims that many useful compounds are lost during these 
extraction processes of flavonoids majorly owing to the chemical reactions of oxidation and 
hydrolysis and long- time of extraction process. Further study by Rodríguez-Pérez et al. (2015) 
entails that the efficacy of ultrasound is effective in extracting the active compounds while 
processing flavonoids, since ultrasonic amplifiers exhibit strength that breaks down the cell 
walls and release compounds in liquid extraction.  
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Structural characterisation of flavonoids (NMR or MS) 
The flavonoids once extracted are elucidated for spectroscopic spectra using different 
techniques like Nuclear Magnetic Resonance (NMR), Mass Spectrometry (MS), 
spectrophotometric ultra-violet (UV) and infrared (IR). Some of the structural properties of 
flavonoids that are observed include melting point, circular dichroism and optical rotatory 
power. The nuclear magnetic resonance technique can be undertaken using 1D or 2D 
analyses, such that the former check for the protons signals and carbon summary and types.  
The basic structural skeleton of flavonoids is presented in Figure 8.  
 
 
Figure 8 Structural backbone of flavonoids (C6-C3-C6) showing a chromane ring (A and C) attaching a second 
aromatic ring (B) in position 2, 3 or 4. Source: Balentine et al. 2015 
Markham and Mabry (1975) provided the values of chemical shift values of protons and 
carbons using NMR in certain flavonoids, which are summarised in Table 3 below. 
Furthermore, 2D NMR techniques are employed in order to assess the correlation of proton-
proton or other NMR nuclei, as follows: COSY (homonuclear correlated spectroscopy) shows 
the correlation between protons coupled to each other,  HMQC (heteronuclear multiple 
quantum coherence) shows the correlation between protons and carbon signals (including 
longer range couplings), HSQC (heteronuclear single quantum coherence) provides 
information on C-H correlations with high resolution for carbon signals, HMBC (heteronuclear 
multiple bond connectivity) shows proton-carbon correlations that are 2 or 3 bonds away from 
each other, NOESY (the nuclear over-hauser spectroscopy) shows signal correlations 
between protons that are close to each other in space, while a TOCSY technique (total 
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correlated spectroscopy) can reveal even smaller proton couplings that COSY cannot 
(Awouafack et al. 2017).  
Table 3 Chemical shifts (ppm) assigned to  proton and carbon atoms in a flavonoid structure. Source: Markham 
& Mabry, 1975 
Chemical shifts (ppm) 1H 
2 - 3 H-3 (flavanone), CH3 aromatic 
4 - 6 H-2 (flavanone, dihydroflavonol) 
6 - 8 A- and B-ring protons 
8 - 8.5 H-2 isoflavone 
12 - 14 5-OH when C=O at C-4 (usually observed in DMSO-
d) 
Chemical shifts (ppm) 13C 
210 - 170 C=O 
165 – 155 (no ortho/para oxygenation) Oxygenated aromatic carbons 
150 – 130 (with ortho/para oxygenation) Oxygenated aromatic carbons 
135 – 125 (para substitution) Non-oxygenated aromatic carbons 
125 – 90 (with ortho/para oxygenation) Non-oxygenated aromatic carbons 
80 - 40 Non-oxygenated (C-2, C-3 flavanone/flavanol) 
28 - 35 C-4, flavanol 
 
Another important technique of analysis is infrared spectroscopy. The research by 
Awouafack et al. (2017) showed that the flavonoids with hydroxyl groups exhibits maxima 
large band absorptions, estimated at 3300-3600 cm-1. The study also shows that the 
flavonoids with carbonyl groups show intense band absorption at 1680 cm-1, and shifts to 
1620 cm-1 when hydroxyl and carbonyl groups are chelated. It has also been found that due 
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to the aromatic double bands, the flavonoids form sharp and intense absorption bands in the 
range of 1600 cm-1 and 1500 cm-1.  
Furthermore, ultraviolet absorption (UV) spectroscopy usually shows two absorption ranges 
for the two bands I and II from A- and B- rings. The results show that the maxima absorption 
in these cases is achieved at a range of 300 - 250 nm and 240 - 285 nm, respectively 
(Awouafack et al. 2013). The detailed results as obtained by Markham (1982) for the two 
bands using ultraviolet spectroscopy in different flavonoids are shown in Table 4. 
Table 4 Wavelength bands typical for various classes of flavonoids. Source: Markham, 1982, pp. 144 
Band II (nm) Band I (nm) Flavonoid class 
250 - 280 310 – 350 Flavone 
250 - 280 330 – 360 Flavonols (3-OH substituted) 
250 - 280 350 – 385 Flavonols (3-OH free) 
245 – 275 
310 – 330 shoulder 
320 peak 
Isoflavone 
Isoflavones (5-deoxy-6,7-dioxygenated) 
275 – 295 300 – 330 shoulder Flavanones and dihydroflavonols 
230 – 270 340 – 390 Chalcones 
230 - 270 380 – 430 Aurones 
270 - 280 465 - 560 Anthocyanidins and anthocyanins 
 
1.2.3  Terpenoids 
Terpenoids are a class of isoprenoids that consist of two or more isoprene units (C5H8) 
(Sarker and Nahar, 2007, p. 331). They are isolated from plant sources and used 
commercially as artificial flavour, fragrance, antimalarial drugs as well as anticancer drugs 
(Martin et al. 2003). Terpenoids are derived from terpenes with multicyclic structures and O-
containing functional groups (Nič et al. 2009). Terpenoids represent a diverse group of 
phytochemicals that are linear or cyclical and can be classified into monoterpenoids (2 
isoprene units), sesquiterpenoids (3 isoprene units), diterpenoids (4 isoprene units), 
triterpenoids (6 isoprene units, e.g. sterols) and tetraterpenoids (8 isoprene units) (Huang et 
al. 2012). Sometimes, they are classified as carotenoids (members of the tetraterpenoids 
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subgroup) and non-carotenoid terpenoids (Thomas et al. 2015). Subclasses and their 
representative compounds, as well as their effects on health, mechanisms of action in cancer 
and cancer localizations they show effect in are described in Table 3 (Huang et al. 2012). 
Still, it is thought that the full potential of terpenoids as anticancer agents is not fully 
investigated yet and needs further confirmation in interventional studies (Huang et al. 2012). 
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Table 5 Subclasses of terpenoids and their chemopreventive properties (Source: Huang et al. 2012) 
Terpenoids 
subclass 
 Subclass 
representative 
Sources Health-related 
properties 
Chemopreventive action Localizations for 
anti-cancer effect 
Monoterpenoids  Limonene Citrus oils Anticancer Anti-angiogenic; proapoptotic; 
antioxidant 
Breast; liver; 
pancreas; stomach; 
colorectal 
 Cantharidin  Chinese blister 
beetles (Mylabris 
phalerata, Mylabris 
cichorii) 
Anticancer; toxicity Proapoptotic Leukaemia; 
colorectum; 
bladder; breast 
Sesquiterpenoids  Artemisinin  Artemisia annua L. Treats infections; 
immunosuppressant; 
anticancer 
Inhibition of cancer cells 
proliferation; chemotherapy 
sensitizer; proapoptotic 
Leukemia; breast; 
ovary; prostate; 
colon; stomach; 
lung 
Diterpenoids  Tanshinones  Salvia miltiorrhiza 
Bunge 
Treats cardiovascular 
diseases; anticancer 
Induction of cancer cell 
differentiation; anti-metastatic 
activity (↓MMP2, ↓MMP9, 
↓NF-kB); anti-angiogenic 
Leukaemia; breast; 
colon; liver 
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 Triptolide  Trypterygium 
wilfordii Hook. f 
Immunosuppressant; 
anti-inflammatory; 
anticancer 
Anti-proliferative All cancer cell lines 
 Pseudolaric acid B Pseudoalari 
kaempferi 
Antifungal; anticancer Anti-angiogenic; Microtubule 
blockage; modulation of 
cancer cell-signaling 
Lung; colon; breast; 
brain; kidney 
 Andrographolide  Andrographis 
paniculata 
Anti-inflammatory; 
↓plasma glucose; anti-
cancer 
NF-kB signaling blockage; 
anti-proliferative; proapoptotic; 
anti-metastatic 
Tongue 
 Oridonin  Rabdosia 
rubescens 
Anticancer Proapoptotic; ↓AP-1, ↓NF-kB, 
↓PI3K/Akt 
Liver; skin; 
colorectum 
Triterpenoids  Celastrol/tripterine  Tripterygium 
wilfordii Hook. f 
Anticancer; anti-
inflammatory 
Tumour growth suppression; 
anti-angiogenic 
Prostate; stomach 
 Cucurbitacin  Cucumis melo L Anti-inflammatory; 
hepatoprotective; 
anticancer 
Induction of JAK/STAT3 
dysfunction 
Uterus; Ovary, 
Lung; Nasopharynx 
 Alisol  Alisma orientalis 
(Sam.) Juzep 
Antihypertensive; ↓lipids; 
anticancer 
Proapoptotic Ovary; Colon 
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Tetraterpenoids  Lycopene  Tomatoes Anticancer Anti-proliferative; anti-
angiogenic 
Prostate 
 β-carotenes  Carrots, spinach, 
sweet potatoes 
Anticancer Pro-apoptotic Breast 
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1.2.4  Organosulfur compounds 
Organosulfur compounds or thiols comprise glucosinolates, allylic sulfides and indoles. A 
sulfhydryl functional group characterizes their chemical structure. Thiols manifest 
chemopreventive activity through ROS scavenging (Huber and Parzefall, 2007). 
Cruciferous vegetables are rich in glucosinolates, sulphur-containing glycosides, which are 
precursors of isothiocyanates and indoles. Besides their anticancer properties, 
glucosinolates are being investigated in cardiovascular and neurological disorders. 
Research shows that they modulate phase I and upregulate phase II enzymes via Keap1-
Nrf2-ARE pathway repression. They also modulate the NF-B signaling pathway (Fuentes 
et al. 2015). Sulforaphane, via epigenetic mechanisms and induction of cytoprotective 
mechanisms, can help in cancer prevention (Dinkova-Kostova and Kostov, 2012). Among 
indoles, the most studied one is indole-3-carabinol, which can be found in Brussel sprouts 
and broccoli (Dinkova-Kostova and Kostov, 2012).  
 
1.2.5  Phytochemicals as chemopreventive agents 
Significant variations in cancer prevalence worldwide have led researchers to investigate 
the epidemiology of cancer (Chikara et al. 2017). Longitudinal observational studies, which 
noted characteristics and habits of individuals and cancer incidence, highlighted diet as a 
significant factor in both onset and progression of cancer (Russo et al. 2010). Research 
shows that about one third of cancers can be linked to improper dietary habits (Ullah and 
Ahmad, 2016). This resulted in numerous studies, which investigated the effects of 
phytochemicals on cancer cells. 
The primary chemopreventive phytochemicals that have been intensively studied include 
polyphenols and sulphur-containing compounds (isothyocyanates and organosulfur 
compounds) (Nair et al. 2007). In mice, pigallocatechin-3-gallate (EGCG), a polyphenolic 
green tea component, increases HO-1 level in endothelial cells, whereas the curcumin from 
turmeric increases the expression of GST, glutathione reductase, epoxide hydrolase, HO-
1 and NQO1 in liver, small intestine and kidney tissues (Shen et al. 2006; Gopalakrishnan 
and Kong, 2008). It has also been suggested that diallyl sulphides from garlic and onions 
are strong inducers of the Nrf2/ARE pathway and can induce NQO1 and HO-1. Also, other 
phytochemicals such as indole-3-carbinol (I3C), coffee diterpenes such as cafestol and 
sesquiterpenes such as parthenolide, have been indicated to have potential 
chemopreventive properties by inducing anti-oxidative stress genes through the Nrf2 
pathway (Gopalakrishnan and Kong, 2008).  
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One of the sulphur containing compounds which has been extensively studied for its 
antioxidant and anti-inflammatory action is an isothiocyanate-sulforaphane (SFN). SFN 
induces the blocking genes (NQO-1, GST, γ-GCS, and UDP-glucuronosyltransferases 
(UGT) through Nrf2 pathway. Studies with Nrf2 knockout mice proved the dependence of 
chemo-preventative activity of SFN on Nrf2 pathway as the upregulation of antioxidant 
genes is blunted in knockout mice. For this study, wild-type Nrf2 mice (nrf2+/+) and Nrf2 
knock out mice (nrf2−/−) were given 9 µmol of SFN every day. The wild type mice showed 
upregulation of antioxidant and detoxification genes while the knockout mice did not show 
any difference in gene expression, which was measured through transcriptional profiling 
(Thimmulappa et al. 2002). Another study performed by McWalter et al. (2004) also reported 
similar results with Nrf2 knockout mice as they also observed increased antioxidant and 
detoxification activities in wild type mice when fed with broccoli based diet but not in 
knockout mice. The increase of antioxidant and detoxification activity as well as 
upregulation of gene expression of blocking genes indicates that SFN plays a vital role in 
blocking of cancer initiation by inhibiting the high oxidative and inflammatory activities in 
body. 
One study by Almagrami et al. (2014) showed that extracts of Acanthus ilicifolius, a 
mangrove plant, significantly decreased lipid peroxidation in rat colon cells, due to its high 
content of phenolics and flavonoids, reducing the number of azoxymethane-induced 
aberrant crypt foci (AOM-induced ACF). Consistent results were obtained in other studies, 
which also showed that isolated phytochemicals such as curcumin (Rao et al. 1993a), 
caffeic acid (Rao et al. 1993b) and diosgenin (Jayadev et al. 2004) could reduce AOM-
induced ACF, and also colon adenocarcinoma. 
The potential chemopreventive mechanisms of phytochemicals include antioxidant and 
anti-inflammatory activities, and regulation of cell cycle and apoptosis (Figure 9). Many 
natural products such as coumarins, diterpenes, indoles, curcuminoids, isothyocyanates or 
plant extracts, e.g., Syzygium formasanum, induce cellular phase II defence enzymes 
through the activation of Nrf2 signaling pathway. They achieve this by inhibiting the 
proteosomal degradation of Nrf2 or by inducing upstream signalling cascades (MAPK, PI3K, 
PKC, PERK), which enhances the translocation of Nrf2 to the nucleus and the subsequent 
expression of detoxifying enzymes such as glutathione-S-transferase (GST), NAD(P)H 
quinone oxidoreductase (NQO1), heme oxygenase 1 (HO-1), glutamylcysteine synthetase 
(GCS), and other antioxidant enzymes via the ARE/EpRE  (antioxidant-responsive 
element/electrophile-responsive element) (Gopalakrishnan and Kong, 2008; Neergheen et 
al. 2010; Iqbal et al. 2018). 
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Figure 9  Mechanisms of chemoprevention exhibited by phytochemicals (Source: Iqbal et al. 2018) 
 
Another important aspect is that phytochemicals have also been shown to work as chemo- 
and radiosensitizers, enhancing the effect of chemotherapeutic agents by promoting cell 
apoptosis. For example, resveratrol, a polyphenol from grapes, increased significantly the 
antiproliferative effect of paclitaxel, but also enhanced the radiation effects by altering the 
cell-cycle progression (Deorukhkar et al. 2007). Also, a terpenoid oridonin makes cells of 
hepatocellular carcinoma more susceptible to arsenic trioxide (Huang et al. 2012). 
Phytochemicals, such as soy isoflavones, could prevent adverse effects in bladder and 
bowel caused by radiation, as well as erectile dysfunction (Ahmad et al. 2008). 
In vitro research as well as numerous epidemiological studies support the cancer 
chemopreventive role of dietary phytochemicals. Lower risk of breast, pancreatic and 
ovarian cancer correlated with higher carotenoids intake, while a lower risk for prostate 
cancer was linked with a higher intake of tomatoes and cruciferous vegetables. Research 
shows that dark chocolate intake was linked to lower risk of colon cancer, coffee 
consumption reduces the risk of skin cancer, and people who drink green tea have lower 
risk of prostate, breast and ovarian cancer. Reduction in lung cancer risk was noted in those 
consuming flavonoids-rich food (Thomas et al. 2015). 
Dietary phytochemicals are potent epigenetic regulators, a function investigated both in 
cancer and other health disorders. Inhibitors of DNA methyltransferases such as curcumin, 
catechin, epicatechin, lycopene, isoflavone daidzein and quercetin have been linked with 
risk reduction for prostate cancer, as well as different levels of antitumour activity. Curcumin, 
apigenin, lycopene, diallyl disulphide, indole-3 carbinol and resveratrol show anti-cancer 
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properties by altering miRNA levels (Meeran, Ahmed and Tollefsbol, 2010; Shankar et al. 
2016). 
1.3 Selected Non-Dietary Plants 
1.3.1 Centaurea asiatica, Centaurea dichroa, Centaurea kirdigensis, Centaurea 
pamphylica, Arctium lappa  (Asteraceae) 
The Asteraceae family is the largest family of flowering plants, and it is found all around the 
world, especially in North America, the Mediterranean region, central Asia and China 
(Panero and Crozier, 2016).   
This family of plants, also called Compositae, encompasses many species of economic and 
medicinal importance. Among these, there are species used for their oils: sunflower oil 
- Helianthus annuus L., safflower oil - Carthamus tinctorius L.; for their medicinal 
importance: anti-malarial - Artemisia annua L., immunity - Echinacea purpurea; for 
industrial purposes: sweetener, Stevia rebaudiana, orange dye, Carthamus tinctorius L. 
and Tagetes patula L., insecticides, Anthemideae; for consumption: artichoke, Cynara 
cardunculus L., endive, Cichorium endivia L., lettuce, Lactuca sativa L. and 
tarragon, Artemisia dracunculus L.  (Dempewolf et al. 2008). 
Compounds of essential oils from the Asteraceae species, including camphor, -pinene, -
eudesmol, Artemisia ketone and thujone, have antibacterial properties against 
Staphylococcus aureus, Salmonella typhimurium, Escherichia coli, Pseudomonas 
aeruginosa and Streptococcus pneumoniae (Rai and Kon, 2013). Lacier et al used disc 
diffusion method to determine the antimicrobial activity of Artemisia echegarayi essential oil. 
Discs diffused with 10 µl of essential oil were used to check the antimicrobial activity and 
for positive control gentamicin discs (10 µg, Britania, Argentina) were used. The inhibition 
zones after 24 h incubation at 37 oC showed that the essential oil was more effective against 
gram positive bacteria. A echegarayi  EO showed highest toxicity towards L. 
monocytogenes CLIP 74903 and B. cereus as their MIC were lowest MIC = 2.4 µg/ml. 
(Laciar et al. 2009). 
Many members of the Centaurea genus (Figure 10) are used as herbal remedies. 
Centaurea amanicola oil shows antibacterial activity against Staphylococcus aureus, 
particularly its sesquiterpenoids. The high content of oxygenated sesquiterpenes in oils 
from Centaurea chamaerhaponticum is responsible for antibacterial activity against 
Staphylococcus aureus, Streptococcus epidermidis, Escherichia coli and Salmonella ser. 
typhymurium (Rai and Kon, 2013). Leaves of Centaurea ragusina L. exhibit both 
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antibacterial as well as cytotoxic properties, which are mostly attributed to isolated 
sesquiterpene lactones (Grienke et al. 2018).  
 
Figure 10 Photo of Centaurea sp. Source: Jouko Lehmuskallio at http://www.luontoportti.com 
Aside from the anti-inflammatory and antioxidant activity, chlorogenic acid found in the 
Asteraceae is effective in carcinogenesis by decreasing cancer cell migration (Belkaid et al. 
2006). Extracts of species of Centaurea have shown antiproliferative and anticancer effects, 
mainly attributed to flavonoids and sesquiterpenes. Apigenin, a flavone found both in 
extracts of Centaurea borysthenica and Centaurea daghestanica, showed cytotoxic activity 
against myeloma cells, and acted synergistically with chemotherapy (Korga et al. 2017). 
Pincomebrin, a flavonoid isolated from Centaurea eryngioides, has shown antibacterial, 
anti-inflammatory and anticancer properties (Rasul et al. 2013). The major targets for the 
anticancer activity of this flavonoid are ROS and NOS downregulation (in colon cancer cells) 
and interference with caspases and Fas/Fas ligand apoptotic pathway (upregulation in the 
case of leukaemia) (Rasul et al. 2013). Fas and Fas Ligand (FasL) are two molecules 
involved in the apoptosis regulation. They are responsible for the apoptosis of thymocytes 
that fail to properly rearrange the TCR genes as well as self-antigen recognizing cells (Volpe 
et al. 2016). 
Bioactive components found in extracts of the aerial parts of Centaurea pamphylica 
(matairesinoside, arctim, matairesinol and pterodontriol) showed significant antioxidant 
activity (Shoeb et al. 2007). Arctiin, arctigenin’s glycoside, was isolated from several 
Centaurea species (C. pamphylica, C. americana, C. melitensis, C. albonitens), and it has 
numerous pharmacological properties including antibacterial, antidiabetic, antioxidative, 
antiproliferative and antitumour activity (Hamedeyazdan et al. 2017). 
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Arctium lappa L. (Figure 11), most often found in China, Japan and Korea, is used in 
traditional medicine as an anti-inflammatory, antioxidant, diuretic and antihypertension 
remedy. Aside from being consumed as tea or a vegetable, A. lappa has been used for its 
antibacterial and antiviral properties (Sun et al. 2014). This plant represents an anti-
influenza remedy frequently used in Asia (Gao, Yang and Zuo, 2018). Arctigenin and arctiin 
from this plant have also been widely investigated for their effects on metabolic disorders 
and different nervous system disorders such as neurodegeneration, cerebral ischemia and 
Alzheimer’s disease (Gao et al. 2018). 
 
Figure 11 Photo of Arctium lappa. Source: http://www.herbgarden.co.za/mountainherb/seedinfo.php?id=201 
The fruit of Arctium Lappa L. contains arctigenin, a lignan that shows anticancer activity via 
Akt signaling regulation and NF-B inhibition (Sun et al. 2014, Feng et al. 2017) and 
antimetastatic activity in human breast cancer cells via downregulation of enzymes involved 
in cell invasion, migration and angiogenesis - matrix metalloproteinases and heparanase 
(Lou et al. 2017). Further, it was found that arctigenin from this plant inhibits STAT3 in triple-
negative breast cancer cells, (Feng et al. 2017). Interestingly, this compound does not have 
a uniform anti-cancer mechanism of action across different cancer types, so it was found 
that in lung adenocarcinoma (non-small-cell lung cancer) cells it acts by affecting cell cycle 
via inhibition of NPAT expression and subsequent modulation of expression of histones 
(Susanti et al. 2013). A Phase I trial in patients with advanced pancreatic cancer who 
received GBS-01, an A. lappa L. extract rich in arctigenin, showed promising results (Ikeda 
et al. 2016). Another constituent extracted from the seeds of this plant, lappaol F, was found 
to induce cell-cycle arrest in human cancer cells, inhibit growth, activate caspases and 
induce cell death in tumour cells (Sun et al. 2014). 
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1.3.2 Equisetum arvense (Equisetaceae) 
The Equisetaceae family has a single surviving genus with around 15 species. Usually, 
Equisetum plants can be found in damp and shaded places and are distributed all around 
the world. The presence of silica on the stems of these plants is the reason for their historical 
use in cleaning and polishing kitchenware because of their abrasiveness, and they are also 
used as dyes (Saslis-Lagoudakis et al. 2015). In traditional medicine, they are used for 
diuretic effects, kidney and bladder stones and wound healing (Menkovic et al. 2011). 
Phytochemistry of Equisetum arvense (Figure 12) is characterised by the presence of 
caffeic acid derivatives, kaempferol, quercetin glycosides, apigenin, chlorogenic acid and 
luteolin. These compounds show wound healing properties (Ali et al. 2014). A randomized 
double-blind placebo-controlled clinical trial showed that ointment with E. arvense led to 
significant decrease in pain intensity and improvement in wound healing in women following 
episiotomy (Asgharikhatooni et al. 2015).  The essential oil of E. arvense contains mainly 
fragrant acetones and thymol and has shown significant antibacterial activity against 
Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli (Ali et al. 2014). 
Antioxidant activity is attributed to high levels of flavonoids and phenolic acids (Ali et al. 
2014). 
 
Figure 12 Photo of Equisetum arvense. Source: Bobby Hattaway at 
https://www.discoverlife.org/mp/20p?see=I_TQBH11687&res=640 
 
Significant radical scavenging activity was described for E. arvense extracts. Main 
constituents responsible for this antioxidative activity are phenolic compounds. HeLa cells 
(Human cervical cancer) were most sensitive to the effects of different E. arvense extracts, 
but with a biphasic antiproliferative activity (Četojević-Simin et al. 2010). 
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1.3.3 Gardenia ternifolia (Rubiaceae) 
The Rubiaceae family is mostly distributed in the tropics region. As one of the largest in the 
Magnoliopsida class, it ranks fourth in diversity of species among Angiosperms and it 
includes approximately 637 genera and 13000 species. This plant family has an important 
economic, ornamental and medicinal role among the Brazilian flora, with 120 genera and 
1400 species. Representative members of this plant family include coffee (Coffea species), 
ipecac (Carapichea ipecacuanha) used as an emetic, and quinine (Cinchona species), a 
drug used for treating malaria (Karou et al. 2011).  
The taxonomic classification of the Rubiaceae family is complex, but recent studies suggest 
this family is divided into three subfamilies: Rubioideae, Cinchonoideae and Ixoroideae 
(Martins and Nunez, 2015). This family is a source of a large diversity of substances such 
as anthraquinones, carotenoids, coumarins, flavonoids, indole alkaloids, iridoids, 
proanthocyanidins, saponins, tannins, terpenoids (diterpenes and triterpenes) and other 
phenolic derivatives and also bioactive alkaloids such as N,N-dimethyltryptamine (Figure 
13), harmine, and tetrahydroharmine (Karou et al. 2011; Martins and Nunez, 2015). 
 
Figure 13 Chemical structure of N,N-dimethyltryptamine from the Rubiaceae 
(Source:https://pubchem.ncbi.nlm.nih.gov/compound/6089#section=2D-Structure) 
Studies have identified antibacterial, antihypertensive, antimalarial, antidiabetic, anti-
inflammatory and antioxidant properties in plants from the Rubiaceae family (Karou et al. 
2011).  Gardenia ternifolia Schumach.& Thonn. (Figure 14) can be found in sub-Saharan 
Africa (Togo, Mali, Guinea) and it has been used in the treatment of malaria and jaundice 
(roots), infectious diseases (root bark) and as an anti-hypertensive agent (leaves and bark) 
(Karou et al. 2011). Gerdenifolins (neolignans), isolated from Gardenia ternifolia Schumach. 
and Thonn., showed cytotoxic activity against HeLa cells, inhibiting cancer cell proliferation 
and inducing apoptosis (Tshitenge et al. 2017). 
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Figure 14 Photo of Gardenia ternifolia Schumach.& Thonn. Source: D.C.H. Plowes at www.zambiaflora.com 
 
1.3.4 Gypsophila pilulifera (Caryophyllaceae) 
The Caryophyllaceae family of angiosperms comprises about 85 genera and 2,630 species. 
They can be found in Europe, North America, Asia and Australia, but particularly in the north 
hemisphere, and are known for surviving in unwelcoming habitats such as deserts. 
Members of this family are mostly known as ornamental plants, but they also have important 
roles in medicine and toxicology. Spergularia rubra has been used in traditional medicine 
in cases of cystitis, while Saponaria officinalis is thought to aid with skin problems (Chandra 
and Rawat, 2015). 
Phytochemistry of the Caryophyllaceae is characterised by the presence of anthocyanin 
pigments (petals), high level of saponins (roots), phytoecdysteroids, isoprenoids and fatty 
acid derivatives. Ethnomedicinal use of different members of the Caryophyllaceae family 
includes treatment of gastric problems, inflammation of urinary and respiratory tract, fever, 
rheumatism. Pharmacological properties of various Caryphyllaceae species include 
antibacterial, antifungal, antiviral, antioxidant and anti-inflammatory activity. Anticancer 
properties have been described for many plants from this family, including Dianthus 
caryophyllus, Saponaria vacaria L., Sileneae (Chandra and Rawat, 2015). 
Anticancer properties have been noted across different members of the Gypsophila species 
(Figure 15). Extracts of Gypsophila arrostii contain gypsogenins and their derivatives, which 
have antiproliferative effects and cause cell cycle arrest and cell death in various cancer 
cell lines (colorectal cancer, breast cancer, cervical cancer etc.). Compounds found in 
Gypsophila oldhamia have exhibited apoptotic activity in human hepatoma cells via 
activation of caspase-3 and MAPK signaling pathways (Chandra and Rawat, 2015). Extract 
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of G. pilulifera Boiss.& Heidr. contains atriterpenoid saponin which exhibits significant 
cytotoxic activity against human pulmonary adenocarcinoma cells (Arslan et al. 2012).  
 
Figure 15 Photo of Gypsophila fastigiata. Source: Jouko Lehmuskallio at http://www.luontoportti.com 
 
1.3.5 Hyssopus officinalis (Lamiaceae) 
The Lamiaceae family includes about 186 genera and 7,200 species. These plants have 
cosmopolitan distribution, but are most commonly found in the Mediterranean. They are 
widely used in cuisine, industry (perfumes and food flavouring) as well as in medicine, and 
are considered the plants with the largest variety in use (Tamokou et al. 2017). 
Remarkable members of the Lamiaceae family include lavender (Lavandula officinalis – 
perfume industry), culinary herbs such as rosemary (Rosmarinus officinalis), thyme 
(Thymus vulgaris), basil (Ocimum basilicum), oregano (Ocimum vulgare), marjoram 
(Ocimum majorana), medicinal plants such as Salviae, Marrubium vulgare, the Stachys 
genus and Prunella vulgaris. Peppermint originates from Mentha piperita, menthol from 
Mentha arvensis and spearmint from Mentha spicata (Tamokou, 2017).  
Phytochemistry of the members of the Lamiaceae family is characterized by the presence 
of quinones, coumarins, saponins, tannins, phenolic compounds, polyphenols, alkaloid and 
iridoids. Pharmacologically, these plants exhibit antioxidant and antimicrobial activity 
(Tamokou et al. 2017). 
Hysoppus officinalis (Figure 16) is used as a medicinal plant in people with respiratory and 
intestinal disorders. Essential oils from this plant showed strongest antimicrobial activity 
against Klebsiella sp. and Pseudomonas aeruginosa isolated from human sputum 
(Stanković et al. 2016), while another study found strong activity against Staphylococcus 
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aureus, Candida albicans, Escherichia coli and Streptococcus pyogenes (Kizil et al. 2010). 
Yet, the antioxidant activity of this oil was low (Kizil et al. 2010; Stanković et al. 2016). The 
main components of essential oil of Hysoppus officinals are 1,8-cineole, isopinocamhpone, 
-pinene, terpinen-4-ol and pinocarvone (Kizil et al. 2010; Stanković et al. 2016). 
 
Figure 16 Photo of Hyssopus officinalis. Source: Jouko Lehmuskallio at http://www.luontoportti.com 
 
1.3.6 Kitaibelia balansae (Malvaceae) 
The Malvaceae family (order Malvales) comprises around 244 genera and 4,225 species 
(Christenhusz and Byng, 2016). Most of these species can be found worldwide (Taia, 2009). 
Different systems of classification exist for this family of plants, and taxonomy is complex. 
Some authors have included the Hibiscus genus into this family, while others have moved 
it to Bombacaceae, which they consider a separate family (Taia, 2009). The most important 
species when it comes to economic value are cacao (Theobroma cacao), cotton 
(Gossypium species), baobab (Adansonia digitata L.) and hibiscus (Dzoyem et al. 2017). 
Plants from this family have been used in folk medicine, specifically as antiseptics, diuretics, 
medicines used for respiratory diseases, antifertility drugs (abortifacient), and remedies for 
skin disorders, and also gastrointestinal disorders due to their carminative activity (Toyin et 
al. 2014; Vadivel, 2016). Phytochemicals behind these effects include phenolic acids, 
flavonoids and polysaccharides. Namely, important compounds encompass kaempferol, 
luteolin, quercetin, thiamine, riboflavin, entriacontane and myricetin, among others (Toyin 
et al. 2014; Vadivel, 2016).  
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Flowers of the plants in the genus Kitaibelia contain these phytochemicals, as well as 
apigenin and chrysoeriol (Vadivel, 2016). Extract of Kitaibelia vitifolia shows antibacterial 
activity, as well as antioxidant activity by acting as a free-radical scavenger and inhibitor of 
lipid peroxidation (Mašković et al. 2011). Extracts of K. balansae Boiss. (Figure 17), plant 
used as a pain remedy, show significant antiviral activity against herpes simplex virus type 
1 (Dikilitas and Duman, 2018). 
 
Figure 17 Photo of Kitaibelia balansae. Source: Prof. Avinoam Danin at https://flora.org.il/en/plants/KITBAL/ 
 
1.3.7 Solanum anguivi (Solanaceae) 
The Solanaceae family of plants has cosmopolitan distribution. It includes about 98 genera 
and 2,700 species (Yadav et al. 2016). Many of the plants in this family are economically 
important, including potato (Solanum tuberosum), tomato (Solanum lycopersicum), 
eggplant (Solanum melongena), tobacco (Nicotiana tabacum et rustica) and peppers 
(Capsicum sp.) (Oyeyemi et al. 2015; Yadav et al. 2016). Many are important for their 
toxicological properties, such as nightshades, belladonna (Atropa belladonna) and 
jimsonweed (Datura stramonium) (Yadav et al. 2016).  
This family produces wide range of secondary metabolites, among which the alkaloids are 
the most prominent ones. These compounds include tropanes, solanine, scopolamine, 
capsaicin, atropine and nicotine. Capsaicin has shown potent anticancer activity across 
different cancers including lung, breast, stomach, prostate cancer and leukaemia (Zheng et 
al. 2016). The mechanisms of action for anticancer effects of capsaicin involve anti-
metastatic effects, NF-B inhibition, inhibition of MMPs expression, induction of apoptosis 
and upregulation of RIP3 (Zheng et al. 2016). Moreover, steroidal glycoalkaloids (α-
tomatine, α-solanine, α-chaconine etc.) from the Solanaceae plants have antitumour effects 
(Sucha and Tomsik, 2016).  
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Fruits of the Solanum anguivi  (Figure 18), found mainly in Africa, contain many important 
phytochemicals, including flavonoids, tannins, phenols, alkaloids, triterpenoids, steroids 
and saponins (Oyeyemi et al. 2015). This plant has been used as food and in folk medicine 
as an antihypertensive agent, pain ailment, cough expectorant and remedy for skin 
disorders (Oyeyemi et al. 2015). Polyphenolic compounds found in this plant (rutin, caffeic 
acid, chlorogenic acid, gallic acid, quercetin) exhibit antioxidant activity (Elekofehinti et al. 
2013). 
 
Figure 18 Photo of Solanum anguivi. Source: Robert v. Blittersdorff at 
http://www.africanplants.senckenberg.de 
 
1.3.8 Ziziphus mucronata (Rhamnaceae) 
The Rhamnaceae family has a cosmopolitan distribution and comprises around 50 genera 
and over 900 species (Chen and Schirarend, 2007). Members of this family have been used 
as laxatives, dyes and drugs (Rhamnus species). Interestingly, timber of Hovenia, 
Alphitonia and Ziziphus species has been used for musical instruments and fine furniture. 
Besides being used as ornamentals, some plants are also used as food (Ziziphus species 
and Hovenia dulcis) (Chen and Schirarend, 2007). 
There are around 100 Ziziphus species, found mostly in Asia, America and Africa. Most 
important phytochemical constituents include phenolics, flavonoids, tetracyclic triterpenoid 
saponins and proanthocyanidins (Mokgolodi et al. 2011). Ziziphus mucronata contains 
cyclopeptide alkaloids (mucronine J, abussenine A and frangufoline) (Mokgolodi et al. 2011; 
Ibrahim et al. 2012).  
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Ziziphus mucronata (Figure 19) is found in Africa. Ethnomedicinal uses of this plant involve 
relief for chest pain, topical application for wounds, remedy for cough, parasitoses and 
gastrointestinal disorders (Mokgolodi et al. 2011; Ibrahim et al. 2012). Extracts exhibit 
antidiabetic and antibacterial activity (Ibrahim et al. 2012). Extracts of Ziziphus mucronata 
were found to improve cell viability and reduce the harmful effects of amyloid-beta peptide 
on neurons, a protein involved in the pathogenesis of Alzheimer’s disease (Adewusia et al. 
2013). Experimental results indicate that administration of root extracts of Z. mucronata led 
to an increase in serum insulin and lower level of blood glucose (Ibrahim and Islam, 2017). 
Extracts of this plant have shown significant antioxidant activity as radical scavengers, with 
ethyl acetate leaf extract yielding the highest content of phenols (Ibrahim et al. 2012). 
 
Figure 19 Photo of mature Ziziphus mucronata. Source: Michael Briza at 
http://www.krugerpark.co.za/africa_buffalothorn.html 
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1.4 Aims and research outlines 
The aim of this research project was to focus on non-dietary plants in search for bioactive 
compounds that can modulate the Nrf2/ARE signaling pathway, in a positive manner to 
provide cancer chemoprevention effects, or in a negative manner to inhibit Nrf2 activation 
that could be useful for chemoresistant cancers (Wang et al. 2008). The research was 
designed as a bioassay-guided investigation, using the MTT assay followed by a luciferase 
reporter gene assay at each step to measure Nrf2 gene induction. The AREc32 reporter 
cell line is a stable cell line derived from MCF-7 cells that contains a luciferase gene 
construct under the control of the Antioxidant Response Elements (ARE) (Wang et al. 2006) 
-  so that an Nrf2 inducer activating the ARE would cause a quantifiable increase in 
luciferase activity (bioluminscence signal). Untransfected MCF-7 cells, a stable human 
breast adenocarcinoma-derived cell line, was chosen for Western blotting of the 
NAD(P)H:quinone oxidoreductase 1 (NQO1) protein and for the study of cytoprotective 
properties of selected bioactive compounds against ethacrynic acid (ETA). 
Selected plant material will be extracted by refluxing hot solvents (Soxhlet extraction) using 
n-hexane and methanol in the order of lower to higher polarity. The resulting solvent, mixed 
with extracted crude mixtures, will be forced to evaporate, and the crude extracts will be 
assayed for cytotoxicity using the MTT assay. Throughout the bioassay-guided 
investigation, the least cytotoxic concentrations will be used in the luciferase reporter gene 
assay as treatment of AREc32 cells. tBHQ (tert-butylhydroquinone), a synthetic derivative 
of hydroxyquinone and a known activator of the Nrf2 transcription factor, will be used as 
positive control for the induction of Nrf2 in the AREc32 assays. 
The extracts will also be assayed for free-radical scavenging properties using the DPPH 
(2,2-diphenyl-1-picrylhydrazyl)  assay. The flavonol quercetin will be used as positive 
control because of its reproducible free radical scavening activity against DPPH in vitro. A 
diagram describing the research process is presented in Figure 20.  
After identification of bioactive extracts, these will be further fractionated, either by solid-
phase extraction (SPE) with methanol and water for methanol extracts, or by vacuum-liquid 
chromatography (VLC) using a ethyl acetate and n-hexane solvent system for n-hexane 
crude extracts.  
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*Bioassays performed were MTT assays, luciferase assays and DPPH assays 
**Bioassays performed were MTT assays followed by luciferase assays, Western blotting for NQO1 detection 
and MTT assay for quantifying the effect of pretreatment with selected flavonoids on the cytotoxicity of 
ethacrynic acid (ETA) in MCF-7 cells. 
Figure 20 Flow diagram of the bioassay-guided investigation 
 
Fractions will be tested in AREc32 cells via luciferase assay for Nrf2/ARE induction and  
also screened for free radical scavenging properties using the DPPH assay. Methanol 
fractions that are most bioactive in the luciferase assay will further be screened for 
separation of components using HPLC, while the n-hexane fractions will be further 
separated using preparative TLC. The isolated compounds will also undergo screening with 
the luciferase reporter gene assay using AREc32 cells, as well as further investigational 
tests such as the detection of the NQO1 protein, a Phase II enzyme whose expression is 
controlled by Nrf2 activity. 
Selected phytochemicals will also be tested for cytoprotective activity against ETA, as 
oxidative stress inducer, using the MCF-7 cell line, thus gaining a better view of the 
biological role that individual compounds from bioactive mixtures have in cancer 
chemoprevention. 
 
 
 
 
  
71 
 
CHAPTER 2 Materials and Methods 
 
2.1 Phytochemical Methods 
2.1.1 Plant materials 
Aerial parts of Arctium lappa L. (Asteraceae), Equisetum arvense L. (Equisetaceae) and 
Hyssopus officinalis L. (Lamiaceae) were sourced from Romania, Dambovita region. Whole 
dry aerial parts of Centaurea pamphylica Boiss.& Heldr. (Asteraceae) were collected from 
West and East Anatolia, Turkey and the voucher specimen (PHSH0011) exists in the 
herbarium of Plant and Soil Science Department of the University of Aberdeen, UK, and 
Canakkale Onsekiz Mart University, Turkey (COMU). Roots of Gypsophila pilulifera Boiss.& 
Heldr (Caryophyllaceae) and aerial parts of Kitaibela balansae Boiss. (Malvaceae) were 
also received from Turkey, as well as the n-hexane and methanol extracts of Centaurea 
asiatica, Centaurea dichroa Boiss.& Heldr. and Centaurea kirdigensis. Aerial parts of 
Gardenia ternifolia Schumach.& Thonn. (Rubiaceae), roots of Solanum anguivi Lam. 
(Solanaceae) and bark of Ziziphus mucronata Willd. (Rhamnaceae) were received from 
Kenya. Voucher specimens of all plants used in this project are kept at the Centre for Natural 
Products Discovery, the Liverpool John Moores University, UK. 
 
2.1.2 Soxhlet extraction 
All aerial parts of plants were air-dried and ground into powder using a regular spice grinder. 
Thimbles made of thick cellulose filter paper were prepared by hand, filled with ground plant 
material and placed in the Soxhlet apparatus as shown in Figure 21 below. 
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Figure 21 Soxhlet apparatus at the end of a reflux cycle (500 ml) 
Soxhlet extraction was performed on all plant materials, with the exception of Centaurea 
asiatica, Centaurea dichroa and Centaurea kirdigensis, for which extracts were received.  
The solvent extraction was performed with 900 ml of n-hexane and methanol (Fisher 
Scientific) successively, using a 500 ml Soxhlet apparatus, for the following plants: 
Centaurea pamphylica, Gardenia ternifolia, Gypsophila pilulifera, Solanum anguivi and 
Ziziphus mucronata. For the other plants, a 250 ml Soxhlet apparatus was used, refluxing 
500 ml of solvent. 
The solvent extraction was performed for 12 reflux cycles with each solvent for each plant 
material. 
The amounts of ground plant material loaded into the thimbles are shown in Table 6. 
Table 6 Amounts of plant materials used for Soxhlet extraction 
Plant Amount in extraction 
thimble (g) 
Arctium lappa L (root) 91.94 
Centaurea pamphylica (aerial parts) 56.98 
Equisetum arvense (aerial parts) 33.52 
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Plant Amount in extraction 
thimble (g) 
Gardenia ternifolia (aerial parts) 110 
Gypsophyla pilulifera (roots) 105.52 
Hyssopus officinalis (aerial parts) 78.8 
Kitaibelia balansae (aerial parts) 41.94 
Solanum anguivi (roots) 73.84 
Ziziphus mucronata (bark) 100.67 
 
2.1.3 Sample cleaning and separation 
The resulting compound-rich solvents were filtered using filter paper to remove traces of 
plant material (impurities) and samples were concentrated by solvent evaporation using a 
rotary evaporator at 45°C, as depicted in Figure 22. Samples were then left overnight to dry 
out further using an air-pump. 
 
Figure 22 Evaporation of methanol from an extract fraction using a rotary evaporator 
Methanol extracts were further fractionated by solid phase extraction (SPE) with a step 
gradient, as exemplified in Table 7 (Chima et al. 2014). Using Strata cartridges, pre-packed 
with reversed-phase silica C18 (10 g), fractions of 250 ml (F1, F2, F3, F4) were collected in 
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flasks, evaporated and reconstituted at various concentrations to be used in HPLC and cell 
culture assays.   
Table 7 SPE solvent gradient steps 
Step gradient 
(methanol %) 
Water (ml) Methanol (ml) Volume of 
fraction (ml) 
20 200 50 F1 = 250 
50 125 125 F2 = 250 
80 50 200 F3 = 250 
100 0 250 F4 = 250 
 
Samples were prepared by dissolving approximately 1 g of crude methanol (MeOH) extract 
in a 10 ml solution of 10-20% MeOH in water and then added to the cartridge.  
Dissolution conditions for methanol extracts were 1 g of crude extract to 10 ml of 10/20% 
methanol in water, as each sample had slightly different solubility. 
The SPE was performed three times in similar conditions for each extract and resulting 
fractions were pooled in together, before undergoing solvent evaporation using the rotary 
evaporator as shown above. 
 
2.1.4 Analytical TLC and free-radical scavenging assay (DPPH qualitative and 
quantitative assay) 
The analytical TLC performed in this study had the qualitative purpose of observing the type 
of compounds in the n-hexane and methanol plant extracts. 
Sheets of silica gel on aluminium, 20x20 cm (Sigma Aldrich), were spotted with n-hexane 
and methanol solvent extracts and also with quercetin (1 mg/ml) as positive control. The 
spotting was made using microcapillary tubes, 3 successive spottings for quercetin, 3 times 
for the undiluted MeOH extracts and 10 times for the n-hexane extracts, both diluted to 10 
mg/ml. 
The solvent system used was n-hexane:ethylacetate 4:1 for n-hexane extracts and n-
hexane:ethylacetate 3:2 for methanol extracts. The development time was around 40 min. 
Visualisation was performed on developed and dried TLC plates using an UV lamp in 
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shortwave (254 nm) and longwave (365 nm) UV, followed by visualisation with the aid of a 
universal spray reagent of anisaldehyde, which can identify steroids, phenols, terpenes and 
sugars (Touchstone and Dibbons, 1978, p.205). After spraying, the chromatoplates were 
heated in the oven at 110°C for 5 min until full development of spots. 
The anisaldehyde reagent used for derivatisation was prepared fresh before spraying the 
chromatoplates, with ingredients from Sigma Aldrich. The solution was a mix of 10 ml glacial 
acetic acid, 5 ml of sulphuric acid and 55 ml of methanol, cooled to room temperature before 
adding 0.5 ml of p-anisaldehyde mixed in 30 ml of methanol. 
A qualitative DPPH assay was performed by spraying a developed TLC plate with DPPH 
solution (80 µg/ml) and observing a colour change from purple to yellow on spots. This 
colour change shows that the stable free-radical DPPH can been reduced by some 
extracted phytochemicals that can act as free-radical scavengers.   
A further quantitative DPPH test was performed with the aim of calculating the concentration 
at which an extract, fraction or compound exerts a 50% inhibition on the free radical DPPH. 
The positive control used for this assay was quercetin.  
A series of four 10-fold dilutions of the test sample were prepared from a stock solution of 
1 mg/ml. Then, 1 ml of each test solution was mixed with 1 ml of DPPH solution (80 µg/ml) 
and left in the dark for approximately 30 min. A standard of 1 ml MeOH and 1 ml DPPH 
solution was also prepared. A Cole-Palmer spectrophotometer was blanked with a sample 
of methanol and absorbance values were read at 517 nm.  
The readings provided data for curve-plotting of absorbance vs %inhibition and the IC50 was 
calculated (Chima et al. 2014) using the following formula: 
%𝐼𝑛ℎ =
(𝐴𝑏𝑠𝑆𝑡𝑑−𝐴𝑏𝑠𝑆)
𝐴𝑏𝑠𝑆𝑡𝑑
𝑥 100, 
where 𝐴𝑏𝑠𝑆𝑡𝑑 was the absorbance value of the standard, 𝐴𝑏𝑠𝑆 was the absorbance value of 
the test sample and %𝐼𝑛ℎ was the % inhibition of DPPH exerted by the test sample relative 
to the standard. 
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2.1.5 Isolation and identification of phytochemicals 
Isolation of phytochemicals 
HPLC analysis of methanol fractions resulting from SPE fractionation was carried out on 
Agilent Technologies 1260 Infinity, equipped with a Diode Array Detector (DAD) to record 
UV-Vis absorption spectra. Prior to HPLC analysis, samples were dissolved in MeOH. 
Method optimisation for the separation of compounds from mixtures was carried out on the 
preparative Agilent 1260, using a semiprep Phenomenex column (Luna 5 µm C18, 150x10 
mm, serial no. 210456-1), fitted with a guard column (Hichrom). The flow was set to 2 ml/min 
and the injection volumes varied between 50 and 200 µL. 
To isolate compounds, peaks were collected in glass beakers as they eluted through the 
Hichrom prep column (ACE 5 µm C18 phase, 150x21.2 mm, serial no. A121687) at a flow 
rate of 10 ml/min, following injections of 200 to 900 µL, while the concentration of samples 
always aimed to be around 100 mg/ml. 
The purity of isolated compounds was checked on the analytical 1260 Agilent HPLC, using 
a Phenomenex Kinetex column (EVO 5 µm C18 phase, 150x4.6 mm, batch no. 5720-0051), 
fitted with a ‘SecurityGuard’ guard column. The flow was adjusted between 0.8 and 1 ml/min 
and the injection volume between 10 and 30 µL for samples at 10 mg/ml. 
The optimal method for separation of semi-polar compounds resulted from methanol 
Soxhlet extraction is shown in Table 8. 
Table 8 Preparative HPLC gradient method 
Time (min) Water (%) Methanol (%) 
0 70 30 
30 0 100 
40 0 100 (cleaning step) 
42 70 30 (re-equilibration step) 
 
Water and MeOH used for HPLC experiments were sourced from Fisher Scientific and were 
of HPLC grade. Prior to use, trifluoroacetic acid (TFA) was added to solvents to make up a 
0.1% concentration. Bottles were then degassed using helium and the HPLC system was 
always kept free of air bubbles by purging before each experiment. 
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The software used to visualise data on computers linked to the Agilent HPLC system was 
ChemStation. 
Identification of phytochemicals 
NMR (Nuclear Magnetic Resonance) spectroscopy techniques were employed in order to 
characterise the molecular structure of the isolated compounds. For NMR, minimum 
available amounts (1 mg - 10 mg) of isolated compounds were dissolved in deuterated 
methanol (CD3OD, Cambridge Isotope Laboratories) and analysed on a 400 MHz Bruker at 
the Liverpool John Moores NMR laboratory and on a 600 MHz Bruker AMX 600 at the 
University of Botswana. The experiments performed were 1D (one dimensional) and 2D 
(two dimensional) and included the following techniques:  1H (Proton), 13C (Carbon), DEPTQ 
(Distorsionless Enhancement by Polarization Transfer Including the Detection of 
Quaternary Nuclei), 1H -1H COSY (Correlated Spectroscopy), ¹H -¹³C HSQC (Heteronuclear 
Single Quantum Coherence Spectroscopy), ¹H-¹³C HMBC (Heteronuclear Multiple Bond 
Correlation Spectroscopy) and NOESY (Nuclear Overhauser and Exchange Spectroscopy). 
The interface to the NMR equipment was the TopSpin 3 software from Bruker. 
Following tentative assignment of molecular formulas using NMR, samples were sent to 
EPSRC UK, the National Mass Spectrometry Facility at Swansea University, UK. Mass 
spectometry data was acquired on Xevo G2-S ASAP or LTQ Orbitrap XL 1 spectrometers. 
 
2.1.6 Selected phytochemical compounds (flavonoids) used for bioassays 
Genkwanin, naringenin, kaempferol and luteolin were purchased from Cayman Chemical 
Company, USA. Apigenin and quercetin were purchased from Sigma Aldrich, Germany, 
whereas hesperetin, hispidulin and velutin were purchased from Henan Allgreen Chemical, 
China.  Sakuranetin was isolated from methanolic fraction F3 (80% MeOH/water) of "GT-
Me". Table 9 below contains structural details of the compounds. 
Table 9 Polyphenolic phytochemicals used in bioassays and their chemical structure. Structures generated in 
ChemDraw 
Phytochemical compound Chemical structure 
Apigenin  
(4′,5,7-trihydroxyflavone) 
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Genkwanin  
(4′,5-dihydroxy-7-methoxyflavone) 
 
Hesperetin  
(3',5,7-trihydroxy-4'-methoxyflavanone) 
 
Hispidulin  
(4′,5,7-trihydroxy-6-methoxyflavone) 
 
Kaempferol  
(3,4′,5,7-tetrahydroxyflavone) 
 
Luteolin  
(3′,4′,5,7-tetrahydroxyflavone) 
 
Naringenin  
(4′,5,7-trihydroxyflavanone) 
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Quercetin  
(3,3',4',5,7-pentahydroxyflavone) 
 
Sakuranetin/F3GT-Me-PA 
(4′-5-Dihydroxy-7-methoxyflavanone) 
 
Velutin  
(4',5-dihydroxy-,3',7-dimethoxyflavone) 
 
 
2.1.6 Sample naming convention 
Table 10 shows the code names allocated to test samples generated such as the crude 
extracts and resulting fractions. 
Table 10 Code names of plant extracts and fractions 
Full plant name Plant name code 
Crude extract code 
n-hexane methanol 
Arctium lappa  AL AL-He AL-Me 
Centaurea asiatica CA CA-He CA-Me 
Centaurea dichroa CD CD-He CD-Me 
Centaurea kirdigensis CK CK-He CK-Me 
Centaurea pamphylica CP CP-He CP-Me 
Equisetum arvense EA EA-He EA-Me 
Gardenia ternifolia GT GT-He GT-Me 
  
80 
 
Full plant name Plant name code 
Crude extract code 
n-hexane methanol 
Gypsophila pilulifera GP GP-He GP-Me 
Hyssopus officinalis HO HO-He HO-Me 
Kitaibelia balansae KB KB-He KB-Me 
Solanum anguivi SA SA-He SA-Me 
Ziziphus mucronata ZM ZM-He ZM-Me 
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2.2 Cell Biology And Biochemical Methods 
2.2.1 Cell culture 
AREc32 cells were obtained from Prof. Roland Wolf from the University of Dundee. AREc32 
cells were cultured in T25 or T75 flasks with vented caps in 5 ml or 15 ml, respectively, of 
complete medium: Dulbecco’s Modified Eagles Medium High Glucose supplemented with 
10% fetal bovine serum, 1% penicillin-streptomycin (Sigma Aldrich), 1% glutamine and 0.8 
mg/ml of antibiotic G418 (Sigma Aldrich). Incubation conditions were 37°C with 5% CO2 in 
a humidified atmosphere. Cells were split and passaged twice a week. 
For each experiment, cells were removed from flasks when they showed a confluence of at 
least 80%. They were washed twice with PBS (37˚C) and detached from the flasks by 
adding trypsin (Sigma Aldrich) and leaving it for 2 min. Trypsin was then removed and flasks 
incubated for 5 min to allow complete detachment. Cells were seeded in 96-well plates at a 
density of 1.2x104 cells per well in 200 µL of complete medium. Seeded cells were incubated 
for 24 h before treatment. After treatment, experiments were performed following another 
24 h incubation period.  
For the experiments where the MCF-7 cell line was used, cell culture was performed as 
described for AREc32 cells. MCF-7 cells were obtained from Dr. Andrew Evans from the 
Liverpool John Moores University. 
2.2.2 Cytotoxicity Assay 
Cytotoxicity assays on treated cells were performed at every step of the bioassay-guided 
investigation to determine a suitable non-cytotoxic concentration of the extract, fraction or 
compound that could be used in further cell-based assays.  
Cytotoxic activities were profiled using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazoliumbromide) assay, a colourimetric assay for revealing cell metabolism 
activity. A volume of 20 μL MTT solution (5 mg/ml) was added to each treated well and the 
plate was incubated in the dark for approximately 4 h. The vehicle was then removed by 
vacuum aspiration and 100 μL DMSO were added for solubilisation of the purple formazan 
precipitate.  
Absorbances were read at 570 nm on a ClarioStar microplate reader with multidetection 
capabilities (BMG LABTECH, Durham, USA). To normalise the experiment, the average 
absorbance value of blank wells was subtracted from the absorbance value of each control 
and treated well. 
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For the MTT assay, all experiments were performed in triplicate and cell viability was 
calculated relative to control (untreated cells). Data was analysed and visualised in 
Microsoft Excel. 
2.2.3 Cell treatment schedules for the MTT assay 
The treatment of cells with compounds of known molecular weight was performed using 
dilutions of molar concentrations. Typically, a stock solution of 1 mM in complete medium 
containing 10% DMSO (Stock 1) would be prepared first and used to prepare a second 
stock solution of 0.1 mM/1% DMSO (Stock 2) that would be used for treating cells directly 
into the wells.  
The treatment of cells with crude extracts or compounds of unknown molecular weight was 
performed using dilutions of mass concentrations. Typically, a stock solution of 1 mg/ml in 
complete medium would be prepared first, containing 0-10% DMSO (Stock 1), depending 
on the solubility of the compound. Stock 1 solution was used to prepare a second stock 
solution of 0.1 mg/ml (Stock 2) if lower concentrations were required.  
2.2.4 Luciferase Assay for measuring Nrf2/ARE induction 
The luciferase assay was performed 24 h after treatment of AREc32 cells using the Dual-
Luciferase Reporter Assay System kit (Promega, UK) containing lysis buffer, luciferase 
assay substrate and buffer.  The vehicle was removed from each well of the seeded plate 
and then washed with 100 μL of PBS before adding 20 μL of 5X Passive Lysis Buffer diluted 
to 1X with distilled water. For the lysis to take place, the plate was frozen immediately (-
20˚C) and thawed right before the bioluminescence reading. After reconstituting the 
luciferase substrate with the buffer, thawed wells were transferred to an opaque 96-well 
plate and 20 µL of substrate were added to 6 wells at a time, recording the bioluminescence 
readings with a ClarioStar microplate reader.  
2.2.5 Western Blotting 
To determine if compounds induced NQ01, an indicative marker of Nrf2 activity, Western 
Blotting was used in order to show the presence of the NQO1 protein. The cell line used for 
this experiment was MCF-7 and it was cultured in the same manner as in 2.2.1 above, 
without the addition of the G418 antibiotic to the culture medium.   
The cytotoxicity assay described in 2.2.2 was also performed on MCF-7 cells, with a change 
in seeding density to 1 x 104 cells/well in 96-well plates. Cells were treated for the MTT 
assay with varying concentrations up to 50 µM. 
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Once the optimal non-cytotoxic concentration had been calculated (no more than 10% 
toxicity), MCF-7 cells were seeded at 0.3 x 106 cells/well in 6-well plates. Twenty-four hours 
after seeding, the cells were incubated with bioactive compounds for 0, 3, 6, and 24 h. For 
each time point, untreated cells were harvested to produce control samples. Table 11 shows 
the compounds used to treat MCF-7 cells and the respective concentrations applied. 
Table 11  Concentrations (µM) of bioactive compounds used, with tBHQ as positive control  
Bioactive compound Concentration 
(µM) 
Naringenin 5 
Sakuranetin 20 
tBHQ 10 
 
Cell harvest 
For cell harvest, the culture plate was placed on ice and cell monolayers were washed 3 
times with ice cold PBS. After PBS was aspirated, 300ul of RIPA lysis buffer was added to 
each well. Adherent cells were scraped off with a plastic cell scraper and placed in pre-
cooled 1.5 ml micro centrifuge tubes. The micro centrifuge tubes containing the cell lysates 
were placed in a tube mixer at 4°C and left for 30 min at constant agitation, followed by 
centrifugation at 14000 rpm for 20 min. The supernatant was removed and aliquoted to be 
kept at -20°C. 
Protein determination 
The Bradford assay was used for protein determination, following the 2 ml microassay 
procedure from the Bio-Rad protocol, Quick Start™ Bradford Protein Assay.   
Firstly, BSA protein standards (1.25 – 20 µg/ml) were prepared from a stock solution of 2 
mg/ml, with RIPA buffer (Sigma-Aldrich) as diluent. Cell lysates were also diluted 10, 100 
and 1000 times with RIPA buffer to a volume of 1 ml. One ml of protein standard and 1 ml 
of 1X Bradford Dye reagent (Sigma-Aldrich) were added to 2 ml disposable cuvettes and 
incubated in the dark at RT for 20 min. Similarly was performed for cell lysate samples. 
Absorbance readings were recorded at 595 nm using a Cole-Parmer Visible 
Spectrophotometer, blanked with diluent. A standard curve of absorbance versus 
concentration of BSA standard was prepared each time before SDS electrophoresis and 
the linear equation and concentrations of lysates were calculated in Excel. 
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Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS-PAGE)  
In order to resolve the cell lysates, a separation of proteins based on their molecular weight 
was performed using 12% precast polyacrylamide gels with 10 well combs (Mini-Protean 
TGX Stain-Free, Bio-Rad).   
The comb was removed and two precast gels were placed in a Mini-PROTEAN® Tetra Cell 
(Bio-Rad). The cell and wells were filled with running buffer (25 mM Tris, 192 mM glycine, 
0.1% w/v SDS).  
For protein preparation, cell lysates were diluted with RIPA buffer to a concentration of 2 
µg/µL and then mixed with an equal amount of 2x Laemlli sample buffer (Bio-Rad), 
containing 10% 2-mercaptoethanol. Samples were heated at 95°C for 5 min, centrifuged for 
1 min in a mini centrifuge at 6000 rpm and loaded into wells (5 µg) along with a prestained 
molecular weight marker (10-250 kDa). The electrophoresis cell was set to run at 200 V for 
almost 3 h. 
Protein transfer from gel to PVDF membrane 
Proteins were transferred onto 0.2 µm PVDF membranes using the Trans-Blot® Turbo™ 
Transfer System from Bio-Rad. Typically, the membrane was equilibrated (activated) by 
soaking it in methanol for 3 min and then rinsed with transfer buffer (25 mM Tris, 192 mM 
glycine, 0.04% w/v SDS, 20% v/v methanol). 
A semi-dry transfer method was used, with the gel and membrane stacked between two 
filter papers saturated with transfer buffer and making sure no air bubbles were trapped 
between the layers. 
Antibody probing 
After transfer, the membrane was blocked for 1 h at RT in blocking buffer (1X Tris buffered 
saline, 0.1% Tween 20, 5% skimmed powder milk) The membrane was then incubated at 
4°C overnight, in 10 ml of blocking buffer containing the anti-NQO1 primary antibody 
(Abcam, 1:1000). After incubation with the primary antibody, the membrane was washed 
with TBST (1X Tris buffered saline, 0.1% Tween 20) 3 times, each time for 5 minutes. After 
washing, the membrane was further incubated at RT for 3 h, in 10 ml of blocking buffer 
containing HRP-conjugated secondary antibody (rabbit anti-mouse IgG, 1:1000). Following 
incubation with the secondary antibody, the membrane was washed again 3 times, 5 
minutes each time, before signal detection. Throughout the incubation steps, the 
membranes were placed on an orbital shaker to maintain agitation of the buffer and an even 
spread of the antibody. 
  
85 
 
Imaging 
To image the blot, 2 ml of the chemiluminescent substrate (Amersham ECL Western 
Blotting Detection Reagent, GE Healthcare) was applied to the whole membrane.  The 
immunoblot was then covered with plastic film and immediately placed in the CCD imager 
(ChemiDoc XRS+, Bio-Rad) which was controlled by the Image Lab software.  
Reprobing step 
After the first imaging step, a second Western blot was performed in order to reveal the 
control bands of beta-actin. For this, the membrane was sealed in plastic foil  with 10 ml 
harsh stripping buffer (20 ml 10% SDS, 12.5 ml Tris HCl pH 6.8 0.5M, 67.5 ml dH2O, 0.8 ml 
2-mercaptoethanol for 100 ml) and placed in a waterbath for 30 min at 50°C. The membrane 
was washed 5 times with TBST, 5 min each time. 
A second round of antibody probing was performed, as described previously, with the 
distinction that the secondary antibody was anti-beta actin (Abcam, 1:1000).  
2.2.6 Cytotoxicity profile (LD50) of ethacrynic acid following pretreatment with 
bioactive compounds 
MCF-7 cells were seeded in 96-well plates at a density of 1 x 104 cells/well and left to 
recover for 24 h. Afterwards, the cells were pre-treated with bioactive compounds at non-
cytotoxic concentrations for 24 h prior to incubation with ethacrynic acid (ETA), a known 
GSH inhibitor and ROS inducer, at the following concentrations: 0, 3.125, 6.25, 12.5, 25, 
50, 100, 150, 250, 350, 500 and 1000 µM for 24 h. Cytotoxicity was then assessed using 
the MTT assay as described in section 2.2.2. This cytotoxic assessment was carried out on 
two occasions, with a total of 6 test wells per ETA concentration. 
A logarithmic graph was generated for concentration of ETA against cell viability and the 
LD50 was calculated using nonlinear regression (least squares fitting method). LD50 values 
corresponding to wells treated with bioactive compounds were then compared to the LD50 
of the wells treated with ethacrynic acid only. Two-way ANOVA was also performed on the 
data sets obtained to see the effects of  the pretreatment conditions at the various 
concentrations of ETA applied. All data analysis was performed in GraphPad Prism 8.3.1. 
Results were considered significant if P<0.05. 
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CHAPTER 3 Results and Discussion 
Nine plants were subjected to successive Soxhlet extractions with n-hexane and methanol 
to yield the starting crude extracts. These extracts were then qualitatively screened for 
components using thin-layer chromatography. The extracts were also tested for DPPH 
inhibition, as an indication of free-radical scavenging activity. See results in Study 1: Sample 
preparation and Soxhlet extraction of plant materials followed by screening of 
phytochemical composition (TLC) and free-radical scavenging activity of crude extracts 
(DPPH assay), page 87. 
The starting crude extracts were also tested for cytotoxicity in AREc32 cells before being 
screened for Nrf2 induction using a luciferase reporter assay. See results in Study 2: 
Cytotoxicity assay and luciferase reporter assay of methanol and n-hexane extracts of 
selected plants and precipitated compounds, page 94.  
The bioactive crude extracts were further fractionated depending on the available material 
and the fractions were also subjected to the previously mentioned assays. See results in 
Study 3: Chromatographic fractionation of bioactive crude methanol extracts of Centaurea 
dichroa (CD), Centaurea pamphylica (CP), Gardenia ternifolia (GT) and Ziziphus mucronata 
(ZM), followed by cytotoxicity assay and luciferase assay using AREc32 cells and DPPH 
assay of fractions, page 117.  
Main compounds from methanol fractions showing good separation in the HPLC screening 
were isolated and further subjected to spectroscopic techniques (mass spectrometry and 
nuclear-magnetic resonance spectroscopy). See results in Study 4: Identification of 
compounds from bioactive fractions of methanol extracts by means of UV-Vis, nuclear 
magnetic resonance (NMR) and mass spectrometry (MS) analysis, page 127. Similar 
compounds were then purchased to be used in cell-based bioassays and the results are 
presented and discussed in Study 5 of this chapter: Cytotoxicity assay and luciferase assay 
in AREc32 cells of selected polyphenolic compounds: apigenin, genkwanin, hesperetin, 
hispidulin, kaempferol, luteolin, naringenin, quercetin, sakuranetin and velutin, page 145.  
The selected polyphenolic compounds were tested for Nrf2 activity and then for the 
expression of NQO1 in MCF-7 cells (naringenin and sakuranetin), a protein whose 
expression is mediated via Nrf2 induction. See results in Study 6: Determination of NQO1 
gene expression induced by selected phytochemical compounds, page 153.  
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Finally, Study 7 (Effect of selected flavonoids on ethacrynic acid-induced oxidative stress 
in MCF-7 cells, p. 161) presents the results of an investigative experiment into the effect of 
the selected flavonoids in MCF-7 cells under increased oxidative stress induced by ETA. 
 
3.1  Study 1: Sample preparation and Soxhlet extraction of plant materials 
followed by screening of phytochemical composition (TLC) and free-radical 
scavenging activity of crude extracts (DPPH assay)  
Soxhlet extraction yielded various amounts of crude extracts and Table 12 presents a 
comprehensive summary of the starting amount of plant materials and the resulting 
amounts and yields of the n-hexane and methanol extracts.  
Table 12 Summary of crude extracts resulted after Soxhlet extraction. Note that as different sample materials 
have different densities, the masses contained in the same thimble vary. 
Plant material 
Weight (g) 
Extract (g)/%Yield as result of: 
n-hexane 
extraction 
methanol 
extraction 
Centaurea pamphylica (CP) 
56.98 
0.34/0.59%  4.87/8.55%  
Gypsophila pilulifera (GP) 
105.52 
0.30/0.28%  26.15/24.78%  
Gardenia ternifolia (GT) 
110 
0.44/0.39%  14.70/13.36%  
Solanum anguivi (SA) 
73.84 
0.21/0.29%  7.12/9.64%  
Ziziphus mucronata (ZM) 
100.67 
0.36/0.35%  26.38/26.2% 
Equisetum arvense (EA) 
33.52 
0.12/0.37% 3.85/11.48% 
Kitaibelia balansae (KB) 
41.94 
0.17/0.41% 6.88/16.40% 
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Hyssopus officinalis (HO) 
78.8 
0.35/0.45% 8.54/10.83% 
Arctium lappa (AL) 
91.94 
0.25/0.28% 16.49/17.93% 
The highest yields of extraction were reached only for the extraction with methanol, ranging 
from the lowest yield of 8.55% for Centaurea pamphylica up to 26.2% for Ziziphus 
mucronata. The n-hexane extracts registered very low extraction yields of less than 0.5% 
of the amount of raw material. 
During the methanol extraction of GP, GT and ZM, precipitates could be observed. They 
were re-dissolved and concentrated in the case of GP, or filtered out, as in the case of GT 
and ZM. Samples were then sent for NMR and MS analysis for identification. The 
precipitated compounds were labelled as GPS1, GTS1/GTS2, and ZMPH1/ZM1. See 
Section 4.1 for identification results and Appendix B for NMR and MS spectra. 
Moreover, analytical TLC of all extracts revealed that they contain a variety of compounds 
and Tables 13 and 14 on the next page show their retention factors (Rf). The solvent system 
of 20% ethyl acetate in n-hexane worked well for the non-polar extracts, as compounds 
moved from the baseline and were not put close to the solvent front. On the other hand, the 
40% ethyl acetate in n-hexane solvent system used for methanol extracts failed to move 
compounds off the baseline and some were found on the solvent front. Streaking was also 
observed for AL-Me, GT-Me, KB-Me and ZM-Me, which points out that the sample was too 
concentrated when applied to the plate.  
Derivatisation with anisaldehyde reagent revealed in visible light mostly violet and 
pink/purple spots for methanol extracts, indicative of phenolic compounds, but also 
terpenes (mono-, di- or triterpenes) or steroids (Agatonovic-Kustrin et al. 2019). n-Hexane 
extracts also showed pink/purple spots.  
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Table 13 TLC retention factors (Rf) of compounds observed at 254 nm and 366 nm for n-hexane and 
methanol extracts. A 1:4 ethyl acetate:n-hexane solvent system was used for non-polar extracts and a 2:3 
ethyl acetate:n-hexane for methanol extracts. Extra spots were observed after spraying with anisaldehyde 
reagent.  
 n-Hexane extracts 
Solvent front = 8.3 cm 
Methanol extracts 
Solvent front = 9.1 cm 
CP-
He 
GP-
He 
GT-
He 
SA-
He 
ZM-
He 
CP-
Me 
GP-
Me 
GT-
Me 
SA-
Me 
ZM-
Me 
 
 
Rf 
0.06 0.16 0.09 0.06 0.39 0.04 0.80 0.04 0.05 0.32 
0.12 0.36 0.21 0.22 0.51 0.25 - 0.85 - - 
0.25 0.38 0.32 0.36 0.59 0.94 - 0.96 - - 
0.30 0.51 0.36 0.38 - - - - - - 
0.36 0.57 0.51 0.50 - - - - - - 
0.38 - 0.65 0.59 - - - - - - 
 
Table 14 TLC retention factors (Rf) of compounds observed at 254 nm and 366 nm for n-hexane and 
methanol extracts. A 1:4 ethyl acetate:n-hexane solvent system was used for non-polar extracts and a 2:3 
ethyl acetate:n-hexane for methanol extracts. For non-polar extracts extra spots were observed after spraying 
with anisaldehyde reagent. 
 n-Hexane extracts 
Solvent front = 8.7 cm 
Methanol extracts 
Solvent front = 9.3 cm 
EA-He KB-He HO-He AL-He EA-Me KB-Me HO-Me AL-Me 
 
Rf 
0.07 0.05 0.16 0.04 0.05 0.14 0.04 0.17 
0.11 0.36 0.28 0.28 0.17 0.89 0.34 0.58 
0.21 0.41 0.42 0.39 0.94 - 0.45 0.86 
0.27 0.52 0.54 0.49 - - 0.89 - 
0.39 - 0.67 0.65 - - - - 
0.55 - - - - - - - 
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After spraying the TLC plates with DPPH solution for qualitative assay of free-radical 
scavenging activity, colour changes from purple to white/yellow were observed for most of 
the methanol extracts, with the exception of GP-Me. 
For the next step, using the quantitative free-radical scavenging assay method described, 
the DPPH assay was carried out on all crude extracts. Out of all the crude extracts tested 
only the methanol extracts of AL-Me, CD-Me, CP-Me, EA-Me, GT-Me, HO-Me, SA-Me and 
ZM-Me exceeded the threshold of 50% DPPH inhibition (Figures 25 and 26).  
Centaurea asiatica, Centaurea kirgidensis and Gypsophila pilulifera (CA-Me, CK-Me and 
GP-Me) methanol extracts did not show significant free-radical scavenging and the results 
were not reported. 
Chima et al (2014) reports an IC50 value for the methanol extract of  the stems of Gypsophila 
pilulifera in the DPPH assay of 0.02 mg/ml and of almost 0.003 mg/ml for the 50% MeOH 
SPE fraction, compared to the positive control quercetin, which showed 50% inhibition of 
DPPH at 0.0025 mg/ml. 
Quercetin, as a positive control, reached 50% inhibition of DPPH at a concentration 
between 0.001 and 0.01 mg/ml. ZM-Me reached 50% inhibition between 0.01 and 0.1 mg/ml, 
whereas CP-Me, GT-Me and SA-Me at a concentration between 0.1 and 1 mg/ml (Figure 
23). 
 
Figure 23 %Inhibition of DPPH by methanol extracts of CP, GT, SA, ZM and quercetin at 10-fold dilutions 
between 0.0001 and 1 mg/ml. Graph shows the average values of triplicate experiments. 
In another assay (Figure 26), quercetin showed 50% inhibition of DPPH at a concentration 
between 0.001 and 0.01 mg/ml. 
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Figure 24 also shows that AL-Me exhibited a 50% inhibition at the lowest concentration, 
between 0.01 and 0.1 mg/ml, out of the methanol extracts tested. EA-Me, HO-Me and CD-
Me caused a 50% inhibition of DPPH between the concentrations 0.1 and 1 mg/ml, 
representing the lowest IC50, along with CP-Me, GT-Me and SA-Me. 
 
Figure 24 %Inhibition of DPPH by methanol extracts of Equisetum arvense, Arctium Lappa, Hyssopus 
officinalis, Centaurea dichroa and the positive control quercetin at concentrations between 0.0001 and 1 
mg/ml. Graph shows the average values of triplicate experiments. 
 
To increase the precision of the IC50 results, the DPPH assay was performed again for the 
samples that exceeded 50% inhibition at 1-fold dilutions in the range of concentrations 
identified previously.  
Figure 25 shows the concentration-dependent inhibition of DPPH by quercetin at 
concentrations between 0.001 and 0.01 mg/ml, resulting in an IC50 of 0.002 mg/ml. 
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Figure 25 %Inhibition of DPPH by quercetin at 1-fold dilutions between 0.001 and 0.01 mg/ml. Graph shows 
the average values of duplicate experiments. 
Similarly, Figure 26 shows the dose-dependat DPPH inhibition of CP-Me, GT-Me, SA-Me, 
EA-Me and HO-Me at concentrations between 0.1 and 1 mg/ml. The IC50 values calculated 
are presented in Table 13. 
 
Figure 26 %Inhibition of DPPH by CP-ME, GTME, SAME, EAME and HOME at concentrations of 1-fold 
dilutions between 0.1 and 1 mg/ml. Graph shows the average values of duplicate experiments. 
Furthermore, ZM-Me and AL-ME exhibited 50% DPPH inhibition at concentrations between 
0.01 and 0.1 mg/ml and Figure 27 shows the concentration-inhibition curves. The IC50 
values calculated are presented in Table 15. 
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Figure 27 Graph showing the %inhibition of DPPH by ZM-Me and AL-Me at 1-fold dilutions between 0.01 and 
0.1 mg/ml. Graph shows the average values of duplicate experiments 
Using the line equations provided in MS Excel for each concentration curve, y = ax + b, the 
IC50 values of the positive control, as well as of the methanol extracts of AL, CP, GT, SA, 
EA , HO and ZM were calculated as: 
 𝐼𝐶50  (𝑚𝑔 𝑚𝑙⁄ ) =
50−𝑏
𝑎
 , and are shown in Table 15: 
Table 15 The DPPH IC50 values (mg/ml) of methanol extracts of Arctium lappa, Ziziphus mucronata, 
Gardenia ternifolia, Equisetum arvense, Centaurea pamphylica, Solanum anguivi and Hyssopus officinalis, 
and positive control quercetin 
Positive control/Extract IC50 (mg/ml) 
quercetin 0.002 
AL-Me 0.045 
ZM-Me 0.055 
GT-Me 0.344 
EA-Me 0.362 
CP-Me 0.366 
SA-Me 0.398 
HO-Me 0.415 
 
y = 969.8x - 3.4429
R² = 0.9972
y = 985.74x + 4.8326
R² = 0.9872
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According to the IC50 values determined from the DPPH assay it was observed that the most 
bioactive methanol extracts with free-radical scavenging capability relative to the positive 
control quercetin were AL-Me and ZM-Me at 0.045 and 0.055 mg/ml concentrations, almost 
25 times higher than the IC50 value of quercetin. 
The methanol extract of Ziziphus mucronata, which showed significant free-radical 
scavenging potential, second after that of Arctium lappa by 0.01 mg/ml, was also identified 
by Olajuyigbe and Afolayan (2011), who confirm that its bioactivity (IC50 approx 0.04 mg/ml) 
is due to the phenolic compounds found in the bark of this plant.  
 
 
3.2  Study 2: Cytotoxicity assay and luciferase reporter assay of methanol and n-
hexane extracts of selected plants and precipitated compounds 
The methanol and n-hexane extracts of the selected plants obtained from Soxhlet extraction 
were tested for cytotoxicity in AREc32 cells and the cell viability values for each 
concentration tested are shown in the sections below. After identifying a safe and non-
cytotoxic concentration of the crude extracts, they were then applied at the respective doses 
to AREc32 cells for treatment; 24 h later the cells were subjected to a luciferase assay to 
assess the Nrf2-inducing capabilities of the crude extracts. 
Another aim was to check if the free-radical scavenging capabilities showed by the 
methanol extracts of Arctium lappa, Ziziphus mucronata and Gardenia ternifolia in Study 1 
would correlate with a potential Nrf2-inducing capacity.  
 
3.2.1  Cytotoxicity (MTT assay) of tBHQ and luciferase activity induction in AREc32 
cells 
Firstly, the positive control tBHQ was screened for cytotoxicity in AREc32 cells at 
concentrations likely to be used for in vitro assays, between 10 µM and 100 µM (Zhang et 
al. 2005).  
Figure 28 shows the cytotoxic profile of tBHQ in AREc32 cells, which lowered cell viability 
to 27.75% at the highest concentration applied of 100 µM. At 50 µM tBHQ the cell viability 
was kept at 78.04%, while treatment with 10 µM and 25 µM did not seem to disrupt the cell 
viability, as this was 101.81% and 99.95%. 
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Figure 28 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h 
with tBHQ (10-100 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=12) 
Therefore, both concentrations of 10 µM and 25 µM of tBHQ were chosen to be assayed 
for induction of luciferase activity linked to Nrf2/ARE activity, along with the 50 µM 
concentration which had been successfully used in other studies (Zhang et al. 2005). 
Figure 27 below shows the results of the luciferase assay. The highest fold to control 
induction recorded for tBHQ was an average of 27.3-fold, at 50 µM concentration. In a dose-
dependent manner, the 25 µM dose ellicited an induction of luciferase activity of 11.39-fold 
to control, followed by the 10 µM dose with the lowest luciferase induction of 4.47-fold 
control.  
 
Figure 29 Effect of tBHQ on the induction of luciferase activity. AREc32 cells were incubated for 24 h with 
non-cytotoxic concentrations of tBHQ (10-50 µM). DMSO represents the vehicle control and its concentration 
is expressed as v/v%. Values show the average of n=3. 
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Reviewing the results of tBHQ in AREc32 assays, a scale for Nrf2 induction was set: an 
induction of less than 5-fold to control would be considered representative of a low cancer 
induction potential, an induction between 5 and 10-fold would be considered a medium 
potential, while an induction of over 10-fold would be considered high. Moreover, tBHQ at 
10 µM was used as positive control during all luciferase assays for characterisation of 
Nrf2/ARE activity induction. 
 
3.2.2  Cytotoxicity (MTT assay) and Nrf2 induction results (luciferase assay) of 
crude methanol extracts 
Crude methanol extracts of AL, CA, CD, CK, CP, EA, GP, GT, HO, KB, SA and ZM (see 
section 2.1.6 in Chapter 2 for naming convention) were tested using the MTT assay to 
identify a non-cytotoxic concentration suitable to be used in the luciferase assay. Figures 
32 to 45 show the percentage viability of AREc32 cells treated with various concentrations 
of crude extracts, using DMSO as vehicle control. 
AL-Me showed a low increase in cytotoxicity with a cell viability starting to decrease from 
98.07% at the lowest concentration of 10 µg/ml down to 61.11% µg/ml at 1000 µg/ml (Figure 
30). 
 
Figure 30 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h 
with AL-Me (0.01-1 mg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
The first cell viability measurement in the range of concentrations tested that reached to 
over 90% in cell viability was recorded for the effect of the 50 µg/ml dose, which was used 
for the subsequent luciferase assay. 
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Figure 31 shows that the methanol extract of Centaurea asiatica lowered the cell viability to 
60.15% at the highest concentration of 1000 µg/ml. At the concentration of 50 µg/ml the cell 
viability was maintained at 94.32%, compared to 78.27% cell viability caused by the next 
highest concentration of 100 µg/ml and it was chosen for further luciferase assay. 
 
Figure 31 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h 
with CA-Me (0.01-1 mg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Centaurea dichroa caused a higher drop in cell viability of AREc32 cells after overnight 
treatment at concentrtions between 10 and 1000 µg/ml (Figure 32). The cell viabilty dropped 
to as low as 29.01% to untreated control at the maximum concentration of 1000 µg/ml. 
Between 10 and 250 µg/ml the cell viability was maintained around 90%, so that 250 µg/ml 
was considered the most suitable concentrationof CD-Me to be assayed for Nrf2/ARE 
induction. 
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Figure 32 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h 
with CD-Me (0.01-1 mg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
On the other hand, the cytotoxicity profile of the methanol extract of Centaurea kirgidensis 
show low effects on the AREc32 cell viability (Figure 33), with the highest concentration of 
1000 µg/ml lowering the cell viability to 75.74%. Overall, the cell viability was maintained 
between 76.10% at 100 µg/ml and 91.84% at 10 µg/ml and the latter dose was used in the 
following luciferase assay.  
 
Figure 33 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h 
with CK-Me (0.01-1 mg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Between 25 µg/ml and 750 µg/ml, CP-Me (Figure 34) caused a decrease in cell viabilities, 
from 97.5% to 86.6%, but as the concentrations increased from 1 to 6 mg/ml, cell viability 
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values decreased consistently to under 47.3% and 0.1 mg/ml was considered the 
appropriate dose for the luciferase assay. 
 
 
Figure 34 Cell viability percentage of control (0 mg/ml) observed after treatment of AREc32 cells for 24 h with 
CP-Me  (0.025-1 mg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Figure 35 below shows that the methanol extract of Equisetum arvense had a low 
cytotoxicity in AREc32 cells, varying between 99.51% at 10 µg/ml and 81.97% at the highest 
concentration of 1000 µg/ml. However, only at doses lower than 50 µg/ml could the cell 
viability be maintained at over 90%. Therefore the concentration of 50 µg/ml was considered 
the most appropriate for further testing in the luciferase assay. 
 
Figure 35 Cell viability percentage of control (0 mg/ml) observed after treatment of AREc32 cells for 24 h with 
EA-Me (0.01-1 mg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
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Moreover, the treatment of AREc32 cells overnight with a range of concentrations of GP-
Me (Figure 36), caused the cell viability to decrease steadily from 94.82% to 78.78% over 
the range of 25 µg/ml to 70 µg/ml. Between 100 µg/ml and 1000 µg/ml the cell viability was 
maintained between 84% and 89%, so that the most suitable dose was identified at 25 
µg/ml, this being the only concentration that could ensure a cell viability of over 90%. 
 
Figure 36 Cell viability percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h with 
GP-Me (0.025-1 mg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
 
Furthermore, AREc32 cells treated with the GT-Me extract at concentrations between 25 
and 1000 µg/ml showed varying viabilities between 117.23% and 89.96%, as shown in 
Figure 37. Higher error bars were recorded for the effects of the concentrations in the mid-
range, 70 to 750 µg/ml, as well as cell viabilities of over 100%. This could be down to 
variation in the sample preparation, including poor mixing of the plate during formazan 
dissolution in DMSO. It could also be noted that a high ±SEM was also recorded for the cell 
viability% exerted by GT-Me at 1000 µg/ml. This could mean that at concentrations of over 
100 µg/ml the phytochemical extract solubilises with more difficulty and creates highly 
variable results in the MTT assay, but also that the GT-Me extract might have a direct 
interaction with the MTT molecules, reducing it to excess formazan. Altogether, 25 µg/ml 
was considered a safe non-cytotoxic concentration of GT-Me that could be assayed for 
luciferase activity in AREc32 cells. 
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Figure 37 Cell viability percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h with 
GT-Me (0.025-1 mg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
 
The methanol extract HO-Me (Figure 38) exhibited a very high cytotoxicity at concentrations 
750 µg/ml (27.48% cell viability) and 1000 µg/ml (7.88% cell viability), otherwise maintaining 
a steady decline from 99.52% at 10 µg/ml to 78.92% at 500 µg/ml. It was determined that 
the concentration of 100 µg/ml of HO-Me which caused a 97.84% viability of AREc32 cells 
would be appropriate for the luciferase assay, as the next highest concentration, 250 µg/ml, 
lowered the cell viability to 81.83%. 
 
Figure 38  Cell viability percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h with 
HO-Me (0.01-1 mg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
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Another methanol extract tested for cytotoxicity, KB-Me, (Figure 39) showed a very high 
cytotoxicity at concentrations between 500 µg/ml (1.60% cell viability) and 1000 µg/ml (3.76% 
cell viability). Overall, 10 µg/ml proved to be the highest dose that reached a cell viability of 
over 90%, namely 94.69% and was considered suitable for the luciferase assay in AREc32. 
 
Figure 39 Cell viability percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h with 
KB-Me (0.005-1 mg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
The MTT assay for methanol extract of Solanum anguivi, SA-Me (Figure 40), showed a high 
decrease in cell viability from 105.90% at the lowest concentration of 5 µg/ml to 9.11% at 
1000 µg/ml. The second lowest concentration of 10 µg/ml caused a cell viability of 84%, 
which was considered too low to be used in the luciferase assay, therefore the 5 µg/ml 
concentration was considered more suitable. 
 
Figure 40 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h 
with SA-Me (0.005-1 mg/ml). DMSO represents the vehicle control and its concentration is expressed as 
v/v%. Results show the mean +/- SEM (n=3, 3 replicates) 
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For the Ziziphus mucronata methanol extract, ZM-Me, (Figure 41), cell viabilities varied 
between 120.43% and 99.09% at concentrations between 25 µg/ml and 1000 µg/ml with 
relatively high ±SEM throughout. 
 
Figure 41 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h 
with ZA-Me (0.025-1 mg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
During the cell viability assay of ZM-Me, a visual observation was made soon after adding 
MTT solution to the vehicle in the wells: the vehicle would exhibit a dose-dependent purple 
colour similar to that of solubilised formazan so that with increased extract concentration 
applied, the more intensely the colour would be observed. This observation was 
inconsistent with the fact that a higher concentration normally causes a low cell viability, 
hence a lighter colourisation. Compared to the development of other plates, this was the 
only case of vehicle colourisation, which meant that the cell culture wells should be washed 
at least two times with PBS before replacing the culture medium and adding the MTT 
solution, as phytochemicals could react with the tetrazolium salt in the well, reducing it. This 
possibility has in fact been reported by Bruggisser et al. (2001). 
Thus, to confirm that the methanol extract of ZM-Me reduced the MTT by direct interaction 
in the cell culture medium, the hypothesis was tested by tailoring a mock-cell viability assay 
where no cells would be seeded. Figure 42 shows that the hypothesis proved to be true, as 
the extract reduced the MTT in a dose-dependent manner in the absence of cells. 
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Figure 42 Simulation of MTT assay on ZMME extract (0.025-1 mg/ml) without seeded cells. The methanol 
extract reacts with the MTT in the culture medium in a concentration-dependent manner. 
Finally, a new MTT assay was performed where the culture medium was removed from the 
wells prior to a washing step with PBS and adding fresh medium containing MTT. Figure 
43 below shows the results of the second MTT assay where the results were consistent 
with expectations; the cytotoxicity was markedly increased throughout the range of 
concentrations used for treatment of AREc32 cells. Moreover, the cytotoxicity exhibited at 
the highest concentration of 1000 µg/ml dropped 72.2% down to 26.88%, whereas at the 
lowest concentrations of ZM-Me, 25 and 30 µg/ml, the cell viability was maintained at over 
100%, decreasing to 91.57% at 40 µg/ml and under 77.28% from 50 µg/ml to 1000 µg/ml.  
 
Figure 43 Cell viability percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h with 
ZM-Me (0.025-1 mg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates). 
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Therefore, the most appropriate concentration of ZM-Me to be used in the luciferase assay 
for Nrf2 induction screening was 40 µg/ml. 
 
3.2.3 Results of luciferase assays of crude methanol extracts in AREc32 cells  
Following the MTT assays, the methanol extracts were tested in the luciferase assay for 
assessing their Nrf2 induction capabilities.  
As Figure 44 shows, four methanol extracts distinguish themselves out of twelve methanol 
extracts tested, with the positive control tBHQ (10 µM) showing 5.6-fold to control induction. 
The methanol extract of Centaurea dichroa, CD-Me (250 µg/ml), exhibited the highest 
luciferase induction with 22.8-fold to control, followed by the methanol extract of Centaurea 
pamphylica, CP-Me (100 µg/ml), with 11.2-fold to control induction.  
The methanol extract of Gardenia ternifoia, GT-Me (750 µg/ml), showed medium cancer 
chemopreventive potential and it was the third most bioactive methanol extract, with a 8.9-
fold to control induction of luciferase activity, followed by the methanol extract of Ziziphus 
mucronata, ZM-Me (40 µg/ml), which reached a fold induction of 3.7, lower than that of the 
positive control tBHQ. 
CA-Me and CK-Me showed similar luciferase activity, 2.2-fold to control, although CA-Me 
was applied at a higher concentration than CK-Me (50 vs 10 µl). 
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Figure 44 Effect of methanol extracts on the induction of luciferase activity and tBHQ as postive control. 
AREc32 cells were incubated for 24 h with non-cytotoxic concentrations of methanol extracts of AL, CA, CD, 
CK, CP, EA, GP, GT, HO, KB, SA and ZM. DMSO represents the vehicle control and its concentration is 
expressed as v/v%. Values show mean +/- SEM (n=3, 3 replicates), control=1. 
The methanol extracts that showed the lowest cancer chemopreventive potential (less than 
5-fold induction to control, arbitrarily set at 1) were: EA-Me (1.85-fold), HO-Me (1.7-fold), 
GP-Me (1.48-fold), AL-Me (1.17-fold), KB-Me (1.27-fold) and SA-Me (0.92-fold). 
An inverse correlation was observed between the free-radical scavenging properties of the 
methanol extracts and their cancer chemopreventive potential. So that CD-Me, CP-Me and 
GT-Me showed the lowest DPPH %inhibition, with IC50 values between 0.1 and 1 mg/ml, 
while increasing luciferase activity over 10-fold in AREc32 cells at concentrations in the 
same range.  
For ZM-Me the same trend was observed; while it showed high free-radical scavening 
compared to other extracts (second to AL-Me), it increased luciferase activity less than the 
positive control tBHQ (5.6-fold). ZM-Me had an IC50 of 0.055 mg/ml in the DPPH assay,  
while the concentration used in the luciferase assay was 0.04 g/ml.  
DMSO used at 1% v/v in the well to help dissolution of phytochemicals showed an effect on 
cell viability after 24 h of treatment, as the cell viability decreased to 75% in the case of the 
Gypsophila pilulifera methanol extract. However, DMSO did not show any effect on the 
luciferase activity in AREc32 cells, measuring a 1-fold to control induction, which can 
indicate the possibility that a higher dose of GP-Me could have exerted a higher effect on 
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the luciferase activity. In the context of low bioavailability of dietary phytochemicals, the 
concentrations used for in vitro assays should also be of the lowest achievable 
concentration that can exert a quantifiable effect.  
 
3.2.3 Cytotoxicity (MTT assay) and Nrf2 induction (luciferase assay) of crude n-
hexane extracts 
All n-hexane extracts were assessed for cytotoxicity using the MTT assay, at concentrations 
between 5 and 1000 µg/ml, before screening them for luciferase activity induction, an 
indicator for activation of the Nrf2/ARE signaling pathway that upregulates the expression 
of cytoprotective genes and enzymes to protect gainst reactive species (Kumar et al. 2014) 
The n-hexane extract of Arctium lappa proved highly cytotoxic from 100 µg/ml upwards to 
1000 µg/ml with decreasing cell viabilities from 59.67% to 1.52% respectively (Figure 45). 
Between 5 and 50 µg/ml the cell viability was maintained at over 78% at 50 µg/ml up to 
90.01% at 5 µg/ml, the latter being the safest concentration of AL-Me tested in AREc32 
cells.  
 
Figure 45 Cell viability as percentage to control (0 µg/ml) observed after treatment of AREc32 cells for 24 h 
with AL-He (5-1000 µg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Another n-hexane extract tested for cytotoxicity in AREc32 cells was that of Centaurea 
asiatica (Figure 46), which dropped slowly from 101.96% at 10 µg/ml to 88.25% at 750 
µg/ml. At the highest concentration of 1000 µg/ml CA-Me caused a cell viability of 37.41%. 
Overall, the most suitable concentration for the luciferase assay was considered to be 250 
µg/ml, which maintained a cell viability of over 90%, at 95.47%. 
0
20
40
60
80
100
120
0 5 10 20 50 100 250 500 750 1000 1%
DMSO
C
el
l v
ia
b
ili
ty
 (
%
 c
o
n
tr
o
l)
Concentration (µg/ml)
Cytotoxicity of Arctium lappa n-hexane extract on AREc32 cells
  
108 
 
 
Figure 46 Cell viability as percentage to control (0 µg/ml) observed after treatment of AREc32 cells for 24 h 
with CA-He (10-1000 µg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Figure 47 shows the cytotoxicity profile of the n-hexane extract of Centaurea kirdigensis 
which recorded a minimum cell viability of 55.35% at the highest concentration of 1000 
µg/ml. However, at 50 µg/ml CK-He maintained a cell viability of 99.99%, making it the most 
suitable candidate dose for the luciferase assay.   
 
Figure 47 Cell viability as percentage to control (0 µg/ml) observed after treatment of AREc32 cells for 24 h 
with CK-He (10-1000 µg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
The n-hexane extract of Centaurea pamphylica, CP-He, maintained a steady decrease in 
cell viability from 106.22% at 5 µg/ml to 79.44% at 250 µg/ml (Figure 48). A sharp decrease 
then followed from 79.44% to 26.04% cell viability at 500 µg/ml CP-He, going as low as 2.8% 
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at the highest concentration of 1000 µg/ml. Ultimately, CP-He was tested for luciferase 
activity at 20 µg/ml (93.06% cell viability). 
 
Figure 48 Cell viability percentage to control (0 µg/ml) observed after treatment of AREc32 cells for 24 h with 
CP-He (10 - 1000 µg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Equisetum arvense recorded a decrease in cell viability from 104.94% at the lowest 
concentration of 5 µg/ml to 21.61% cell viability at the highest concentration of 1000 µg/ml 
(Figure 49). The steepest decrease in cell viability was noted between the concentrations 
500 µg/ml and 750 µg/ml, of 32%. 
 
Figure 49 Cell viability percentage to control (0 µg/ml) observed after treatment of AREc32 cells for 24 h with 
EA-He (5-1000 µg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
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At 250 µg/ml dose of EA-He the cell viability was slightly below 90%, at 89.75 µg/ml, so that 
the next lower concentration of 100 µg/ml maintained a cell viability of 92.83% and it was 
most suitable for use in the AREc32 luciferase assay. 
Furthermore, Figure 50 shows that GP-He, the n-hexane extract of Gypsophila pilulifera 
maintained a high cell viability between 10 µg/ml and 100 µg/ml, of around 100%, with 96.20% 
at 100 µg/ml. From 250 µg/ml to 1000 µg/ml the cell viability of AREc32 cells was strongly 
affected by GP-Me, decreasing from 38.70% to 3.69% cell viability. Thus, the 100 µg/ml 
concentration was chosen for the luciferase assay (96.20%). 
 
Figure 50 Cell viability percentage to control (0 µg/ml) observed after treatment of AREc32 cells for 24 h with 
GP-He (10-1000 µg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates). 
The n-hexane extract of Gardenia ternifolia, GT-He, caused a steady decrease in cell 
viability (Figure 51), from 94.54% to 84.82% between the lowest concentration of 5 µg/ml 
going up 50 µg/ml. A steep decrease to 38.32% at 100 µg/ml followed, after which the 
cytotoxicity became more pronounced, causing a cell viability of 10.94% at the highest 
concentration of 1000 µg/ml. Thus the concentration suitable for the luciferase assay was 
10 µg/ml (99.79%). 
 
0
20
40
60
80
100
120
0 10 20 50 100 250 500 750 1000 1%
DMSO
C
el
l v
ia
b
ili
ty
 (
%
  c
o
n
tr
o
l)
Concentration (µg/ml)
Cytotoxicity of Gypsophila pilulifera n-hexane extract on 
AREc32 cells
  
111 
 
 
Figure 51 Cell viability percentage to control (0 µg/ml) observed after treatment of AREc32 cells for 24 h with 
GT-He (5-1000 µg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates). 
HO-He, the n-hexane extract of Hyssopus officinalis, also showed a steady cell viability 
from the starting dose of 5 µg/ml to 100 µg/ml, between 92.98% and 93.95%, respectively. 
Marked cytotoxicity was noted between the doses of 250 µg/ml and 1000 µg/ml, where the 
cell viability dropped further from 63.30% to 4.50%. Therefore, the non-cytotoxic 
concentration of 100 µg/ml was used in the subsequent luciferase assay (Figure 52). 
 
Figure 52 Cell viability percentage to control (0 µg/ml) observed after treatment of AREc32 cells for 24 h with 
HO-He (5-1000 µg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
As it can be observed in Figure 53 below, the n-hexane extract of Kitaibelia balansae 
showed significant cytotoxic properties against AREc32 cells at doses between 250 µg/ml 
and 1000 µg/ml, as the cell viability was measured at maximum 2.88% and 1.50% 
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respectively. However, only at 5 and 10 µg/ml was the cell viability over 90%, with 94.23% 
cell viability noted at 10 µg/ml, which was the chosen concentration for the luciferase assay. 
 
Figure 53 Cell viability percentage to control (0 µg/ml) observed after treatment of AREc32 cells for 24 h with 
HO-He (5-1000 µg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Figure 54 below shows the cytotoxicity produced by SA-He, the n-hexane extract of 
Solanum anguivi, in AREc32 cells. SA-He caused cell viabilities between 121.76% and 
97.80% at concentrations between 5 µg/ml and 100 µg/ml. A sudden drop in cell viability 
from 109.45% (100 µg/ml) to 53.95% cell viability (250 µg/ml) was then noted, followed by 
markedly high cytotoxicity, driving the cell viability to less than 9.86% at concentrations 
between 500 and 1000 µg/ml. Overall, the safest concentration of SA-He to be used in the 
luciferase assay was 100 µg/ml. 
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Figure 54 Cell viability percentage of control (0 µg/ml) observed after treatment of AREc32 cells for 24 h with 
SA-He (5-1000 µg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates). 
Finally, the n-hexane extract of Ziziphus mucronata, ZM-He, showed a steady decrease in 
cell viability (Figure 55), from 103.61% to 36.05%, as concentrations decreasing from 5 to 
1000 µg/ml. The non-cytotoxic concentration of ZM-He chosen for the subsequent 
luciferase assay was 100 µg/ml, which caused a viability of 94.05%, before decreasing to 
81.60% at 250 µg/ml. 
 
Figure 55 Cell viability percentage of control (0 µg/ml) observed after treatment of AREc32 cells for 24 h with 
ZM-He (5-1000 µg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates). 
Lastly, the final n-hexane extract tested for cytotoxicity in AREc32 cells was CD-He, the n-
hexane extract of Centaurea dichroa. Having observed from previous MTT assays that the 
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n-hexane extracts would exert high cytotoxicity at concentrations higher than 500 µg/ml, the 
range of concentrations was lowered to 1 – 500 µg/ml. 
Figure 56 below shows that CD-He affected the cell viability of AREc32 to 90.08% at the 
lowest concentration of 1 µg/ml, before decreasing it to 56.01% at the highest concentration 
of 500 µg/ml. Because the second lowest concentration of CD-He, 5 µg/ml, also maintained 
a cell viability of over 90% (90.78% cell viability), this was eventually considered the most 
suitable concentration for further luciferase assay tests. 
 
Figure 56 Cell viability as percentage to control (0 µg/ml) observed after treatment of AREc32 cells for 24 h 
with CD-He (1-500 µg/ml). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
All the n-hexane extracts of the selected plants were screened for Nrf2/ARE induction at 
non-cytotoxic concentrations.using AREc32 cells after a 24 h treatment. The results are 
presented in Figure 57 below. 
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Figure 57 Effect of n-hexane extracts on the induction of luciferase activity and tBHQ as positive control. 
AREc32 cells were incubated for 24 h with non-cytotoxic concentrations of AL-He, CA-He, CD-He, CK-He, 
CP-He, EA-He, GP-He, GT-He, HO-He, KB-He, SA-He and ZM-He. DMSO represents the vehicle control and 
its concentration is expressed as v/v%. Values show mean +/- SEM (n=3, 3 replicates), control=1. 
 
One n-hexane extract was noted for exhibiting a very high potential of Nrf2/ARE activation, 
namely SA-He, showing a 20.2-fold to control luciferase induction.  
The other n-hexane extracts tested showed a luciferase induction of less than half of that 
of the induction recorded for the positive control tBHQ, of 6.32-fold. The Gypsophila 
pilulifera n-hexane extract exhibited the second highest luciferase induction of 3.08-fold, 
followed by the n-hexane extract of Kitaibelia balansae with 3.03-fold to control induction. 
The only other n-hexane extract that achieved a luciferase induction of more than 2-fold 
was that of Gardenia ternifolia, GT-He, with a 2.05-fold to control induction.  
AL-He, CA-He, CD-He, CK-He, CP-He, EA-He, HO-He, ZM-He did not show a significant 
luciferase induction, with results of maximum 1.9-fold to control.  
Ultimately the analysis was constrained by the lack of crude extract needed for VLC (at 
least 2 g) and the lack of plant raw material for a new Soxhlet extraction. 
Apart from SA-He, no other non-polar crude extract exhibited a luciferase fold induction of 
over 20%. Although, GP-He and KB-He did show a fold induction of approximately 3-fold to 
control, which indicates a potential for Nrf2/ARE activation. 
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3.2.4  Cytotoxicity and luciferase assay results for compounds precipitated during 
the Soxhlet extraction of Gypsophila pilulifera, Gardenia ternifolia and Ziziphus 
mucronata 
One of the precipitates, GPS1, resulted from the methanol extraction of Gipsophila pilulifera 
and a second compound, GTS1/GTS2, precipitated out of solution during the methanol 
extraction of Gardenia ternifolia. These compounds were pure and they were tested on 
AREc32 cells using the MTT assay at a range of concentrations between 0.625 and 40 µM. 
For structural characterisation details see Study 4 in Section 3.4. 
The cell viability was consistently high (140.8% to 96.4%, n=3, 4 replicates) over a range of 
concentrations between 5 and 40 µM. The compounds were then tested at 40 µM in the 
luciferase assay where no significant results in Nrf2 induction were recorded. Cell viabilities 
exceeding 100% could be due to uneven seeding of cells, causing the control to have a 
lower value, relative to which cell viabilities were calculated.  
On the other hand, the precipitate, ZMPH1, resulted from the n-hexane extraction of 
Ziziphus mucronata was tested in the MTT assay at concentrations starting at 0.625 µM 
(Figure 58). Cell viabilities decreased steadily from 95.9% to 62.3% as the concentration 
increased to 40 µM, and the concentration of 2.5 μM, which was responsible for 92.6% cell 
viability, was considered non-cytotoxic at an appropriate level for the luciferase assay. 
 
Figure 58 Cell viability as percentage of control (0 mg/ml) observed after treatment of AREc32 cells for 24 h 
with betulinic acid (0.625-40 μM). DMSO represents the vehicle control and its concentration is expressed as 
v/v%. Results show the mean +/- SEM (n=3, 4 replicates) 
Betulinic assay exhibited an Nrf2 induction of 1.08-fold to control (SEM = 0.075, n = 3, 3 
replicates) and was considered not to be capable of up-regulating the Nrf2/ARE signaling 
pathway. 
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3.3  Study 3: Chromatographic fractionation of bioactive crude methanol extracts 
of Centaurea dichroa (CD), Centaurea pamphylica (CP), Gardenia ternifolia (GT) and 
Ziziphus mucronata (ZM), followed by cytotoxicity assay and luciferase assay using 
AREc32 cells and DPPH assay of fractions   
Guided by the results of Study 2, methanol extracts that showed significant Nrf2 induction 
levels were further fractionated using appropriate chromatographic separation techniques. 
The fractions obtained were assayed again using the luciferase assay using AREc32 cells 
in order to measure Nrf2 induction. 
As all n-hexane extracts showed insignificant luciferase activity, further purification was 
performed only on the methanol extracts of Centaurea dichroa (CD-Me), Centaurea 
pamphylica (CP-Me), Gardenia ternifolia (GT-Me) and Ziziphus mucronata (ZM-Me). 
Methanol extracts were fractionated by solid phase extraction (C18) with a step gradient of 
methanol in water (%MeOH/H2O): 20% - F1 (fraction 1), 50% - F2 (fraction 2), 80% - F3 
(fraction 3) and 100% - F4 (fraction 4). Fractions of solvent mix containing dissolved 
phytochemicals were collected in flasks, evaporated and reconstituted with culture medium 
to be used in the cytotoxicity and luciferase assays using AREc32 cells.  
Fractions F1 always resulted in a higher amount, 200-300 mg, following solid phase 
extraction of 1 g of starting material, while fractions F2 and F3 were separated with a much 
a lower weight of around 40 to 100 mg. Fractions F4 weighed between 10 and 40 mg with 
an overall recovery of the extraction of approximately 40%. 
 
3.3.1  Cytotoxicity results for methanol fractions of Centaurea dichroa (CD-Me), 
Centaurea pamphylica (CP-Me), Gardenia ternifolia (GT-Me) and Ziziphus mucronata 
(ZM-Me) in AREc32 cells 
The experiment was performed three times and results were recorded for three wells for 
each repetition of the experiment. No DMSO was required at this stage, as samples 
solubilised readily in the culture medium at 37˚C using a sonication bath.
The methanol extract sample of Centaurea dichroa was received at a later date than the 
preparation of the other extracts; so that after reviewing the MTT assay results of CP-Me 
(Figure 60), GT-Me (Figure 61) and ZM-Me (Figure 59) it could be observed that the 
cytotoxicity of methanol fractions on AREc32 cells from concentrations of 500 µg/ml 
upwards was too high and more useful insight could be found in the range of 1 µg/ml to 500 
µg/ml. The results of the MTT assay of fractions of CD-Me are presented in Figure 59 below. 
 
Figure 59 Cell viability as percentage to control (0 µg/ml) observed after treatment of AREc32 cells for 24 h 
with CD-Me fractions (1-500 µg/ml). Results show the mean +/- SEM (n=3, 3 replicates). 
Fraction F1 of CD-Me at 10 µg/ml was determined appropriate for further luciferase assay 
as it caused a 102% cell viability, the first concentration lower than 500 µg/ml to maintain a 
cell viability of over 90%. 
Fractions F2, F3 and F4 of CD-Me maintained cell viabilties of 97% and 90% -  F2 at 100 
µg/ml, F3 and F4 at 50 µg/ml. These were concentrations chosen for further luciferase 
assay. 
All four fractions of CP-Me caused a sustained decrease in cell viability at concentrations 
increasing from 20 to 1000 µg/ml as shown in Figure 60, with F2 CP-Me showing the 
steepest decrease, from 95% to 12%. 
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Figure 60 Cell viability as percentage to control (0 µg/ml) observed after treatment of AREc32 cells for 24 h 
with CP-Me fractions (20-1000 µg/ml). Results show the mean +/- SEM (n=3, 3 replicates). 
The non-cytotoxic dose of F1 CP-Me was determined to be 500 µg/ml (95% cell viability), 
for F2 was 50 µg/ml (91%), for fraction F3 it was 250 µg/ml (93% cell viability) and for 
fraction F4 the appropriate concentration was determined to be 750 µg/ml (92% cell 
viability). 
GT-Me fractions behaved in a similar fashion causing a decrease in cell viability at 
concentrations increasing from 20 to 1000 µg/ml as shown in Figure 61, but with fraction 
F4 showing a significant decrease from 116% to 16%, whereas the other fractions 
maintained a cell viability of over 40% at the highest dose. 
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Figure 61 Cell viability as percentage to control (0 µg/ml) observed after treatment of AREc32 cells for 24 h 
with fractions of GT-Me (20-1000 µg/ml). Results show the mean +/- SEM (n=3, 3 replicates). 
Therefore, fraction F4 of GT-Me at 50 µg/ml proved to be a safe concentration to use in the 
luciferase assay, as well as fractions F1 and F3 at 500 µg/ml and fraction F2 at 250 µg/ml 
(over 90% cell viability). 
Figure 62 shows the cytotoxicity profile of the methanol fractions of the bioactive Ziziphus 
mucronata methanol extract. As discussed previously in Section 3.2.2, when the methanol 
extract ZM-Me was assessed for cytotoxicity in AREc32 cells, this bioactive extract also 
readily reduces the MTT in the culture medium to formazan, so that, as expected, the extract 
fractions behaved similarly, especially F2, F3 and F4, indicating cell viabilities of over 145% , 
112% and 166% even at the lowest concentration of 20 µg/ml.  
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Figure 62 Cell viability as percentage to control (0 µg/ml) observed after treatment of AREc32 cells for 24 h 
with ZM-Me fractions (20-1000 µg/ml). Results show the mean +/- SEM (n=3, 3 replicates). 
Therefore, given the known capacity of methanol fractions of ZM-Me to exhibit falsely low 
cytotoxicity, the concentrations to be used in the luciferase assay were determined as one 
step lower than the information presented in the graph. So that F1 was best to use in 
AREc32 cells luciferase assay at 50 µg/ml (91%) according to the graph. F3 caused a cell 
viability of 95% at 750 µg/ml, which continued upwards as the dose decreased, so it was 
chosen as a safer concentration for the luciferase assay. 
Fractions F2 and F4 were least cytotoxic over the entire range of 20 µg/ml to 1000 µg/ml 
(Figure 62), so the concentration used in the subsequent luciferase assay was 1000 µg/ml 
for both fractions, as they exhibited cell viabilities of 114.67% and 142.85% respectively. 
Following the MTT assay, each fraction was tested in the luciferase assay at the appropriate 
non-cytotoxic concentration and the results are presented in the next section. All 
phytochemical samples were prepared in warm culture medium before each experiment.  
 
3.3.2  Luciferase assay results for methanol fractions of Centaurea dichroa (CD-Me), 
Centaurea pamphylica (CP-Me), Gardenia ternifolia (GT-Me) and Ziziphus mucronata 
(ZM-Me) 
Figure 65 below shows that fractions F2 and F3 of the methanol extract of Centaurea 
dichroa (20 µg/ml) exhibited the highest induction of luciferase activity, which is linked to 
the activation of Nrf2/ARE signaling pathway in AREc32 cells. These methanolic fractions 
caused an increase in fold to control induction of 3.7 and 5.5, respectively.  
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The positive control tBHQ caused a 6.4-fold to control increase in luciferase activity, 
whereas Fraction 1 and Fraction 4 of CD-Me showed the lowest luciferase induction with 
1.3-fold and 1.3-fold to control, respectively. Fractions F2 and F3 showed low to medium 
luciferase induction, 3.7 and to 5.5-fold, respectively (Figure 63). 
 
Figure 63 Effect of fractions of Centaurea dichroa methanol extract on the induction of luciferase activity and 
of tBHQ as positive control. AREc32 cells were incubated for 24 h with non-cytotoxic concentrations of CD-
Me. Values show mean +/- SEM (n=3, 3 replicates), control=1. 
CP-Me fractions showed, in Figure 66 below, the highest increase in luciferase activity than 
all other Centaurea species tested, with F3 (500 µg/ml) and F4 (750 µg/ml) reaching 
induction folds of 12.5 and 13.4, respectively. Fraction 2 (50 µg/ml) exhibited a medium 
induction of luciferase with 6.4-fold to control increase, close to the 5.6-fold to control 
induction reached by the positive control tBHQ (at least 50% lower than the highest fold 
induction recorded by Fraction 3 and Fraction 4 of CP-Me).  
 
Figure 64 Effect of fractions of Centaurea pamphilica methanol extract on the induction of luciferase activity 
and of tBHQ as positive control. AREc32 cells were incubated for 24 h with non-cytotoxic concentrations of 
CP-Me. Values show mean +/- SEM (n=3, 3 replicates), control=1. 
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GT-Me fractions exhibited similar results (Figure 65) with F3 (500 µg/ml) and F4 (100 µg/ml) 
reaching high induction folds of 11.6 and 12.6, respectively. These results are also almost 
50% higher than the induction achieved by the positive control tBHQ, of 5.6-fold to control 
luciferase activity induction. 
On the other hand, fractions F1 (500 µg/ml) and F2 (250 µg/ml) of GT-Me exhibited a low 
level of Nrf2 induction with 1.1 and 2.9-fold to control (Figure 65). 
 
Figure 65 Effect of fractions of Gardenia ternifolia methanol extract on the induction of luciferase activity and 
tBHQ as positive control. AREc32 cells were incubated for 24 h with non-cytotoxic concentrations of GT-Me. 
Values show mean +/- SEM (n=3, 3 replicates), control=1. 
The methanol fractions of ZM-Me did not show any significant fold increase in luciferase 
activity (Figure 66), with fraction F2 (1000 µg/ml) exhibiting the highest fold to control 
induction of 2.3-fold, compared to the positive control induction of 5.6-fold to control 
induction. 
 
Figure 66 Effect of fractions of Ziziphus mucronata methanol extract on the induction of luciferase activity and 
tBHQ as positive control. AREc32 cells were incubated for 24 h with non-cytotoxic concentrations of ZM-Me. 
Values show mean +/- SEM (n=3, 3 replicates), control=1. 
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3.3.3  DPPH assay results for bioactive methanol fractions of Centaurea dichroa 
(CD-Me), Centaurea pamphylica (CP-Me), Gardenia ternifolia (GT-Me) and Ziziphus 
mucronata (ZM-Me) 
The methanol fractions of the above mentioned plant species that showed high fold 
induction in the luciferase assay in AREc32 were also tested in the DPPH assay to check 
their potential as free radical scavengers. Quercetin was used as positive control in every 
experiment. 
Because the fractions F4 of the methanol extracts identified previously as bioactive (CP-Me 
and GT-Me) did not reach a 50% inhibition of DPPH, these results were not shown. 
Figure 67 below shows the dose dependent inhibition of DPPH by fractions F3 of bioactive 
methanol extracts of Centaurea dichroa, Centaurea pamphylica and Gardenia ternifolia, as 
well as that of quercetin. 
 
Figure 67 %Inhibition of DPPH by fractions F3 of methanol extracts of Centaurea dichroa, Centaurea 
pamphylica, Gardenia ternifolia and the positive control quercetin at concentrations between 0.0001 and 1 
mg/ml. Graph shows the average values of triplicate experiments. 
In Figure 67, fractions F3 of GT-Me and CD-Me both reached 50% inhibition of DPPH 
between 0.1 and 1 mg/ml concentrations, whereas fraction  F3 of CP-Me reached the same 
level of inhibition at a lower concentration, between 0.01 and 0.1 mg/ml. The positive control 
quercetin achieved 50% inhibition of DPPH somewhere between 0.001 and 0.01 mg/ml.  
Fractions F3 of GT-Me and CD-Me were further investigated for free-radical scavenging 
activity at 1-fold dilutions between the concentrations identified previously. So that Figure 
68 shows that the IC50 values for these two plant extracts would be between 0.1 and 0.2 
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mg/ml, almost 40 times higher than the positive control quercetin with IC50 of 0.005 mg/ml 
(Figure 70). 
 
Figure 68 Graph showing the %inhibition of DPPH by CD-Me and GT-Me at 1-fold dilutions between 0.1 and 
0.01 mg/ml. Graph shows the average values of duplicate experiments 
The IC50 of fractions F3 of GT-Me and F3 CD-Me were calculated as 0.132 mg/ml and 0.230 
mg/ml, respectively. 
Fraction F3 of CP-Me was further assayed at concentrations between 0.01 and 0.1 and 
Figure 69 shows the concentration-dependent profile of percentage DPPH inhibition. 
Moreover, the IC50 value for F3 of CP-Me was determined to be 0.072 mg/ml. 
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Figure 69 Graph showing the %inhibition of DPPH by CP-Me at 1-fold dilutions between 0.1 and 0.01 mg/ml. 
Graph shows the average values of duplicate experiments 
Figure 70 shows the concentration-dependent inhibition of DPPH exhibited by positive 
control quercetin between the concentrations of 0.001 and 0.01 mg/ml, which indicates an 
IC50 of 0.005 mg/ml. 
 
Figure 70 Graph showing the %inhibition of DPPH by quercetin at 1-fold dilutions between 0.001 and 0.01 
mg/ml. Graph shows the average values of duplicate experiments. 
Out of the six fractions of methanol extracts tested for free-radical scavenging activity, 
fraction F3 of Gardenia ternifolia methanol extract produced a 50% inhibition of DPPH at 
the lowest concentration, namely 0.132 mg/ml, 66 times higher than the IC50 of 0.005 mg/ml 
achieved by the positive control quercetin.  
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3.4 Study 4: Identification of compounds from bioactive fractions of methanol 
extracts by means of UV-Vis, nuclear magnetic resonance (NMR) and mass 
spectrometry (MS) analysis 
Fractions F2 and F3 of Centaurea dichroa, fractions F2, F3 and F4 of Centaurea pamphylica 
and F3 and F4 of Gardenia ternifolia methanol extracts were found to be most bioactive in 
terms of Nrf2 induction in the luciferase assay and they were subjected to preparative HPLC 
for isolation and purification of compounds. The purest compounds isolated were then 
analysed using NMR and MS techniques.  
The aim was to characterise novel structures of phytochemicals from the plant species 
screened, but also to test the ability of individual compounds to modulate the Nrf2/ARE 
signaling pathway in AREc32 cells. However, the starting material consisting of methanol 
extracts and subsequent fractions was not sufficient for isolation of pure compounds for cell 
based assays, with the exception of F3 GT-Me-P4/PA. 
 
3.4.1 Structural characterisation of compounds precipitated during Soxhlet 
extraction 
3.4.1.1  Structural characterisation of GPS1 as stachyose 
One of the precipitates, GPS1, resulted from the methanol extraction of Gypsophila pilulifera, 
was identified as stachyose (Figure 71), as one of the most common tetrasaccharides 
commonly found in woody plants, which is involved in storage and transport of sugar 
(Avigad and Dey, 1997).  
 
Figure 71  Chemical structure of stachyose C24H42O21, 666 g/mol. 
  
128 
 
The NMR spectra of GPS1 indicate the formula of Stachiose (Appendix A.1):  
[Gal(a1-6)Gal(a1-6)Glc(a1-2b)Fru 
aka 
O-α-d-Galactopyranosyl-(1→6)-[O-α-d-galactopyranosyl-(1→6)]2-O-α-d-glucopyranosyl-
(1→2) β-d-frutofuranoside ]. 
The chemical shift values in both 1H-NMR and 13C-NMR spectra are in agreement with the 
ones reported in the literature by MyIntyre and Vogel (1989) and Youssef et al (2016). 
For the GPS1 precipitate assignments were based on comparison to the literature data and 
the correlations presented by the 1H, COSY, HSQC, HMBC and DEPTQ experiments 
presented in Appendix A.1. Figure 74 depicts the assignments. 
1H-NMR (D2O, d, ppm) spectra: 
Overlapped anomeric protons can be observed, at 4.95 (m, 2H, glycosidic); 5.40 (d, H 
glycosidic). 
Peaks in the 3.4 - 4.18 ppm domain represent all the other protons (non-anomeric). While 
the chemical shift range is very narrow, causing signal overlapping, this region is identical 
to the ones observed in catalogues and reported literature. 
13C-NMR (D2O, d, ppm spectra): 
Peaks at 61.14, 61.45, 62.46, 65.87 and 66.48 ppm may be assigned to C atoms in the -
CH2-O- groups found in positions 6 in galactose and glucose pyranosic rings and the 1 and 
6 positions in the fructose furanosic ring. 
Peaks at 68.30, 68.45, 68.79, 69.24, 69.51, 70.29, 70.98, 71.28, 72.39, 72,56, 72.73, 74,01, 
76.37, 81.35 ppm may be assigned to C atoms in the >CH-O- groups. 
Peaks at 92.10, 98.37 and 98.03 ppm may be assigned to the three anomeric C atoms in 
the pyranose rings, while the 103.8 ppm value is clearly attributed to the unique quaternary 
C atom, the fructose anomeric C-2 atom. The chemical shifts of all anomeric carbon atoms 
show greater values due to the deshielding produced by the oxygen atoms in the acetal > 
C(-O-)2 bonds. 
NMR assignments for GPS1 precipitate, as well as a comparison between the GPS1 NMR 
assignments (in black) and those reported in literature for stachyose are presented in Figure 
72 (MyIntyre and Vogel, 1989). 
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Figure 72 GPS1 experimental NMR assignments (in black) compared to those for stachiose in literature (blue 
and magenta in the image) 
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3.4.1.2  Structural characterisation of GTS1/GTS2 as mannitol 
Similarly, another compound, GTS1/GTS2, precipitated out of solution during the methanol 
extraction of Gardenia ternifolia and was identified as mannitol. See the chemical structure 
in Figure 73.  
 
Figure 73 Chemical structure of mannitol 
 
The [M-H]-  ion at m/z 181.05 confirmed the molecular formula C6H14O6. The molecular 
weight of mannitol is 180 g/mol. For MS spectra see Appendix A.2. 
From the NMR spectra it could be observed that in D2O, the primary alcohol groups (CH2OH) 
show more shielded values for the chemical shifts of the methylene group (3.4 ppm), while 
the CH protons in the CH-OH groups show less shielded chemical shifts in the 3.5 - 3.62 
ppm interval. 
The same relation "shielded-deshielded" is also apparent in the 13C spectra: the primary C 
atoms show peaks at 65 ppm (more shielded), while the peaks at 70 - 72 ppm can be 
assigned to the less shielded CH-OH carbon atoms.  
The identification of the GTS1/GTS2 precipitate as mannitol was attempted by comparing 
the chemical shifts recorded (see NMR spectra in Appendix A.2) to the values reported in 
the literature by Voelter et al (1970) and to those from chemical compounds and spectra 
online databases, such as chemicalbook and molbase. 
The proposed assignments of the GTS precipitate as mannitol are shown in Figure 74, 
compared to those from literature. More literature information is presented in Figure 75. 
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Figure 74 1H and 13C assignments for mannitol (upper left) based on NMR spectra presented in Appendix 
A.2; 1H and 13C assignments for mannitol (lower right) based on NMR spectra from literature 
 
 
 
Figure 75 1H and 13C assignments for mannitol from online catalogues. 
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3.4.1.1  Structural characterisation of ZMPH1 as betulinic acid 
The precipitate ZMPH1, resulted from the n-hexane extraction of Ziziphus mucronata, was 
identified as betulinic acid (Figure 76). 
 
Figure 76 Chemical structure of betulinic acid 
 
The MS spectrum of ZMPH1 showed a pseudomolecular ion [M-H]- at m/z 455.33, indicative 
of the formula of betulinic acid, C30H48O3, with the molecular weight, 456 g/mol.  
For NMR and MS spectra see Appendix A.3. 
The ZMPH1 precipitate was identified as betulinic acid based on the 1H and 13C NMR 
spectra and on the 2D correlation experiments and comparison of the chemical shift values 
taken into account for the complete assignment of the NMR peaks to the carbon and H 
atoms as reported in literature (Berger, 2009, p. 481).  
The spectra showed most 1H NMR signals in the range 0.6 ppm – 4.70 ppm and intensely 
overlapping peaks could be observed, especially in the 1.0 – 2.3 ppm region. 
Based on the HSQC, HMBC experiments and the comparison with literature information, 
the following assignments could be made (in black for 1H/black bold for 13C, see Figure 77 
below): 
 4.70 ppm, broad singlet, 1.5 Hz, 1H for the proton at C29 in cis-configuration with 
the C30 methyl group, noted as Ha, and 4.57 ppm, broad singlet for the C29-Hb 
proton in trans relation with the C30 methyl group; 
 4.24 ppm, broad singlet, 1H, attributed to C3-H; 
 2.92 ppm, multiplet, 1H, to C19-H; 
 peaks at 0.67 ppm, 0.78 ppm, 0.90 ppm,0.93 ppm and 1.24 ppm are assigned to 
protons in the methyl groups C23  -  C27. 
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13C NMR spectra also showed chemical shifts values that were in agreement with the 
literature and with the DEPTQ experiment (see Appendix A.3). These values are presented 
in bold black font in Figure 77. Values reported in the literature for 13C, by  Berger and Sicker 
(2009), are presented in bold magenta font. 
 
 
Figure 77 1H and 13C assignments for betulinic acid based on NMR data recorded for ZMPH1 (in black) and 
on NMR data from literature (blue and magenta; Berger and Sicker, 2009) 
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3.4.2  Structural characterisation of compounds isolated from bioactive methanol 
fractions  
 
3.4.2.1   Isolation of compounds from F3 CDME 
The most bioactive methanol fraction of Centaurea dichroa was subjected to preparative 
HPLC and a separation of main compounds absorbing at 290 nm was observed (see Figure 
78).  
 
Figure 78 Preparative HPLC chromatogram of F3 CD-Me (30% to 90% MeOH in H2O gradient solvent 
system, 200 µL injection) 
For Peak 1 noted in Figure 80 above, the highest absorbing values were strongest for Band 
I and lowest for Band II, as shown in Figure 79. 
 
 
1    2
 
2 
3 
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Figure 79 UV spectrum of Peak 1 of F3 CD-Me  
Peaks 2 and 3 exhibited very similar UVmax values, although Peak 3 eluted at a much lower 
intensity, 50 mAU, compared to over 200 mAU for Peaks 1 and 2.  
See UV spectra of Peak 2 (tR =20.793 min) and Peak 3 (tR =22.233 min) in Figures 80 and 
81, respectively, as compound eluted. 
 
Figure 80 UV spectrum of Peak 2 of F3 CD-Me  
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Figure 81 UV spectrum of Peak 3 of F3 CD-Me  
 
Isolation of F3CDMe-P2  
A first compound that was isolated and showed good chromatographic separation was 
assigned the code name F3 CD-Me-P2 and it eluted at tR=13.365 min, showing UVmax 
values of 270 nm, 336 nm, identical to the UV spectrum observed in the mixture of F3CD-
Me for Peak 2 (Figure 82). 
 
Figure 82 Analytical chromatogram of isolated compound F3CD-Me-P2, with the UV spectrum recorded on 
Agilent 1260 in methanol:water gradient solvent system. 
The NMR spectra did not confirm a chemical structure for the possible molecular weight of 
300 g/mol suggested by the MS results in Figure 83. 
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Figure 83 MS spectrum of F3CD-Me-P2 
 
Isolation of F3CD-Me-P3 
A second compound isolated from F3CD-Me eluted at tR=14.5 min and its UV spectrum 
revealed high absorbtion peaks at 274 nm and 336 nm (Figure 84), typical of flavonoids and 
identical to the UV spectrum of Peak 3 of F3CD-Me chromatogram. 
 
Figure 84 Analytical HPLC chromatogram of isolated compound F3CDMe-P3 in methanol/water solvent 
system with gradient; 10 mg/ml. 
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The NMR spectra did not confirm a chemical structure for the possible molecular weight of 
314 g/mol suggested by the MS results in Figure 85. 
 
Figure 85 MS spectrum of F3CD-Me-P3 
 
3.4.2.2   Isolation of compounds from F3 CP-Me 
Because fraction F4 CP-Me yielded only 42.6 mg, an appropriate HPLC method for isolation 
could not be developed, given the complex mix of semi-polar compounds present in the 
methanol fraction. 
The F3 CP-Me chromatogram (Figure 86) showed some separation between compounds 
using the standard gradient method and five main compounds were observed, of which 
compound P7 showed the best separation . 
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Figure 86 Preparative HPLC chromatogram for F3 CP-Me 
 
Isolation of F3 CP-Me-P5 
After isolation from F3CP-Me, F3CP-Me-P5 eluted at tR=15.6 min in the same solvent 
system in the analytical HPLC. Figure 87 below shows the chromatogram and the UV 
spectrum with peak absorbtion at 266 nm and 340 nm, typical of flavones or flavonols 
(Mabry, Markham and Thomas, 1970, p. 41-164). 
Figure 87 Analytical HPLC chromatogram of F3CPME-P5, 1 mg/ml 
One step in elucidating the structure of F3 CP-Me-P5 was to compare its analytical HPLC 
chromatogram to that of apigenin, using the same standard gradient method of 30% to 100% 
methanol in water over 30 min (injection volume of 20 µL).  
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The chromatogram in Figure 90 below shows that the concentration of apigenin was higher 
than that of F3CP-Me-P5 and it affected the cut-off point at 2500 mAU for the second peak 
(Band I). 
 
Figure 88 Analytical chromatogram of apigenin, 10 mg/ml 
Because only 2.5 mg of F3CP-Me-P5 was isolated from F3CP-Me using preparative HPLC, 
further studies for structural elucidation or assays for bioactivity could not be carried out. 
 
Isolation of F3 CP-Me-P7(IV) 
A second compound, F3CPME-P7(IV), was isolated and purified from F3 CP-Me and Figure 
91 shows the analytical chromatogram of F3CP-Me-P7(IV) in the standard solvent system. 
 
Figure 89 Analytical HPLC chromatogram of F3CP-Me-P7(IV) and recorded UV spectrum 
 
 
Apigenin (Sigma) 
tR = 15.247 min 
UV max: 266 nm, 336 nm 
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3.4.2.3  Isolation and characterisation of compounds from F3 GT-Me 
The preparative HPLC chromatogram of F3 GT-Me (Figure 90) shows the presence of two 
main compounds with retention times of 17.171 min and 19.981 min, respectively. 
 
 
Figure 90 Preparative HPLC chromatogram for F3 GT-Me 
After isolation, the weight of these compounds was 43.4 mg and 32.6 mg respectively, and 
the analytical HPLC chromatograms confirmed they were more than 90% pure (Figures 93 
and 97). 
Structural characterisation of F3 GT-Me-P4/PA 
The analytical HPLC chromatogram of F3 GT-Me-P4/PA showed a pure compound with a 
retention time of 11.15 min, almost 6 min faster than the tR of the same compound in the 
fraction mixture (Figure 91). The UV spectrum confirmed a possible isoflavone, flavanone 
or dihydroflavonole structure, according to Mabry, Markham and Thomas (1970, p.165-226), 
with a strong signal for Band II (around 280 nm) and a small shoulder for Band I. 
 
Figure 91 Analytical HPLC chromatogram for F3 GT-Me-P4/PA, 1 mg/ml 
1 – 17.171 min, F3 GT-Me-PA 
2 – 19.981 min, F3 GT-Me-PB 
 
254 nm 
310 nm 1 2 
1 
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F3GTME-P4/PA was identified as the flavanone sakuranetin (Figure 92). 
 
Figure 92 Chemical structure of sakuranetin C16H14O5, 286 g/mol 
 
The MS data showed a molecular ion [M-H]-  at m/z 285.07, which is compatible with the 
formula C16H14O5 for sakuranetin and the molecular weight of 286 g/mol. The NMR spectra 
also confirmed the identity. See supplemental material in Appendix B.1. 
The 1H and 13C NMR spectra confirm precipitate F3GT-Me-P4/PA as sakuranetin (Appendix 
B.1). 
The values of the chemical shifts identified in the NMR spectra were also compared to 
literature data produced by Grecco et al (2014), Mabry et al (2012, p. 330) and Agrawal 
(1989). The assignments are depicted in Figure 93, while Figure 94 shows the literature 
assignments. 
The 1H-NMR spectrum (CD3OD, 400 MHz) revealed the CH3-O signals at δ = 3.80 ppm (s, 
3H) and also a singlet at 6.04 ppm(2H), corresponding to the C6 and C8 protons. The C2 
H is a dd at 5.36 ppm (1H) since this proton couples with each of the C3 protons (J = 13.0 
and 3.0 Hz), and the two geminal protons at C3 (Ha and Hb) present dd-s at 2.71 ppm and 
3.14 ppm respectively. The two chemical shift values are different due to the deshielding 
produced by the aromatic ring on the space neighbouring Hb. The Ha proton shows J = 17.2 
Hz as geminal coupling with Hb and J = 3 Hz for the coupling with H at C2.The Hb proton  
shows a J = 13 Hz coupling constant with C2 proton. 
In the phenol ring B, protons 2’ and 6’  and protons 3’ and 5’  are equivalent. The former 
show a dd signal, (2H) at 7.32 ppm, J = 8.0Hz, due to the coupling with the vicinal protons. 
The 13C NMR spectra (CD3OD, 400 MHz) showed peaks around δ 56.28 for the methoxy 
group, 165.27, 164.25, 159.11 ppm for aromatic C atoms in positions 7, 5, 8a deshielded 
by neighbouring O atoms. Also deshielded C atoms C4, C2, C-1'  and C4’ have assigned 
ppm values of 198.25, 80.64, 130.97, 169.58 ppm respectively. The chemical shifts and the 
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coupling values in the spectra are consistent with the structure of sakuranetin (5,4'-
dihydroxy-7-methoxyflavanone). 
 
Figure 93 Experimental NMR assignments for F3GT-Me-P4/PA as sakuranetin 
 
 
 
 
Figure 94 NMR assignments presented in literature for sakuranetin (in blue or magenta depending on source; 
references in text) 
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Isolation of F3 GT-Me-PB/P6 
The isolated compound F3-GT-Me-PB eluted at 11.6 min, almost 9 minutes sooner than its 
elution time from the mixture F3 GT-Me (Figure 90). Figure 95 shows the analytical 
chromatogram after isolation. 
 
Figure 95 Analytical HPLC chromatogram for F3 GT-Me-PB/P6, 1 mg/ml 
The UV spectrum showed two intense peaks corresponding to Band II, at 265 nm and for 
Band I at 366 nm, indicating the presence of a flavanone or flavonol (Figure 96). 
 
 
 
 
 
 
  
 
 
 
 
Figure 96 UV spectrum of Peak 2 as F3 GT-Me-PB/P6 
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3.5  Study 5: Cytotoxicity assay and luciferase assay in AREc32 cells of selected 
polyphenolic compounds: apigenin, genkwanin, hesperetin, hispidulin, kaempferol, 
luteolin, naringenin, quercetin, sakuranetin and velutin. 
The flavonoids apigenin, genkwanin, hesperetin, hispidulin, kaempferol, luteolin, naringenin, 
quercetin, sakuranetin and velutin were tested in AREc32 cells for toxicity using the MTT 
assay in order to identify a non-cytotoxic concentration (≥90% cell viability) of each 
phytochemical compound to then be able to safely check their potential to activate the 
Nrf2/ARE signaling pathway, which translates into a measurable increase of luciferase 
activity in the luciferase reporter assay. 
3.5.1 Cytotoxicity assay results for selected polyphenolic compounds: apigenin, 
genkwanin, hesperetin, hispidulin, kaempferol, luteolin, naringenin, quercetin, 
sakuranetin and velutin 
Apigenin below (Figure 97) registered consistent cell viabilities of over 65% within 1 and 50 
µM (94.39%-74.84%); and the concentration considered appropriate for the luciferase 
assay was 10 µM, which exerted a cell viability of 92.93% 
 
Figure 97 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h 
with apigenin (1-50 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Genkwanin (Figure 98) showed a gradual loss of cell viability as the concentration of 
treatment increased from 1 µM to 50 µM, from 92.72% to 43.40% cell viability respectively. 
The most appropriate dose for further luciferase assay was identified as 1 µM, as this was 
the only dose that did not affect the cells beyond 90% cell viability, while the next dose up, 
at 5 µM caused a cell viability of 86.70%. 
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Figure 98 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h 
with genkwanin (1-50 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Figure 99 shows that hesperetin was fairly non-cytotoxic to AREc32 at concentrations 
between 1 µM and 40 µM (96.79%-96.48% cell viability), although it did cause a decrease 
to 73.31% cell viability at the highest non-cytotoxic concentration of 40 µM. Hesperetin was 
therefore subsequently tested at the dose of 40 µM in the luciferase reporter assay. 
 
Figure 99 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h 
with hesperetin (1-50 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Hispidulin (Figure 100) shows a range of cell viabilties that reach over 65% after treatment 
at concentrations between 1 µM and 50 µM. However, only the lowest concentration, 1 µM, 
reached a cell viability of over 90%, specifically 93.40%. This was the concentration chosen 
to use for treatment of AREc32 cells to measure luciferase activity linked to the Nrf2/ARE 
activation. 
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Figure 100 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h 
with hispidulin (1-50 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
AREc32 treatment with kaempferol (Figure 101) at concentrations between 1 µM and 40 
µM revealed cell viabilities of over 65%, with the exception of the result of the treatment 
with kapemferol at 50 µM, which caused a very low cell viability of 24.71%. However, at 20 
µM treatment, the cell viability went to 91.43%, before falling to 73.79% following 30 µM 
treatment; therefore the concentration appropriate for the luciferase assay was determined 
to be 20 µM for kaempferol. 
 
Figure 101 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h 
with kaempferol (1-50 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Figure 102 shows the cytotoxicity exerted by luteolin in AREc32 cells over a range of 
dosage from 1 µM to 50 µM, resulting in 92.38% to 66.16% cell viability, respectively. 
Similarly to hispidulin, the most appropriate non-cytotoxic concentration of luteolin to be 
used in further testing was 1 µM. 
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Figure 102 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h 
with luteolin (1-50 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Naringenin (Figure 103) determined a range of cell viabilities starting from 97.64% after 1 
µM treatment to as low as 57.88% after 50 µM overnight treatment.  The concentration that 
determined a cell viability of 92% was 20 µM and it was chosen to be used in the subsequent 
luciferase assay, as the following concentration of 30 µM caused a slightly lower cell viability 
of 87.71%. 
 
Figure 103 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h 
with naringenin (1-50 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Quercetin (Figure 104) produced a decrease in cell viability ranging from 106.4% after 
treatment with 1 µM to 51.84% cell viability after 50 µM treatment. The steepest rise in 
cytotoxicity was marked by a 58.16% cell viability after overnight treatment of AREc32 cells 
with quercetin at 40 µM, noting a fall in cell viability of approximately 31% compared to the 
effect of the 30 µM dose treatment. Overall, the safest concentration of quercetin that could 
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draw forth an effect in the luciferase assay was considered to be 10 µM (94.98% cell 
viability). 
 
Figure 104 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h 
with quercetin (1-50 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Figure 105 below shows the low cytotoxicity capability of sakuranetin in AREc32 cells at 
concentrations between 1 µM and 50 µM (100.29% - 88.59% cell viability). In this case, the 
most appropriate concentration of natural product to be used in the planned luciferase assay 
was 40 µM, which caused a cell viability of 91.70%. 
 
Figure 105 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h 
with sakuranetin (1-50 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Velutin (Figure 106) showed a trend of cytotoxicity increase from 88.31% cell viability at 1 
µM to 34.52% at 50 µM.  Along the range of concentrations tested, only 5 µM was a dose 
that caused a reach over 90% of the cell viability (91.50%) after 24 h treatment. The next 
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concentration of velutin used was 10 µM and caused a 82.77% cell viability, which was 
considered too low so that 5 µM was used to treat cells for the luciferase assay. 
 
Figure 106 Cell viability as percentage to control (0 mg/ml) observed after treatment of AREc32 cells for 24 h 
with velutin (1-50 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Overall, the lowest concentration of flavonoids deemed non-cytotoxic for the luciferase 
assay was 1 µM (genkwanin, hispidulin, luteolin), while most compounds maintained a high 
cell viability at concentratios between 5 µM and 20 µM. The highest concentration of 
flavonoids deemed non-cytotoxic for the luciferase assay was 40 µM, for hesperetin and 
sakuranetin. 
 
3.5.2 Luciferase assay results on AREc32 cells for selected polyphenolic compounds: 
apigenin, genkwanin, hesperetin, hispidulin, kaempferol, luteolin, naringenin, 
quercetin, sakuranetin and velutin 
The relative luciferase activity of the known flavonoids that were selected for testing is 
presented in Figure 107 below. The figure shows that the treatment of AREc32 cells with 
the positive control, the known Nrf2 activator tBHQ, caused a fold increase of 7.9 times than 
in the absence of treatment (control). 
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Figure 107 Effect of various flavonoids on the induction of luciferase activity and tBHQ as positive control. 
AREc32 cells were incubated for 24 h with non-cytotoxic concentrations of apigenin, genkwanin, hesperetin, 
hispidulin, kaempferol, luteolin, naringenin, quercetin, sakuranetin and velutin. DMSO represents the vehicle 
control and its concentration is expressed as v/v%. Values show mean +/- SEM (n=3, 3 replicates), control=1. 
The bioactive phytochemicals tested showed an induction in luciferase activity between 1.1-
fold, for apigenin, to 3.1-fold, for hesperetin. The highest fold-induction of luciferase activity 
was noted for quercetin, kaempferol, sakuranetin, velutin and hispidulin, between 2.5-fold 
for quercetin at 10 µM and 2.3-fold for hispidulin at 20 µM. Kaempferol (20 µM), sakuranetin 
(40 µM) and velutin (5 µM) all caused an induction of 2.4-fold to control.  
Luteolin was previously reported as an inhibitor of the Nrf2/ARE signaling pathway by 
decreasing the Nrf2 expression at mRNA and protein level in A549 cells.(Tang et al. 2011). 
The luciferase activity measured in AREc32 cells after 24 h treatment with luteolin at 1 µM 
was 0.8± 0.05 fold relative to the induction caused by the vehicle control DMSO and was 
found to be Keap1-independent.  
Tang et al (2011) also reported luteolin to cause a dose-dependent reduction in the 
expression of the phase II detoxifying enzimes NQO1 and HO-1 in Caco2 (human colon 
cancer), MCF-7 (human breast cancer) and A549 (human non-small-cell lung cancer) cells. 
Sulforaphane was found to increase the mRNA level of NQO1 and HO-1 in Caco2 cells at 
a dose of 5 µM, but further RT-PCR tests would be necessary to establish if the selected 
flavonoids increase mRNA expression of Nrf2/ARE controlled detoxifying genes. 
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Because the luciferase activity exerted by tBHQ in AREc32 cells in the study by Tang et al 
(2011) was 9.7±0.1 SD fold, and the average of fold induction achieved in this study was 
6.46±0.98 SD. 
Although flavonoids have been the most studied group of compounds amongst polyphenols, 
it is still not fully understood how they manage to exert their effects on the Nrf2/ARE pathway 
in terms of transcriptional activation. However, research indicates that cytoprotective genes 
involved in phase 2 metabolism are largely induced by pro-oxidant compounds, such as 
ROS and electrophiles, and flavonoids, as well as tBHQ, show electrophilic properties (Lee-
Hilz et al. 2006; Pandey and Rizvi, 2009). 
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3.6  Study 6: Determination of NQO1 gene expression induced by selected 
phytochemical compounds 
According to Valerio et al. (2001), treatment of MCF-7 cells with quercetin (15 µM for 24 h) 
resulted in a rise in the expression of the NQO1 gene activity, observed through increased 
luciferase activity, as well as increased NQO1 mRNA expression. The cells had been 
transfected with a reporter gene construct containing copies of the ARE element of the 
human NQO1 gene and it concluded in support of the hypothesis that dietary polyphenols 
increase the expression of phase II enzymes via a mechanism involving the ARE element. 
Therefore, complementary to the luciferase reporter assay screening of extracted and 
selected compounds with various flavonoid structures previously performed with AREc32 
cells in Study 5, these Nrf2 inducers were also examined for their ability to increase the 
expression of NQO1 in MCF-7 cells. 
 
3.6.1  Cytotoxicity assay of bioactive compounds on MCF-7 cells 
In order to establish a safe concentration for the subsequent in vitro studies, all flavonoids 
were first assessed for cytotoxicity using the MTT assay.  
The graphs below (Figures 108 – 117) represent the dose-dependent cell viability of MCF-
7 cells as affected by various flavonoids. 
Quercetin (Figure 108) produced a cell viability of 86.51% at 5 µM, but at 2.5 µM the cell 
viability was higher, at 93.37%. The lowest cell viability was recorded at the highest 
concentration and was 73.36%.  
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Figure 108 Cell viability as percentage to control (0 mg/ml) observed after treatment of MCF-7 cells for 24 h 
with quercetin (2.5 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Apigenin (Figure 109) was also fairly non-cytotoxic when used at the highest concentration 
of 50 µM, resulting in 74.83% cell viability and as the concentration dropped to 5 µM, the 
cell viability went up to 96.03%.  
 
Figure 109 Cell viability as percentage to control (0 mg/ml) observed after treatment of MCF-7 cells for 24 h 
with apigenin (5 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Genkwanin (Figure 110) exhibited the highest and most consistent cytotoxicity in MCF-7 
cells, starting from 10.95% after a treatment of 24 h with 50 µM, only increasing to 51% 
when cells were treated with 5 µM. The following lowest concentration of 2.5 µM caused a 
cell viability of 91.11%. 
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Figure 110 Cell viability as percentage to control (0 mg/ml) observed after treatment of MCF-7 cells for 24 h 
with genkwanin (2.50 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Hesperetin (Figure 111) showed a 24.33% cell viability when used at 50 µM, which 
increased steadily to 93.99% when hesperetin was used for overnight treatment of MCF-7 
cells at 1 µM.  
 
Figure 111 Cell viability as percentage to control (0 mg/ml) observed after treatment of MCF-7 cells for 24 h 
with hesperetin (1 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Figure 112 below shows that the compound hispidulin was fairly non-cytotoxic between 1 
and 40 µM, reaching a cell viability of 94.76% at 2.5 µM treatment. At 50 µM hispidulin 
cased a 14.8% cell viability. 
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Figure 112 Cell viability as percentage to control (0 mg/ml) observed after treatment of MCF-7 cells for 24 h 
with hispidulin (2.5 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Figure 113 shows the cell viability profile created by kaempferol in MCF-7 cells and it was 
consistently high at concentrations applied in the range of 1-50 µM (95.56%-78.47%). 
 
Figure 113 Cell viability as percentage to control (0 mg/ml) observed after treatment of MCF-7 cells for 24 h 
with kaempferol (2.5 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Luteolin (Figure 114) exhibited a steady cytotoxicity profile in MCF-7 cells when used 
between 1 and 50 µM, with cell viabilities dropping from 92.99% to 66.16% at 50 µM. The 
concentration of 2.5 µM of luteolin was considered non-cytotoxic, as it caused a 93.40% 
cell viability. 
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Figure 114 Cell viability as percentage to control (0 mg/ml) observed after treatment of MCF-7 cells for 24 h 
with luteolin (2.5 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Naringenin (Figure 115) was shown to exert high cytotoxicity at the highest concentrations, 
40 µM and 50 µM, of 35.81% and 32.60% respectively. From the next lowest concentration 
of 20 µM the cell viability increased from 65.93% to 94.41% at 2.5 µM, the highest non-
cytotoxic dose. At the lowest concentration of 1 µM naringenin the cell viability was 98.01%. 
 
Figure 115 Cell viability as percentage to control (0 mg/ml) observed after treatment of MCF-7 cells for 24 h 
with naringenin (2.5 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Treatment of MCF-7 cells with sakuranetin (Figure 116) resulted in the highest cell viability 
profile out of all the flavonoids tested. The cell viability varied between 99.28% at the lowest 
concentration of 1 µM and 83.60% at 50 µM.  
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Figure 116 Cell viability as percentage to control (0 mg/ml) observed after treatment of MCF-7 cells for 24 h 
with sakuranetin (20 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Figure 117 below shows the cytotoxicity profile of velutin in MCF-7 cells at concentrations 
between 1 µM and 50 µM (85.85%-74.04%).  
 
Figure 117 Cell viability as percentage to control (0 mg/ml) observed after treatment of MCF-7 cells for 24 h 
with velutin (1-50 µM). DMSO represents the vehicle control and its concentration is expressed as v/v%. 
Results show the mean +/- SEM (n=3, 3 replicates) 
Overall, the cytotoxicity study of flavonoids in MCF-7 cells revealed cancer cytotoxicity 
potential for genkwanin (confirmed in literature), hispidulin, naringenin and hesperetin. 
Genkwanin (20 µM) decreased MCF-7 cell viability to 23% after 24 h treatment and 
hispidulin (50 µM) proved even more cytotoxic, causing 15% cell viability to control. 
0
20
40
60
80
100
120
0 1 2.5 5 10 20 40 50 0.5%
DMSO
C
e
ll 
v
ia
b
ili
ty
 (
%
 c
o
n
tr
o
l)
Concentration (µM)
Cytotoxicity of sakuranetin in MCF-7 cells
0
20
40
60
80
100
120
0 1 2.5 5 10 20 40 50 0.5%
DMSO
C
el
l v
ia
b
ili
ty
 (
%
 c
o
n
tr
o
l)
Concentration (µM)
Cytotoxicity of velutin in MCF-7 cells
  
159 
 
Li et al (2017) reported on the preparation of nanosuspensions of genkwanin, using  D-
alpha tocopherol acid polyethylene glycol succinate, as an effective formulation for a 
anticancer drug. The nanosuspension of genkwanin also showed increased cytotoxicity in 
the following cancer cell lines: HeLa, HepG2, A549, as well as MCF-7, BT-474 and MDA-
MB-453 (human breast cancer cell lines). 
Hispidulin has been shown to have antiproliferative properties against MCF-7 and Hep-2 
cells by Talib et al (2012) with IC50 values of 10 and 19.5 µg/ml. 
In trypan blue exclusion assays, naringenin was shown to have insignificant cytotoxic 
effects on various breast cancer cell lines, with IC50 values higher than 200 µM (Yadegarynia 
et al, 2012). 
Naringenin and sakuranetin were subsequently tested for detection of expression of NQO1 
protein after 24 h treatment with MCF-7 cells. The results are presented in the following 
section. 
3.6.2 Western Blotting results for induction of NQO1 by sakuranetin and naringenin 
The flavanones sakuranetin (20 µM) and naringenin (5 µM) did not induce expression of 
NQO1 protein after 24 h treatment, as compared to the control (untreated MCF-7 cells). 
Figure 120 shows the results of sampling at three time points after treatment: 3 h, 6 h and 
24 h.  
Control samples at time 0 h and 24 h resemble the bands revealed under treatment 
conditions for both compounds used. 
tBHQ as positive control significantly increased the expression of the NQO1 protein after 
24 h treatment with 10 µM, compared to untreated control, causing overexposure in imaging 
(Figure 118, b). 
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Figure 118 Effect of 24 h treatment of MCF-7 cells with (a) sakuranetin and (b) naringenin on NQO1 protein 
expression.  
Western Blotting should be performed for all the bioactive compounds, including a HO1 
antibody that would reveal another detoxifying enzyme at around 33 kDa. The use of 
densitometric analysis of the blots to produce histograms would also provide insight into the 
results, as a quantitative approach. 
Tanigawa et al (2007) show that tBHQ acts to induce Nrf2/ARE by stimulating the 
ubiquitination of Keap 1 protein, which in turn cannot act as a substrate adaptor for 
conjugation with ubiquitin to form a Keap1/Nrf2 complex that would normally remove Nrf2 
and inhibit ARE transcriptional activity.  
Sulforaphane and quercetin, on the other hand, do not promote the ubiquitination of Keap1 
(Zhang et al, 2005).  
Moreover, as tBHQ is a synthetic Nrf2 inducer which acts by creating oxidative stress via 
redox cycling, which is a distinct mechanism of Nrf2/ARE activation than that of the 
flavonoid quercetin or the organosulfur compound sulforaphane, the positive control for 
future studies with phytochemicals should be a Nrf2-promoting compound typical for the 
class of compounds screened. In detail, because tBHQ can undergo modifications that lead 
to the formation of reactive oxygen species, this causes the disruption of Nrf2 degradation 
process via Keap1 and promote its binding instead with the ARE transcriptional elements 
in the nucleus. 
It was also noticed that the results were in agreement with the low Nrf2 induction levels 
sakuranetin and naringenin demonstrated in AREc32 cells (see Section 3.5.2), with 2.4 and 
1.4-fold to control induction, respectively.  
a 
b 
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3.7  Study 7: Effect of selected flavonoids on ethacrynic acid-induced oxidative 
stress in MCF-7 cells 
Flavonoids of similar structures to compounds isolated from GT-Me, CD-Me and CP-Me 
were previously screened for Nrf2 induction potential using AREc32 cells, finding a 
maximum of 3-fold induction (see Study 5). Subsequent experiments were carried out to 
evaluate the NQO1 gene expression in un-transfected MCF-7 cells. The cell line was 
selected based on its feature of overexpressing the Nrf2 transcription factor (Zhang et al, 
2016).  
Furthermore, using the same cell line, the cytoprotective potential of the flavonoids was 
challenged again by examining if they can provide protection against the oxidative stress 
inducer ethacrynic acid (ETA). The flavonoids apigenin, genkwanin, hesperetin, hispidulin, 
kaempferol, luteolin, naringenin, quercetin, sakuranetin and velutin were applied at non-
cytotoxic concentrations determined in Study 6. 
Figure 119 below shows the cytotoxicity profile of ETA in MCF-7 cells in vitro as a graph of 
cell viability (%) against ETA concentrations (µM), starting from 3.125 µM, dose which 
resulted in 93.58% cell viability, and going up to 1000 µM, causing a cell viability of 3.62%. 
 
Figure 119 Cell viability as percentage to control (no treatment) observed after treatment of MCF-7 cells for 24 
h with ethacrynic acid (3.125-1000 µM). Results of the MTT assay show the mean of 3 experiments (n=3, 2 
replicates). 
In the experimental conditions applied it was estimated that the median lethal dose of ETA 
in MCF-7 cells was 68.5 µM. Also to be noted is that the cytotoxicity of ETA lowered the cell 
viability to less than 90% starting from 25 µM and at 50 µM it decreased to 65.57%. 
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Figure 120 below shows the protection against ETA-induced cytotoxicity exerted by tBHQ, 
which was the positive control used throughout the bioassay-guided investigation as 
chemopreventive agent/Nrf2 inducer. MCF-7 cells pre-treated with tBHQ at 10 µM showed 
no cytotoxicity effect at the lowest dose of ETA (3.125 µM). The cell viability decreased to 
71.63% after ETA treatment at the highest concentration of 1000 µM. The highest dose of 
ETA caused a cell viability 68% higher than in cells without pre-treatment. 
MCF-7 cells were treated with 10 µM of tBHQ overnight before applying ETA at a range of 
concentrations. Figure 120 below shows the results of the cytotoxicity profile of ETA in 
pretreated cells, as well as in cells without pretreatment. 
 
Figure 120 Cell viability as percentage to control (no treatment) observed after pre-treatment of MCF-7 cells 
for 24 h with tBHQ (10 µM) and ethacrynic acid (3.125-1000 µM). Results of the MTT assay show the mean of 
2 experiments (total n=6). P<.0001, significant difference between the cytotoxicity of ETA in pretreated cells 
and the cytotoxicity of ETA alone. 
The absolute LD50 of ETA in pretreated cells was 2463 µM, almost 36 times higher than the 
LD50 exhibited in cells without pretreatment. 
Apigenin (Figure 121) also exerted a protective effect against ETA in MCF-7 cells, 
maintaining the cell viability at the highest dose of 1000 µM ETA at 53.17%, an increase of 
almost 50% than in the absence of pre-treatment. However, the lowest dose of ETA, 3.125 
µM, caused a decrease in cell viability to 74.97%.  
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Figure 121 Cell viability as percentage to control (no treatment) observed after pre-treatment of MCF-7 cells 
for 24 h with apigenin (5 µM) and ethacrynic acid (3.125-1000 µM). Results of the MTT assay show the mean 
of 2 experiments (total n=6). P<.0001, significant difference between the cytotoxicity of ETA in pretreated cells 
and the cytotoxicity of ETA alone. 
Genkwanin (Figure 122) also showed cytoprotective effects against ETA, causing an 
increased cell viability at the highest dose of ETA, from 4% to 60.7%. However, at the lowest 
doses of ETA, pretreated cells showed a lowered cell viability (around 80%) that of cells 
without genkwanin pretreatment. The LD50 of genkwanin was calculated at 5384 µM, more 
than 70 times higher than the LD50 of ETA in cells without pretreatment. 
 
Figure 122 Cell viability as percentage to control (no treatment) observed after pre-treatment of MCF-7 cells 
for 24 h with genkwanin (2.5 µM) and ethacrynic acid (3.125-1000 µM). Results of the MTT assay show the 
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mean of 2 experiments (total n=6). P<.0001, significant difference between the cytotoxicity of ETA in 
pretreated cells and the cytotoxicity of ETA alone. 
Pretreatment of MCF-7 cells with hesperetin at a dose of 1 µM offered good protection 
against the oxidative stress caused by ETA, with cell viabilities decreasing from 100.25% 
to 48.3%, increasing the LD50 of ETA almost 10 times, to 661 µM (Figure 123). 
 
Figure 123 Cell viability as percentage to control (no treatment) observed after pre-treatment of MCF-7 cells 
for 24 h with hesperetin (1 µM). and ethacrynic acid (3.125-1000 µM). Results of the MTT assay show the 
mean of 2 experiments (total n=6). P<.0001, significant difference between the cytotoxicity of ETA in 
pretreated cells and the cytotoxicity of ETA alone. 
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When cells were pretreated with hispidulin at 2.5 µM, the LD50 of ETA increased to 2248 
µM, from 68.5 µM, when measured in cells without pretreatment. Hispidulin maintained the 
cell viability up to 61.9%, decreasing from 97.6% (Figure 124). 
 
Figure 124 Cell viability as percentage to control (no treatment) observed after pre-treatment of MCF-7 cells 
for 24 h with hispidulin (2.5 µM) and ethacrynic acid (3.125-1000 µM). Results of the MTT assay show the 
mean of 2 experiments (total n=6). P<.0001, significant difference between the cytotoxicity of ETA in 
pretreated cells and the cytotoxicity of ETA alone. 
Kaempferol (2.5 µM) provided good cytoprotection against ETA at doses of 50 µM and up 
to 150 µM, maintaining  the cell viability at over 80% in this range. The most cytotoxic range 
of ETA was 100 µM  to 1000 µM and kaempferol counteracted the effects of ETA resulting 
in cell viabilities between 92.50% and 62.98%, respectively (Figure 125). Moreover, the 
LD50 of ETA after kaempferol pre-treatment was more 46 times higher than that of ETA 
alone. 
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Figure 125 Cell viability as percentage to control (no treatment) observed after pre-treatment of MCF-7 cells 
for 24 h with kaempferol (2.5 µM) and ethacrynic acid (3.125-1000 µM). Results of the MTT assay show the 
mean of 2 experiments (total n=6). P<.0001, significant difference between the cytotoxicity of ETA in 
pretreated cells and the cytotoxicity of ETA alone.  
Pre-treatment of MCF-7 cells with luteolin (Figure 126) at 2.5 µM offered protection against 
the effects of ETA, maintaining the cell viability slightly over 50% (52.63%) at the highest 
dose of ETA of 1000 µM. The LD50 of ETA in cells pretreated with luteolin was 2094 µM, 30 
times higher that that of ETA alone. 
 
Figure 126 Cell viability as percentage to control (no treatment) observed after pre-treatment of MCF-7 cells 
for 24 h with luteolin (2.5 µM) and ethacrynic acid (3.125-1000 µM). Results of the MTT assay show the mean 
of 2 experiments (total n=6). P<.0001, significant difference between the cytotoxicity of ETA in pretreated cells 
and the cytotoxicity of ETA alone. 
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Figure 127 below shows the cytotoxicity profile of ETA in MCF-7 cells at a range of 
concentrations from 3.125 to 1000 µM, alongside its nonlinear cytotoxic profile in cells 
pretreated with naringenin (2.5 µM). Pretreatment with naringenin lowered the cell viability 
to 56.5%. 
 
Figure 127 Cell viability as percentage to control (no treatment) observed after pre-treatment of MCF-7 cells 
for 24 h with naringenin (2.5 µM) and ethacrynic acid (3.125-1000 µM). Results of the MTT assay show the 
mean of 2 experiments (total n=6). P<.0001, significant difference between the cytotoxicity of ETA in 
pretreated cells and the cytotoxicity of ETA alone. 
Figure 128 shows the cell viability response (%) in MCF-7 cells produced by one-time 
treatment with ETA, with and without pretreatment with sakuranetin at a dose of 20 µM. 
Sakuranetin exhibited cytoprotection in MCF-7 cells against ETA at concentrations higher 
than 25 µM. Pretreatment with sakuranetin maintained the cell viability at 90% with 25 µM 
ETA, decreasing to 62% at 1000 µM ETA.  
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Figure 128 Cell viability as percentage to control (no treatment) observed after pre-treatment of MCF-7 cells 
for 24 h with sakuranetin (20 µM) and ethacrynic acid (3.125-1000 µM). Results of the MTT assay show the 
mean of 2 experiments (total n=6). P<.0001, significant difference between the cytotoxicity of ETA in 
pretreated cells and the cytotoxicity of ETA alone. 
MCF-7 cells pre-treated with velutin (2.5 µM) proved more resistant metabolically to 
treatment with ETA for 24 h at a range of concentrations between 3.125 µM and 1000 µM, 
compared to treatment with ETA alone (Figure 129). Having decreased the cell viability to 
66.5% at the highest dose of ETA, the LD50 of ETA increased with applied pretreatment of 
velutin to 15496 µM, from 68.5 µM.  
 
Figure 129 Cell viability as percentage to control (no treatment) observed after pre-treatment of MCF-7 cells 
for 24 h with velutin (2.5 µM) and ethacrynic acid (3.125-1000 µM). Results of the MTT assay show the mean 
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of 2 experiments (total n=6). P<.0001, significant difference between the cytotoxicity of ETA in pretreated cells 
and the cytotoxicity of ETA alone. 
Table 16 depicts an overview of the LD50 values recorded for ETA in MCF-7 cells pretreated 
with a selected flavonoid, tBHQ, as well as in cells without pretreatment. Overall, all 
flavonoids applied as pretreatment increased the LD50 of ETA, used in the range of 3.125-
1000 µM, at least 9 times (hesperetin, 1 µM) compared to ETA alone (68.5 µM).  
Table 16 Overview of LD50 of ethacrynic acid after pre-treatment with various flavonoids and without 
pretreatment 
Compounds for pre-
treatment and dose 
ETA LD50 (µM) 
w/ pre-treatment w/o pre-treatment 
Hesperetin 1 µM 661 
68.5 µM 
Naringenin 2.5 µM 1038 
Apigenin 5 µM 1468 
Luteolin 2.5 µM 2094 
Hispidulin 2.5 µM 2248 
tBHQ 10 µM 2463 
Kaempferol 2.5 µM 3171 
Genkwanin 2.5 µM 5384 
Sakuranetin 20 µM 10891 
Velutin 2.5 µM 15496 
 
The results show that with the exception of pre-treatment with hesperitin and hispidulin, all 
flavonoids tested caused a lower cell viability at the lowest concentration of ETA in the 
range tested than with ETA alone.  
However, all pre-treatments with flavonoids resulted in significant protection against the 
cytotoxic effects of ETA applied at doses of 50 µM and higher.  
Overall, 24-hour pre-treatment of MCF-7 cells with velutin, kaempferol, sakuranetin, 
hispidulin and genkwanin, maintained a cell viability of more than 60% and up to 66.51% in 
the case of velutin, when followed by treatment with ETA at the highest dose of 1000 µM. 
Pre-treatment with naringenin, apigenin and luteolin caused final cell viabilities between 53% 
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and 57%, whereas pre-treatment with hesperetin yielded the lowest cell viability, 48%, in 
the presence of ETA at the highest concentration of 1000 µM.  
One inference would be that ETA increased the accumulation of reactive oxygen species 
intracellularly and the process was inhibited by the flavonoids tested by reacting in a ROS 
scavenging manner and deactivating the ROS molecules. Hence, the flavonoids could have 
acted in a non-enzymatic way to remove the oxidative agents by reducing them to stable 
products (Ahmadinejad et al, 2017).  
In addition, for the investigation of the cytoprotective effects of flavonoids it is relevant to 
consider the presence of metal ions, such as copper and iron, in the experimental setup. 
These metals have the capability to chelate and the flavonoids could enhance the DNA 
damage done by reactive oxygen species  (Nimse and Pal, 2015).   
Talalay et al. (1983) proposed that compounds which contain a Michael acceptor or from 
which a Michael acceptor can be formed during metabolism, are usually inducing agents 
for GST. A Michael reaction represents the addition via conjugation of a carbon anion or 
another carbon nucleophile, also called a Michael donor, to the carbon of a α, β – 
unsaturated compound, called a Michael acceptor. Michael acceptors are olefinic 
compounds conjugated with electron-withdrawing groups that can interact with nucleophilic 
compounds such as cysteine, lysine or serine (Kumar et al, 2014). 
Considering that flavonoids also present electron-donating properties (electrophilic feature) 
and can undergo oxidation to quinones or semiquinones (usually when presenting a 
catechol moiety, which is an example of a α, β – unsaturated structure), they may cause a 
direct modification to Keap1, by oxidation of its cysteine residues, resulting in Nrf2 release 
and relocalisation (Lee-Hilz et al, 2006).  
ETA acts as a reversible inhibitor of GST, the flavonoids tested could act by competing with 
ETA. Moreover, ETA also forms a ETA-GSH conjugate that is considered primarily 
responsible for the inhibition of GST (Awasthi et al, 1993; Oakley et al, 1997). The high 
cytoprotective effect shown by the flavonoids tested against ETA could also indicate that 
the flavonoids may interact with the ETA-GSH conjugate, disrupting it from inhibiting GST 
activity. 
So far it has been shown that polyphenols and sulfur-containing dietary compounds act as 
positive modulators for regulation of detoxifying enzymes and they can trigger various 
signaling cascades to contribute to the accumulation of the Nrf2 protein in the nucleus 
increasing the expression of detoxifying enzymes (Chen et al. 2004). 
  
171 
 
For example, the 5,6,7-trihydroxyflavone and the 3,3′,4′,5,7-pentahydroxyflavone are two 
highly hydroxylated flavonoids, namely baicalein and quercetin. These compounds were 
shown to have a capacity to modulate the Nrf2/Keap pathway by preventing the 
ubiquitination and proteasomal degradation of the Nrf2 protein (Tanigawa et al, 2007 and 
Qin et al, 2014). 
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CHAPTER 4 Conclusions and recommendations for future work 
For each study presented and discussed in Chapter 3, the conclusions and 
recommendations for future work for each investigational step are presented in this chapter. 
Final conclusions of the bioassay-guided investigation into the cancer chemopreventive 
properties of selected non-dietary plants and selected flavonoids close the chapter. 
The selection of plants were subjected to Soxhlet solvent extraction with n-hexane and 
methanol and the crude extracts were screened for Nrf2 induction potential using a AREc32 
cell-based luciferase gene reporter assay, as well as for free-radical scavenging activity 
using the DPPH assay.  
 
4.1  Conclusions of Study 1  
Natural products were extracted from a selection of plants and an initial phytochemical 
screening on the crude extracts was performed. 
Overall, all methanol extracts showed a mixture of compounds during the TLC screening at 
254 nm and 366 nm, with the exception of GP-Me, SA-Me and ZM-Me, which revealed only 
one prominent compound. 
It was noted that AL-Me and ZM-Me were the samples with the highest free-radical 
scavenging activity in the DPPH assay, with an IC50 almost 25 times lower than the positive 
control quercetin of 0.002 mg/ml. The third most bioactive crude extract was GT-Me, 
followed by EA-Me, CP-Me and SA-Me with IC50 values between 0.344 and 0.398 mg/ml. 
 
4.2  Conclusions of Study 2 
The n-hexane extract of Solanum anguivi (SA-He, 100 µg/ml) caused a high Nrf2 activity of 
20.2-fold to control.  
However, the highest increase in Nrf2 induction was achieved by the methanol extract of 
Centaurea dichroa (CD-Me, 250 µg/ml) with a 22.7-fold to control induction. The Nrf2/ARE 
signaling pathway was also up-regulated by two other methanol extracts, of Centaurea 
pamphylica (CP-Me, 100 µg/ml) and Gardenia ternifolia (GT-Me, 750 µg/ml), with 11.2-fold 
and 9-fold to control luciferase induction, respectively.  
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Furthermore, the luciferase assay results of n-hexane extracts showed only one strong Nrf2 
inducer. After 24 h treatment of AREc32 cells with the Solanum anguivi extract (SA-He) at 
100 µg/ml, Nrf2 activity was increased 20.2-fold to control.  
The MTT assays performed pointed out that the use of natural products for in vitro assays 
can pose a few problems, including poor water solubility of non-polar mixtures of 
phytochemical compounds. To this end, the solvent DMSO can be used effectively as 
vehicle medium for non-polar crude extracts at maximum 1% v/v per well for extract 
concentrations below 100 µg/ml. 
 
4.3  Conclusions of Study 3 and recommendations for future work 
The bioassay guided investigation led to further fractionation of the bioactive methanol 
extracts and indicated that the less polar fractions, F2-F4, were responsible for the highest 
Nrf2 induction in the extract mixture. The most polar fractions, F1, showed low bioactivity 
values, between 1 and 3.4-fold. CD-Me fractions F2 and F3 of medium polarity caused 
luciferase inductions between 3.7 and 5.5-fold to control, respectively, which was four times 
lower than the induction exerted by the CD-Me methanol extract. 
Also, CP-Me fractions F3 and F4 increased Nrf2/ARE activity over 10-fold and up to 13.4-
fold (max. 11.2-fold for CP-Me), whereas GT-Me fractions F3 and F4 reached luciferase 
activity inductions of over 10-fold, one-fold higher than the induction achieved by GT-Me. 
 
4.4  Conclusions of Study 4 and recommendations for future work 
The compounds precipitated during the Soxhlet extraction were identified as stachyose 
(GP-Me), mannitol (GT-Me) and betulinic acid (ZM-He). 
The compounds isolated from the bioactive methanol fractions of Centaurea dichroa, 
Centaurea pamphylica and Gardenia ternifolia indicated flavonoid type structures, but 
because of limited starting material, various types of flavonoids such as flavones, 
flavanones and flavonols were eventually purchased with the purpose of screening them 
for Nrf2 activity in AREc32.  
Compound F3GT-Me-P4/PA was identified as sakuranetin based on NMR and MS spectra 
and to date it has not been reported as a component of Gardenia ternifolia Schumach. & 
Thonn.  
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Compounds were isolated from the bioactive methanol fractions by means preparative 
HPLC. The chromatographic separation of peaks during prep HPLC allowed for UV-Vis 
spectral data to be recorded and it showed that all the compounds isolated with highest 
purity were flavonoids, as indicated by the two major wavelength intervals of their UVmax 
values: 240 nm – 280 nm (Band II) and 300 nm – 340 nm (Band I). The lowest wavelength 
interval, Band II, corresponds to the absorption of components of the A-ring system, 
whereas the second wavelength interval is observed because of the B-ring absorption 
pattern (Mabry, Markham and Thomas 1970, p.41). 
Mass spectrometry, using a liquid chromatograph (LC) inlet with electrospray ionisation 
mode (ESI), was used as a complementary tool for structure elucidation in both positive and 
negative ionisation modes. The first-order mass spectra gave insight into the molecular 
masses of flavonoid aglycones mainly, by detecting protonated, [M+H]+, or deprotonated 
base peak molecular ions [M-H]- (Fossen and Andersen, 2006). 
Future work is recommended in order to improve the structural characterisation process. 
Ensuring sufficient amounts of starting material as a prerequisite is one solution. This way 
more analyses could be performed, such as MS, LC-MS/MS and NMR spectroscopy using 
different solvents, such as DMSO and CDCl3, as well as infrared spectroscopy, to determine 
the functional groups in the molecule. 
 
4.5  Conclusions of Study 5 and recommendations for future work 
The flavonoids tested increased the Nrf2-mediated luciferase activity in AREc32 cells to no 
more than 3.1-fold, with most of them reaching slightly above 2-fold induction. To test for 
their capacity to exert effects as a result of synergistic mechanisms, the flavonoids should 
be tested together in the luciferase assay in various ratios and structural combinations e.g. 
two flavonols together vs one flavonol and one flavone together.  
The flavonoids tested in the Nrf2/luciferase assay should also be tested in the DPPH assay 
that was performed for the crude extracts and subsequent fractions. Such a test would 
inform the hypothesis that a high free-radical scavenging ability of phytochemicals 
correlates with a low Nrf2 induction in the luciferase assay and further relationships between 
bioactivity levels of flavonoids, composition, concentration and chemical structure can be 
studied. 
Future work could also be done to increase the robustness of the phytochemical isolation 
method by adding extra steps to the solvent reflux extraction with solvents of intermediary 
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polarity between those of n-hexane and methanol e.g. DCM. This could allow for isolation 
of more compounds and possibly a better chromatographic separation. The DCM extract, if 
Nrf2 inducing, could be screened using a TLC system (n-hexane:ethylacetate). Testing a 
third extract for Nrf2 induction could also increase specificity of the bioassay-guided 
investigation into non-dietary phytochemicals. Using an extraction procedure with 
petroleum ether instead of n-hexane would also be an option, as reported by Chima et al 
(2014). 
 
4.6  Conclusions of Study 6 and recommendations for future work 
In the immunoblotting assay flavanones sakuranetin and naringenin showed no significant 
expression of NQO1 compared to the untreated control after 24 h treatment, which was a 
finding consistent with the low Nrf2 induction recorded for these compounds in the luciferase 
assay presented in Study 5.  
Because Nrf2 and Keap1 rarely mutate in cancer cells (Taguchi, Motohashi and Yamamoto, 
2011), this constitutes an advantage for future investigations into the activity of Nrf2 in 
cancer cell lines and solid tumours to understand the mechanisms by which various types 
of compounds can exert a positive modulation or inhibition of the phase II detoxification 
phase of metabolism via the Nrf2/ARE signaling pathway.  
Moreover, future investigations are also required in order to try to establish the risk for 
carcinogenesis induced by chronic exposure of healthy cells to Nrf2 inducers. Studying how 
the Nrf2/ARE signaling pathway becomes susceptible to regulation by natural products of 
various chemical structures is an important domain of research that adds up to the field of 
cancer chemoprevention and cancer research which aims to control and treat cancers as a 
deadly disease. 
 
4.7  Conclusions of Study 7 and recommendations for future work 
AREc32 cells pre-treated with flavonoids (apigenin, genkwanin, hesperetin, hispidulin, 
kaempferol, luteolin, naringenin, quercetin, sakuranetin and velutin) showed significantly 
higher cell viability after 24 h, compared to cells treated with ETA alone. 
Observing the significant cytoprotective effects of flavonoids against ETA-induced oxidative 
stress at various concentrations, TUNEL assays for quantification of DNA fragmentation 
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could be performed in order to determine the DNA protective effects of the bioactive 
fractions identified in Study 3 and the resulting compounds. 
4.8  Final conclusions and recommendations for future work 
Plants have always been an invaluable source of bioactive compounds with a plethora of 
properties such as antioxidant, free-radical scavening, cytotoxic, anti-inflammatory and also 
anti-viral and anti-microbial (Nijveldt et al, 2001).  
The phytochemical isolation process was robust and efficient in pointing towards the 
direction of bioactive mixture of compounds or individual compounds. Out of twelve plants 
used as starting material in the bioassay-guided investigation, three demonstrated 
bioactivity in terms of Nrf2 induction in AREc32 cells.  
In terms of free-radical scavenging potential, fraction F3 of CP-Me (80% MeOH/water) 
showed the lowest IC50, of 0.072 mg/ml, followed by F3 GT-Me.  
Furthermore, as a result of the DPPH assays, it was observed that mixtures or compounds 
with high potential for DPPH free-radical scavenging also showed low potential for Nrf2 
induction in AREc32 cells. Thus, all flavonoids should be further assayed for DPPH 
inhibition to have a better picture over the possible inverse relationship between various 
cancer chemopreventive properties of phytochemicals. 
Further work is necessary in order to isolate and identify the compounds in the most 
bioactive extract identified, in terms of Nrf2 induction quantification, namely the methanol 
extract of Centaurea dichroa. Testing to find the most efficient composition of flavonoids  
that is able to ellicit a cancer chemopreventive response would also be useful. A chemical 
profiling of the bioactive extract and fractions could be performed, using HPLC coupled to 
MS, with a solvent system of methanol:acetic acid:water (Ferrante et al, 2019). This 
qualitative composition fingerprint could also help identify phytochemicals.  
The bioassay-guided investigation also revealed that the most non-polar methanol fractions 
(F3 and F4) of Centaurea pamphylica and Gardenia ternifolia were most bioactive in terms 
of luciferase activity induction in AREc32 cells. Further research should be carried out to 
characterise the mixture of compounds in fractions F4 (100% MeOH). 
Moreover, flavonoids tested (apigenin, genkwanin, hesperetin, hispidulin, kaempferol, 
luteolin, naringenin, quercetin, sakuranetin and velutin) did not show significant Nrf2 
induction and this was in part confirmed by the immunoblotting of NQO1, where the 
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flavanones naringenin and sakuranetin did not alter the protein levels of NQO1 following 
treatment as compared to control. 
However, the cytotoxic potential of genkwanin, naringenin and hispidulin against the breast 
cancer cell line MCF-7 has been confirmed following treatment with concentrations lower 
than 50 µM. 
The flavonoids tested also showed cytoprotective effects in MCF-7 cells as a result of ETA-
induced oxidative stress. Pre-treatment of MCF-7 cells with the selected flavonoids showed 
potential for further testing in more cell lines, such as primary cells. Their potential for 
protection against DNA damage should also be assessed, as well as for the bioactive 
fractions identified in the luciferase assay (F3 and F4 of CP-Me and GT-Me). 
The effects of Nrf2 inducers on various tissues are not entirely known yet and further studies 
are required, while clinical trials are underway for assessing the outcome of the Nrf2/ARE 
pathway activation in obesity, the progression of type 2 diabetus and cardiovascular disease 
such as atherosclerosis (da Costa et al, 2019).  
Because most studied phytochemical compounds are sourced from dietary plants, studying 
the effects of non-dietary extract mixtures and compounds on various tissues could prove 
insightful with regards to the wealth of knowledge necessary for successful management of 
chronic disease and cancer chemoprevention strategies. 
In conclusion, the studies performed in this bioassay-investigation showed and confirmed 
the potential for the various plant extracts and flavonoids to exert cancer chemopreventive 
effects by increasing Nrf2 induction, but more work is needed to support health applications 
for these bioactive natural products. A more focused approach to understanding the 
pharmacokinetics of natural products and flavonoids in particular could lead to a better 
understanding of the bioavailability and metabolism of flavonoids, as well as of the 
pharmacological effects they exert in their dual role as antioxidants/free radical-scavengers 
and cell signalling modulators. Further studies on the mechanisms of action of flavonoids 
in various cancer cell lines, as well as in primary cell cultures, and evaluating their effect on 
the regulation of redox homeostasis at the various stages of tumorigenesis, could support 
the development of novel strategies for cancer chemoprevention, management and 
treatment. 
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Appendices 
Appendix A  NMR and MS spectra of precipitated compounds 
Appendix A.1 NMR and MS data for precipitate GPS1 as stachyose 
 
 
Figure 130 +H NMR spectrum of GPS1 
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Figure 131 DEPTQ experiment spectrum of GPS1 
 
Figure 132 COSY experiment spectrum of stachyose 
 
  
198 
 
 
Figure 133 HSQC experiment spectrum of stachyose 
 
Figure 134 HMBC experiment spectrum of stachyose 
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Appendix A.2  NMR and MS data for precipitate GTS1/GTS2 
 
Figure 135  +H NMR spectrum of mannitol isolated after filtration of GT methanol extract 
 
Figure 136 +H NMR spectrum of mannitol isolated after evaporation of GT methanol extract 
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Appendix A.3  NMR and MS data for precipitate ZMPH1 
 
 
Figure 137 +H NMR spectrum of betulinic acid 
 
Figure 138 Expansion of +H NMR spectrum of betulinic acid 
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Figure 139 DEPTQ experiment spectrum of betulinic acid 
 
Figure 140 HSQC experiment spectrum of betulinic acid 
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Figure 141 HMBC experiment spectrum of betulinic acid 
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Appendix B NMR and MS data for isolated compounds from Gardenia ternifolia 
Schumach.& Thonn. (GT-Me) 
Appendix B.1 NMR and MS data for compound F3-GT-Me-PA (aka F3GTME-
PA/F3GTME-P4) 
 
Figure 142 Proton NMR spectrum of F3GT-Me-P4/PA 
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Figure 143 Proton NMR spectrum of F3GT-Me-P4/PA 
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Figure 144 +H NMR spectrum of F3 GT-Me-P4 
 
 
Figure 145 COSY experiment spectrum for F3GT-Me-P4/PA 
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Figure 146 13C NMR spectrum of F3 GT-Me-P4/PA 
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Figure 147 HSQC experiment spectrum of F3 GT-Me-P4/PA 
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Figure 148 MS spectrum for F3 GT-Me-P4/PA (data entry error for sample name displayed at the top of 
spectrum) 
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Figure 149 MS spectrum for F3 GT-Me-P4/PA (data entry error for sample name displayed at the top of 
spectrum) 
 
Figure 152 MS results for F3 GT-Me-P4/PA (data entry error for sample name displayed at the top of 
spectrum) 
